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Summary
Dirofilaria immitis is a parasitic nematode that infects dogs and causes cardiopulmonary 
disease. Members from both the closely related avermectin and milbemycin classes (the 
AMs) o f anthelmintics are used in the preventative treatment o f D. immitis infection. These 
drugs are able to kill larval stages o f the nematode but are ineffective at killing the adult 
worms. Both classes appear to target the glutamate-gated chloride channels (GluCls), which 
are neurotransmitter receptors closely related to the GABAa- and glycine-gated chloride 
channels. The objective o f this project was to isolate and characterise GluCls from D. 
immitis, in an attempt to address why the AMs exhibit such contrasting potencies towards 
the larval and adult stages o f the parasite.
Two cDNAs have been cloned that encode candidate D. immitis GluCl subunits. Based on 
homology searches, the subunits appear to be orthologues o f the alternatively spliced 
GluCla3A and a3B subunits (from the avr-14 gene) identified in both the free-living 
nematode Caenorhabditis elegans and the sheep parasite Haemonchus contortus. The 
pattern o f alternative splicing appears conserved across the species examined, with the 
subunits possessing identical glutamate binding N-terminal domains, but differing channel- 
forming C-terminals. However, the processing o f the mature GluCla3A mRNA appears to 
differ in D. immitis compared to C. elegans and H. contortus.
The D. immitis GluCla3 subunits failed to express at detectable levels in mammalian cell- 
lines. Therefore to investigate their pharmacology two-electrode voltage clamp recordings 
were made from Xenopus oocytes injected with subunit-specific cRNA. The GluCla3B 
subunits formed channels that were gated, in typical fashions, by glutamate (1-lOOmM) and 
IVM (IjliM). Oocytes injected with GluCla3A cRNA failed to respond to glutamate; the 
response to IVM in these oocytes was not tested. The qualitative responses obtained were 
consistent with the pharmacology observed for the GluCla3 subunits in C. elegans and H. 
contortus. In addition, a glutamate dose response curve was generated for C. elegans 
GluCla3B homomeric channels expressed in oocytes. From the curve an EC50 o f 2.2 ±
0.12mM and a Hill co-efficient o f 0.72 ± 0.08 were determined. Whilst comparable to other
selected GluCls expressed in oocytes, these values suggest the CeGluCla3B subunits do 
not form homomers in vivo.
A novel LGIC subunit o f unknown function, termed DG1, has also been cloned from D. 
immitis. The subunit exhibits low amino acid identity (25-30%) to GluCl and selected other 
LGIC subunits, but 50% identity to a predicted LGIC subunit (T27A1.4) from C. elegans. 
Initial RNAi experiments failed to establish a potential function for the T27A1.4 subunit.
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Nematodes, commonly termed “round worms”, are the most populous metazoan animals on 
the planet, estimated by some to account for 80% o f the total number (Platt, 1994). They 
are distinguished from other helminths (i.e. from flukes and tapeworms) by their non­
segmented, cylindrical morphology, which along with their anatomy is highly conserved 
across species (White, 1988). Despite their body plan uniformity, which has bestowed 
nematodes with phylum status, i.e. the Nematoda, these worms exhibit considerable 
biological diversity (Blaxter et al., 1998a). Approximately half the 20,000 described 
species o f nematode, the large majority in terms o f numerical abundance, are free-living; 
these worms typically only reach l- 2 mm in length when adult, and can be found in both 
terrestrial (i.e. soil) and marine (both fresh and sea water) environments (Wood, 1988). A 
prime example o f a free-living species is Caenorhabditis elegans, the “model” nematode 
(Blaxter, 1998b). As one o f the species used in this study C. elegans is considered in more 
detail in section 1.4. The remaining species o f nematode are parasitic, infecting a broad 
range o f host organisms spanning both plant and animal (including vertebrates and 
invertebrates) kingdoms (Blaxter & Bird, 1997). Unlike their free-living counterparts 
certain parasitic species can reach considerable sizes, as illustrated below.
1.2 Parasitic nematodes
Nematodes are important parasites o f humans, their domesticated animals and their crops. 
Of those nematodes that infect humans, a taxonomically diverse group o f parasitic species 
termed the geohelminths are without doubt responsible for causing the most disease. 
Primary members o f this group are Ascaris lumbricoides, Trichuris trichiuria and 
hookworm species. All o f these nematodes have direct lifecycles, which means no 
intermediate hosts or vectors are required for their completion, but rather transmission 
occurs by faecal contamination o f soil, foodstuffs and water supplies (Holland & Kennedy, 
2002). Adult geohelminths reside within the intestine where they compete with the host for 
nutrients. Infection can lead to problems with appetite, growth, physical fitness, physical 
activity, work capacity, cognitive development and school performance in malnourished 
populations. In severe cases infection may also cause death (Kvalsvig, 2002; Stephenson, 
2002). The singularly most important geohelminth is A. lumbricoides (the large gut 
roundworm), which has been recently estimated to infect over a quarter o f the world’s
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population (1,472 million) (Crompton, 1999). Adult A. lumbricoides can reach up to 35cm, 
illustrating the considerable difference in size between free-living nematodes and certain 
parasitic species.
A second group o f parasitic nematodes that have profound importance to human and also 
veterinary medicine are the filaria, which unlike the geohelminths, are taxonomically 
closely related (Blaxter et al., 1998a; Dorris et al.9 1999). These nematodes are long-lived, 
tissue dwelling worms, which require biting arthropods to complete their lifecycles 
(Kazura, 2002); this is in contrast to the direct lifecycles o f geohelminths. There are two 
major diseases attributed to filarial worms, lymphatic filariasis and onchocerciasis. 
Although not generally life threatening both conditions have serious socio-economic 
consequences. Lymphatic filariasis is principally caused by Wuchereria bancrofti (and to a 
lesser degree Brugia species) and affects 120 million people worldwide, mainly in sub- 
Saharan Africa and Asia (Crompton, 1999). Characteristically, affected individuals exhibit 
severe swelling o f various body parts (lymphoedema), rendering them practically disabled 
(Kazura, 2002). Onchocerciasis (commonly termed river blindness) is the most severe 
result o f infection with Onchocerca volvulus. O f the 18 million people infected with this 
parasite, mainly in sub-Saharan Africa (Crompton, 1999), 750,000 are either blind or 
severely disabled due to onchocercal eye diseases (Fischer & Btittner, 2002). Filarial 
nematodes are also important in veterinary medicine. Indeed, the species o f major interest 
to this study is the filarial nematode Dirofllaria immitis, an important parasite o f dogs (see 
section 1.3).
Nematodes are also important parasites o f livestock, a chief example being Haemonchus 
contortus, which is a blood-sucking worm that infects sheep and other ruminants (Blaxter 
& Bird, 1997). H. contortus is a member o f the group Strongylida that includes other 
parasites o f veterinary importance such as Trichostrongylus colubriformis, a parasite o f 
goats and sheep, and Ostertagia ostertagi, a parasite o f cattle (Blaxter et al., 1998a). 
Members o f this family have direct lifecycles and reside within the intestine o f their hosts. 
Infection causes anaemia, which leads to a reduction in the animal’s condition and in 
certain cases death. The knock-on effect is reduced productivity and hence economic loss 
(Blaxter & Bird, 1997). There are increasing cases o f drug resistance in these parasites, 
which is o f growing concern in the livestock industry (Gill & Lacey, 1998; Kohler, 2001).
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Plant parasitic nematodes cause billions o f dollars worth o f crop destruction per year. 
Although an old figure now, it has been estimated that they reduce the yield o f the world’s 
40 major cash crops by approximately 12%. In poorer countries this can have a severe 
effect on malnutrition and the economics o f the region. The main offenders responsible for 
the damage are the Meloidogyne species or “root-knot” nematodes, which are obligate root 
endo-parasites. After entering the roots they migrate to the developing vascular cylinder 
where they set-up a permanent feeding site (Blaxter & Bird, 1997).
1.3 Dirofilaria immitis (“Heartworm”)
Dirofilaria immitis is a filarial nematode that primarily infects domesticated dogs and to a 
lesser degree domesticated cats; wild canines and ferrets can also act as potential reservoirs 
o f infection. The adult nematodes usually reside within the infected animal’s pulmonary 
arteries. However, they may also be found during chronic cases in the right side o f the heart 
thus giving rise to their common name, “heartworm”. There are a number o f clinical 
manifestations associated with heartworm infection, the most significant being pulmonary 
hypertension, which in severe cases leads to right-sided heart failure (Knight, 1987). 
However, cases o f heartworm are generally preventable and often curable with the 
application o f the appropriate anthelmintic drugs (see section 1.7), although there are some 
limitations and problems associated with current treatments (Knight, 1998). Commercial 
interest in D. immitis and other such parasites is growing as the market for companion 
animal drugs expands (Witty, 1999; Meinke, 2001). The worldwide distribution o f D. 
immitis across both temperate and tropical climates makes this parasite a prime target for 
the development o f novel anthelmintics (Lok, 1988). Successfully improving existing 
treatments and developing new ones to combat D. immitis infections may also benefit how 
we deal with the closely related filarial nematodes that cause so much disease in humans,
i.e. W. bancrofti, O. volvulus and Brugia species.
As stated, D. immitis is a filarial nematode and as such the ovoviviparous females, which 
reside in the pulmonary arteries, release (unsheathed) microfilariae (a pre-larval 
developmental stage) following successful fertilisation. Microfilariae are only -300pm  in 
length and circulate in the host’s bloodstream until ingested by specific species o f
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mosquito. Within the mosquito microfilariae develop (through intermediate larval stages) to 
become infective third stage larvae (L 3 ), which are ~ 1.3mm in length. This period of 
development takes approximately 2-3 weeks. During a second blood meal the L 3 S enter the 
primary host, moulting to become L4S at the infection site before migrating towards the 
pulmonary arteries. En route the larvae undergo one further moult to become immature 
adults, sometimes referred to as L 5 S. These worms reach the pulmonary arteries between 
70-120 days post-infection. The immature adults at this point are 2-4cm in length and 
require several months of further development before attaining sexual maturity. This is 
reached when the adult worms reach 75% of their full-length; adult males reach 15-19cm 
whereas adult females reach 23-3lcm. Microfilariae are observed circulating in the host’s 
blood system at approximately 6.5 months post infection. D. immitis are long-lived 
parasites, having a mean life expectancy of 5-7 years (Knight, 1987). Their lifecycle is 
summarised in figure 1.1.
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Figure 1.1. Lifecycle of Dirofilaria immitis. The image of the adult worms can be found at 
http://ucdnema.ucdavis.edu/imagemap/nemmap/entl56.html/slides/fromCD/1939/56B.Gif.
1.4 Caenorhabditis elegans
Caenorhabditis elegans is a small free-living species o f nematode commonly found in soil, 
which feeds on anything it can fit into its mouth (usually bacteria) (Riddle et al., 1997). In 
the 1960’s Sydney Brenner selected C. elegans to address issues o f animal development, 
particularly focusing on the nervous system (Brenner, 1973; Brenner, 1974). It has since
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risen to become one o f the most prominent model organisms in biological research. Indeed, 
it was the first metazoan to have its genome fully sequenced (The C. elegans Sequencing 
Consortium, 1998).
The two sexes, hermaphrodites and males, grow to 1-1.5mm in length and are only easily 
distinguished between when adult. Hermaphrodites, the more prevalent gender, reproduce 
by self-fertilisation and lay up to 300 eggs during their lifespan. As in other species o f 
nematode, the hatched larvae undergo four stages o f development to reach adulthood. This 
lifecycle takes only three days although once adult the worms may live for a further 2-3 
weeks. Males arise spontaneously in the population at low frequency (~1 in 1000), but can 
also mate with hermaphrodites; hermaphrodites cannot mate with each other (Wood, 1988).
The inbreeding displayed by the self-fertilising hermaphrodites was perhaps the most 
important factor in the original decision by Brenner to use C. elegans in genetic studies, as 
it enables mutants to be easily maintained in the lab. The rare event o f fertilisation by males 
can then be used to move mutations between strains. However, there are an increasing 
number o f other reasons why C. elegans is appealing as a model organism. Their small size 
coupled to their rapid lifecycle facilitates cultivation and manipulation; the worms can be 
grown at 20°C on agar plates or in liquid cultures using Escherichia coli as their food 
source. They are anatomically simple (hermaphrodites have 959 somatic nuclei), with 
constancy o f cell number and cell position; the complete wild-type cell lineage from 
fertilised egg to adult worm has been described (Riddle et al., 1997). C. elegans are also 
genetically simple and as stated, their genome has been fully sequenced (The C. elegans 
Sequencing Consortium, 1998). This makes them amenable to a number o f genetic 
screening processes (Jorgensen & Mango, 2002) and the increasingly popular technique o f 
RNA interference (RNAi) (Hannon, 2002). Both sexes throughout their lifecycles are 
transparent, which makes analysis o f development and the identification o f mutants 
possible at the cellular level in living preparations, using light microscopy (Riddle et al., 
1997). Finally, every cell in the body is accessible to laser microsurgery (Bargmann & 
Avery, 1995).
With such an extensive understanding o f its biology, it is perhaps no wonder that C. 
elegans has been adopted as a “model nematode” for parasitic species. It has certainly been
crucial to identifying and generally understanding the modes o f action o f several classes o f  
anthelmintic drugs, including the macrocyclic lactones (the avermectins/milbemycins) 
(Geary & Thompson, 2001). Although C. elegans may represent a good model for studying 
drug action in closely related parasitic species o f nematode such as H  contortus (Blaxter et 
al., 1998a), inferences made to describe their activity in distantly related species, such as 
the filaria, must be treated with more caution (Geary & Thompson, 2001). For example, 
although inhibition o f feeding and motility appear to be important targets for the 
macrocyclic lactones in C. elegans and H. contortus (Kass et al., 1980; Avery & Horvitz, 
1990; Gill et al., 1991, 1995; Geary et al., 1993; Arena et al., 1995; Paiement et al., 1999), 
in adult filariae, fecundity may be the most important biological process affected by these 
drugs (Awadzi et al., 1985; Duke et al., 1991; Lok et al., 1995).
1.5 Nematode anatomy
Nematodes, despite their diversities in habitat, lifestyle and size, share considerable 
similarities in both morphology and anatomy. Their basic body plan is that o f two 
concentric tubes separated by a fluid-filled cavity, termed the pseudocoelom. Major 
components o f outer tube include the cuticle, hypodermis, body musculature and the 
nervous system whereas the inner tube contains the digestive system (including the pharynx 
and intestine). In adult worms, the pseudocoelomic space houses the gonad (White, 1988). 
The digestive tract and pseudocoelomic space are under considerable hydrostatic pressure, 
maintained by osmoregulation probably carried out within the intestine. One function o f 
this hydrostatic “skeleton” is to maintain the worm-like morphology o f the nematode in the 
face o f external forces (e.g. surface tension) that might otherwise flatten it (Avery & 
Thomas, 1997). Below is a description o f selected aspects o f nematode anatomy; the 
nervous system is described in section 1 .6 .
Surrounding the outer tube o f the nematode is the cuticle, which is a complex layered 
structure, composed mainly o f collagenous material. The cuticle plays a crucial role in the 
maintenance o f morphology, protection from and/or interaction with the external 
environment and motility. The proteins that constitute the cuticle are secreted by the 
underlying hypodermis, the external epithelium. During larval moults the cuticle is shed 
and replaced in most species by one that varies in chemical composition and ultrastructure,
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although this appears not to be a requirement related to growth (Kramer, 1997). In parasitic 
species, it has been suggested this may be a way o f adapting to the different environments 
faced by the various developmental stages. For example, the cuticle may play a role in 
evasion or modulation o f the host’s immune system during invasive stages o f the parasite’s 
lifecycle (Blaxter & Bird, 1997; Page, 2001).
The nematode’s body musculature is attached to the cuticle via the hypodermis. The body 
wall muscle cells are arranged into four strips (two dorsally and two ventrally) that run the 
length o f the whole worm. Co-ordinated contraction and relaxation o f these muscle strips 
generates the characteristic sinusoidal movement o f nematodes in the dorsal-ventral plane. 
Hence, C. elegans observed on agar plates in the lab are moving on their lateral side. The 
muscles are able to generate this movement by working against the internal hydrostatic 
pressure and the cuticle (White, 1988). The orientation o f muscles in the head is somewhat 
different, permitting movement in the lateral as well as dorsal-ventral plane. This is 
important given the head contains an abundance o f sensory neurons that monitor the 
external environment (Driscoll & Kaplan, 1997).
The inner tube contains the digestive system This consists o f the intestine, which runs the
length o f the worm and two elaborate muscle complexes at either end that control the flow
through it. This is necessary as the intestine is devoid o f surrounding muscle cells and thus
is mechanically passive, although the muscles involved in locomotion can be exploited to
influence the process. At the anterior end o f the worm is the pharynx, the muscular organ
by which the worms feed, to greater or lesser degrees. The rhythmic pumping o f the
pharynx enables food to be ingested and then crushed before being forced against the
internal hydrostatic pressure into the intestine. Absorption o f nutrients within the intestine
is rapid. It is thought they are distributed to other parts o f the worm via the pseudocoelomic
fluid. The muscles at the posterior end o f the intestine, surrounding the anus, periodically
open to allow defecation, which is driven by the internal hydrostatic pressure. The
pharynxes o f different species vary considerably in both their morphology and importance
to feeding. C. elegans is a free-living nematode and a filter feeder, and thus derives the
majority o f its nutrients via pharyngeal pumping. Hence, the pharynx o f this species has a
very muscular design (Avery & Thomas, 1997). In contrast, adult filaria appear to only
have limited gut function and are thought to obtain a large proportion o f their essential
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nutrients via transcuticular absorption. This is reflected in the considerably less muscular 
design o f the filarial pharynx (Geary et al., 1995).
1.6 The nematode nervous system
Our understanding o f nematode neurobiology has largely been the result o f studies 
conducted on C. elegans and Ascaris suum, a gut parasite found in pigs that is closely 
related to A. lumbricoides. The similarities observed between the two species has lead some 
to infer that the nervous system is highly conserved in both anatomy and function across 
the phylum. Nematode neurons are usually quite simple in morphology, many being 
monopolar with a single unbranched process although this is not always the case. In 
addition, strict classification o f these cells as motor neurons, intemeurons or sensory 
neurons has proved difficult as many perform two (or more) o f these functions. As in 
vertebrates however, nematode neurons are able to form both chemical and electrical (gap 
junctions) synapses. The structures though o f these synapses are unusual: synaptic 
connections between neurons are made en passant whereas at neuromuscular junctions 
(NMJs) it is the muscle cells and not the neurons that extend processes to form the synapes 
(Chalfie & White, 1988; Rand & Nonet, 1997).
Although only composed o f a relatively small number o f component neurons (in C. elegans 
hermaphrodites there are 302; A. suum has 298), the nervous system is the most 
complicated organ in nematodes. It is composed o f two near autonomous units, the 
pharyngeal and somatic (extrapharyngeal) nervous systems. The pharyngeal nervous 
system is comprised o f approximately 2 0  neurons all o f which, as the name suggests, are 
located in the pharynx and are responsible for its pumping action (Chalfie & White, 1988). 
Indeed, if the pharynx o f C. elegans is separated from the rest o f the body pumping 
continues for sometime afterwards indicating the myogenic nature o f this system (Avery & 
Horvitz, 1989). The somatic nervous system is connected to its pharyngeal counterpart by a 
pair o f neurons, which in C. elegans are termed the RIP cells, thus enabling communication 
between the two.
In the somatic nervous system neuronal processes generally run in bundles orientated 
longitudinally as cords or circumferentially as commissures. The major areas o f  neuropil
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are the nerve ring, which is located in the anterior o f the worm surrounding the pharynx, 
and the ventral cord, the major process bundle to emanate from it that runs posteriorly for 
almost the entire length o f the animal. The nerve ring is the major site o f signal integration 
in the animal. It is here that information from the major sensory neurons, located in the 
head, are collected, processed and acted upon; the emanating signals frequently alter 
locomotion but may also regulate other processes such as feeding and fecundity. The 
ventral cord consists o f intemeuron and motomeuron processes, their cell bodies lying 
adjacent to these bundles. The other major longitudinal bundle running posteriorly from the 
nerve ring is the dorsal cord. Motomeuron axons that form NMJs with the ventral muscles 
run in the ventral cord. Motomeuron axons that form NMJs with the dorsal muscle also 
originate in the ventral cord; the axons then run circumferentially around the animal to the 
dorsal midline where they then turn and run either anteriorly or posteriorly to the site where 
they form their NMJs. The synaptic connections between the motomeurons and either the 
ventral or dorsal muscles provide the framework for regulating movement. A number o f  
sublateral cords also originate from the nerve ring. The neurons found in the tail regions 
vary considerably between sexes (Chalfie & White, 1988).
Based again on studies principally conducted in C. elegans and A. suum, the nematode
nervous system has been determined to use a number o f classical neurotransmitters
including ACh (acetylcholine), GABA (y-aminobutyric acid), glutamate, 5-HT (5-
hydroxytryptamine/serotonin) and other monoamines. It has also been established that
nematodes possess an extensive number o f neuroactive peptides (reviewed in Brownlee et
al., 2000). GABA is the major inhibitory neurotransmitter in nematodes, whereas the major
excitatory transmitters are ACh (on to the somatic muscle) and glutamate (in intemeurons).
Glutamate also functions as an inhibitory neurotransmitter on to pharyngeal muscle,
controlling the timing o f pharyngeal relaxation (Avery & Thomas, 1997), and as a
neuromodulator in the somatic nervous system; ACh also has an inhibitory role in the
pharynx. The contrasting roles o f glutamate are likely to be achieved via interactions with
different ion-selective classes o f neurotransmitter receptors. For example, the excitatory
role in the somatic nervous system is conveyed by the cation-selective GLR (non-NMDA
type glutamate receptor) and NMR (NMDA-type glutamate receptor) glutamate receptors
(Zheng et al., 1999). The inhibitory role in the pharynx is also most certainly due to
interaction with glutamate-gated chloride channels (GluCls) (Martin, 1996; Avery &
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Thomas, 1997; Pemberton et al., 2001) whereas the modulatory roles may involve both 
classes o f receptor.
1.7 D. immitis chemotherapy
Treatment strategies exist to both prevent and cure D. immitis infections. The approaches 
briefly described here are derived from guidelines issued by the American Heartworm 
Society (Knight, 1998), although the drugs detailed are commonplace globally. 
Chemoprophylaxis is the most effective way o f controlling heartworm disease. The timing 
and duration o f the treatment coincides with the transmission season, which effectively 
means the warmer months o f the year when mosquito populations are sustained. The major 
drugs used in preventative treatment are members o f the macrocyclic lactone class 
(avermectin/milbemycins) o f anthelmintics. These compounds are discussed in more detail 
in later sections as they target the GluCls, the focus o f this study. The macrocyclic lactones 
licensed in the USA as chemoprophylactics are ivermectin (IVM), milbemycin oxime, 
moxidectin and selamectin. These compounds are extremely effective at killing larval 
stages o f heartworm although are less effective against adult worms, hence their primary 
use as chemoprophylactics. One advantage o f these drugs is that they only need be 
administered monthly with certain members o f this group exhibiting impressive retro­
activities; an added bonus if a dose is missed. An alternative to these drugs is 
diethylcarbamazine (DEC). However, if not taken every day DEC provides little protection 
against infection making the macrocyclic lactones a much more attractive option. The 
macrocyclic lactones also generally provide a greater margin o f safety compared to DEC, 
although in certain breeds o f dogs, notably collies, these drugs can have a neurotoxic effect. 
This is because collies are homozygous for a mutated version o f the mdrl gene, which 
encodes P-glycoprotein (P-gp), a transmembrane protein pump found in the blood brain 
barrier; the mutant alleles encode a truncated protein (Mealey et al., 2001). IVM is a 
substrate for P-gp, therefore in dogs expressing the truncated form the drug accumulates in 
the central nervous system. It may then reach concentrations that have been shown to 
interact with other neurotransmitter receptors in vitro, probably explaining the 
neurotoxicity observed (Krause et al., 1998; Khakh et al., 1999; Adelsberger et al., 2000; 
Dawson et al., 2000; Shan et al., 2001).
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Should an animal be already infected with heartworms the first step is usually to remove 
the adult worms. Although it has been recently shown that IVM may have a partial 
adulticidal effect over long treatment periods (Rawlings, 2002), removal o f the adults is 
usually achieved by surgery, in very severe cases, or by the administration o f arsenical 
compounds (melarsomine or thiacetarsemide). Treatment o f heartworm with either o f these 
drugs is risky for the dog. During this period the animal is carefully monitored for toxic 
side effects o f the drugs and for pulmonary thromboembolism, an unfortunate but frequent 
outcome caused by the dead or dying adult worms. Once the removal o f the adult 
heartworms has been established and the dogs have recovered from the toxic side effects o f 
the arsenical compounds removal o f the microfilariae may begin. Although no drugs are 
officially licensed as microfilaricides, in the US at least, extra-label use o f certain drugs is 
permitted. In this instance the macrocyclic lactones, particularly IVM and milbemycin 
oxime, are extremely effective and frequently used. The rapid death on mass o f microfilaria 
can promote a toxic reaction in the dog and for a short duration after treatment the dogs 
again must be carefully monitored. The prolonged used o f macrocyclic lactones drugs 
should then remove further larval stages within the infected animal (Knight, 1998).
1.8 The avermectins/milbemycins (the macrocyclic lactones)
1.8.1 Introduction
The avermectins (AVMs) and milbemycins are structurally related classes o f 16-membered 
macrocyclic lactones that possess potent anthelmintic, insecticide, and acaricide properties. 
Both were isolated in the 1970’s from soil-dwelling Streptomyces species and remain at the 
forefront o f control for a range o f endo- and ecto-parasites, including nematodes. However, 
they have little effect on tapeworms or flukes. A feature o f these compounds is their low 
toxicity towards host species. The first commercial member o f the AVMs/milbemycins 
(AMs), ivermectin (IVM), was introduced in 1981. IVM (22,23-dihydroavermectin Bia) is 
a semi-synthetic derivative o f avermectin Bia, the most potent o f the 8 natural AVMs 
originally isolated (Chabala et al., 1980). Like the other AMs, IVM has a broad spectrum o f 
activity and has been widely used to combat nematode parasitism o f humans, their livestock 
and other domesticated animals, and crops (Campbell, 1989). In man IVM has become the 
cornerstone o f the mass drug administration program to eradicate onchocerciasis (river 
blindness) (Meredith & Dull, 1998) and is used in part for a similar program to eliminate
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lymphatic filariasis (Brown et al., 2000). Given the similarity in structure and action 
between the AVMs and milbemycins, it is often assumed that data obtained with one 
member o f the family is generally applicable to all. Though this may be true, it is probably 
sensible to note that this may not always be the case. Therefore, a point is made in the 
following sections to note which compounds were used in the data reviewed.
1.8.2 Biological effects
A number o f in vitro studies have shown that the AMs inhibit pharyngeal pumping (and 
hence feeding), motility and fecundity in susceptible nematodes. In H. contortus, 
pharyngeal pumping is the most sensitive o f the processes affected by these anthelmintics 
(Gill et al., 1991, 1995; Geary et al., 1993; Paiement et al., 1999). IVM concentrations 
>0.1 nM paralyse the pharynx o f adult H  contortus, whereas a reduction in motility leading 
to overall paralysis requires >10nM IVM. Interestingly paralysis is confined to the mid- 
body region o f the worm, with the head and tail regions still able to move normally (Geary 
et al., 1993). AVMs exert similar effects at comparable concentrations on H, contortus 
larvae (Gill et al., 1991, 1995) and C. elegans (Kass et al., 1980; Avery & Horvitz, 1990; 
Arena et al., 1995). In filaria, as observed for D. immitis, the AMs appear to very effective 
at killing larval stages o f the parasite, which presumably occurs through inhibition o f one o f  
these processes. Microfilariae do not possess a functioning intestine (Bryant, 1988) and so 
overall paralysis seems the most likely way that these drugs kill this larval stage. The most 
important effect on the adult filaria appears to be suppression o f new microfilariae 
production (Awadzi et al., 1985; Duke et al., 1991; Lok et al., 1995), as the AMs are not 
particularly effective at killing the resident macrofilariae; similar effects on fecundity are 
seen in H. contortus and C. elegans (Le Jambre et al., 1995; Grant, 2000). It remains 
unclear which mechanism is responsible for the overall potency o f the AMs in vivo towards 
parasitic nematodes, but it seems likely that the relative importance o f each o f these major 
effects may differ between species (Gill & Lacey, 1998) and even developmental stages.
1.8.3 Molecular targets of the AMs
The major sites o f action o f the AMs appear to be the GluCls, although as discussed below, 
other molecular targets may also be important to mediate some o f their biological effects. It
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was apparent from early experiments that the AVMs interacted with ligand-gated chloride 
channels from both target and non-target species (Kass et al., 1980; Supavilai 8c Karobath, 
1981; Graham et al., 1982; Pong & Wang, 1982). It was therefore not surprising that it was 
thought that their main target could be the GABA receptor present at the nematode 
neuromuscular junction, though micromolar concentrations were required to elicit the 
blocking effects observed (Holden-Dye & Walker, 1988; Holden-Dye & Walker, 1990). A 
patch-clamp study by Martin and Pennington (1989) on A. suum muscle also demonstrated 
that IVM antagonised GABA receptors, reducing the single-channel conductance and the 
frequency o f channel openings. The same study showed that IVM activated both non- 
GABA chloride channels on outside-out patches and ‘noisy’ cation-selective channels on 
inside-out patches. Both channels remain poorly characterised and have not been observed 
in other preparations (Holden-Dye & Walker, 1990). Older studies have also indicated that 
AVM Bia could also block transmission between intemeurons and excitatory motomeurons 
in the ventral cord and ventral inhibitory neuromuscular transmission (Kass et al., 1980; 
Kass et al., 1984). Delany et al (1998) proposed that this could be explained by the 
presence o f GluCls on motor neurons innervating the somatic muscles. Again the 
concentrations o f AVMs used were in the micromolar range, significantly higher than those 
found to exert anthelmintic effects in vivo or in vitro. Today it is clear that the AMs can 
interact with a wide variety o f channels, including mammalian glycine and GABAa 
receptors (Adelsberger et al., 2000; Dawson et al., 2000; Shan et al., 2001), a l  nicotinic 
acetylcholine receptors (nAChRs) (Krause et al., 1998) and P2 X4 receptors (Khakh et al., 
1999). However, the AMs low toxicity towards most mammalian species suggests that they 
do not normally interact with these latter receptors; they probably do not reach the required 
concentrations to elicit the observed in vitro effects, as the therapeutic doses required to 
eliminate the parasites are low and the compounds are constantly removed from the host’s 
central nervous system by P-glycoproteins (Burkhart, 2000).
The first direct evidence for an AM interaction with GluCls was revealed in insect muscle.
IVM was shown to activate a chloride channel, which was sensitive to the glutamate
analogue ibotenate but insensitive to GABA (Duce & Scott, 1985). In nematodes, IVM was
shown to bind a site in membranes prepared from C. elegans with a 100-fold higher affinity
than binding to membranes from rat brain. The relative binding affinities o f IVM and a
number o f derivatives were shown to correlate well with their ability to inhibit motility in
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C. elegans, i.e. the higher the binding affinity the more potent the effect on motility 
(Schaeffer & Haines, 1989). High affinity binding by a series o f AM analogues has also 
been demonstrated to membranes prepared from H  contortus (Rohrer et al., 1994; Hejmadi 
et al., 2000; Cheeseman et al., 2001). When avermectin-sensitive chloride currents were 
produced in Xenopus oocytes injected with C. elegans mRNA, they were found to be 
GABA-insensitive (Arena et al., 1991) but, later, to be sensitive to glutamate (Arena et al., 
1992). This, and the subsequent cloning o f cDNAs encoding avermectin sensitive 
glutamate-gated chloride channel (GluCl) subunits from C. elegans, parasitic nematodes 
and insects (Cully et al., 1994; Cully et al., 1996b; Dent et al., 1997; Laughton et al., 
1997a; Forrester et al., 1999; Jagannathan et al., 1999; Dent et al., 2000; Cheeseman et al., 
2001; Horoszok et al., 2001; Forrester et al., 2002; Forrester et al., 2003) has led to the 
belief that the GluCls are the principal targets through which the AMs exert their biological 
effects on nematodes. Electrophysiological studies o f pharyngeal preparations from both C. 
elegans and A. suum have shown that the AMs act on GluCls to inhibit pumping (Martin, 
1996; Adelsberger et al., 1997; Pemberton et al., 2001), though Brownlee et al (1997) also 
suggested a possible interaction with GABA receptors in the A. suum pharynx. In insects 
the situation has been recently complicated by the suggestion that the Drosophila 
avermectin receptor may contain both the GluCl subunit and the GABA receptor subunit, 
RDL (Ludmerer et al., 2002) and by the discovery o f avermectin-sensitive histamine-gated 
chloride channels (HisCls) in this species (Gisselmann et al., 2002; Zheng et al., 2002). 
Mutations in the ort gene, which encodes one o f the HisCl subunits, alter the susceptibility 
o f the flies to the avermectins (Georgiev et al., 2002; Iovchev et al., 2002) suggesting that 
these channels may be important targets in vivo. In nematodes, where no HisCls have been 
demonstrated, the evidence remains strongly in favour o f the GluCls as the clinically 
relevant AM target.
1.9 The glutamate-gated chloride channels
1.9.1 Molecular biology
The initial isolation o f the C. elegans GluClal and GluClp cDNAs by the Merck group 
(Cully et al., 1994) showed that the GluCls are members o f the ligand-gated ion channel 
(LGIC) superfamily, closely related to the GABAa and glycine receptors. The individual 
subunit sequences show all the characteristics o f this family, with a long N-terminal
extracellular domain followed by four membrane-spanning domains (Ortells & Lunt, 1995). 
There is a long intracellular loop between the third and fourth o f these membrane-spanning 
domains that contains consensus sequences for protein kinases: in other members o f the 
family protein phosphorylation has been shown to affect the channel properties (Porter et 
al., 1990; Wafford & Whiting, 1992; Leidenheimer et al., 1993; Krishek et al., 1994; 
McDonald & Moss, 1994, 1997; Moss et al., 1995, 1996; Macdonald, 1995; McDonald et 
al., 1998; Filippova et al., 2000). By analogy with other ligand-gated ion channels, the 
mature receptor is presumed to be a pentamer, made up o f different types o f subunit and 
with the second membrane-spanning domains lining the ion pore. This presumption is 
largely based on biochemical and structural studies conducted on nAChRs (reviewed in 
Karlin, 2002).
Further cloning studies, together with the complete C. elegans genomic sequence, have led 
to the identification o f a small family o f six GluCl genes in the model nematode (table 1.1). 
At least two o f these genes, avr-14 and avr-15, are alternatively spliced (Dent et al., 1997; 
Laughton et al., 1997a; Vassilatis et al., 1997a) to yield at least eight possible subunits. 
Since the native GluCls are presumed to be pentamers, it is clear simply from the number 
o f GluCl subunit genes that multiple forms o f this channel must exist in worms, and there 
are therefore likely to be multiple AM target sites. To date there is no direct evidence on the 
subunit composition o f any nematode GluCl. The parasitic species about which we have 
most information is H. contortus. So far, three genes encoding four GluCl subunits have 
been identified in this organism (table 1.1) (Delany et al., 1998; Forrester et al., 1999; 
Jagannathan et al., 1999; Cheeseman et al., 2001). Three o f the H. contortus subunits are 
clearly orthologues o f ones in C. elegans, the HcGluCip and a3 subunits; in the absence o f 
a complete genome sequence it is impossible to know whether or not orthologues o f the 
other C. elegans genes await discovery. HcGluCla does not seem to be orthologous to any 
o f the C. elegans genes (Cheeseman et al., 2001), indicating that there are differences in the 
genetics o f the GluCls between even quite closely related nematode species: H. contortus 
and C. elegans are in the same clade o f the phylogenetic tree proposed by Blaxter et al 
(1998a). Before commencing this project partial sequences corresponding to avr-14 had 
also been isolated from A. suum and the filarial species O. volvulus and D. immitis (Cully et 
al., 1996a): the alternative splicing o f this gene is conserved in all the nematodes where this
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has been examined (Jagannathan et al., 1999). The final member o f the C. elegans GluCl 
family, glc-4, is somewhat divergent from the a  and p subunits and may therefore represent 
a ‘y’ subunit. Partial GluCl cDNAs have also been discovered in Onchocerca ochegi (a 
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Table 1.1 Nematode GluCl genes and subunits identified before commencing the project. The names 
used for the GluCl genes and subunits are taken from Yates et al (in press): other names that have been used 
in the literature are given in brackets.
1.9.2 GluCl pharmacology
Our current understanding of nematode GluCl pharmacology has been derived from a 
number of experimental approaches: two-electrode voltage clamp (TEVC) recordings from 
Xenopus oocytes mainly expressing C. elegans GluCl subunits (see table 1.2 for summary), 
radioligand binding studies on membranes from either whole worms or cell-lines 
expressing GluCl subunits (see table 1.3 for summary), and electrophysiological 
investigations using nematode tissue preparations. Ivermectin phosphate (IVMPO4) was 
used in a number o f experiments reviewed below instead of IVM due to its increased 
solubility in water. In subsequent chapters for convenience the distinction is not made 
between the two compounds.
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GluClal and GluClp were the first GluCl subunits to be cloned and expressed in oocytes 
(Cully et al., 1994). Cells expressing both subunits exhibited responses to applied 
glutamate and IVMPO4 comparable to those previously reported in oocytes injected with C. 
elegans mRNA (Arena et al., 1991, 1992). Glutamate rapidly activated an inward chloride 
current that was fully reversible when the ligand was washed out. However, the high EC50  
value for glutamate (1.36mM) is not comparable to that for oocytes injected with C. 
elegans mRNA (300pM) (Arena et al., 1992), and this, coupled with the lack o f any 
evidence that the two genes are expressed in the same cells, may argue against GluClal 
and GluClp co-assembly in vivo. Partial desensitisation o f the response was observed with 
glutamate at concentrations >lmM . IVMPO4  at high concentrations (>10nM, 
EC5o=190±7nM) also directly activated the chloride current, albeit with a slower onset. The 
current was essentially irreversible, even when the IVMPO4 was removed, and the channels 
exhibited little desensitisation. At lower concentrations (<10nM) IVMPO4 was unable to 
activate the channels but potentiated the glutamate response at sub-maximal glutamate 
concentrations. GluClalp heteromers exhibited a distinct pharmacology compared with 
other LGICs, including the glutamate-gated cation channels. Although activated by 
ibotenate, a structural analogue o f glutamate, GluClal p were insensitive to NMD A, 
kainate, quisqualate, AMP A, acetylcholine and muscimol at ImM and L-aspartate, GABA, 
glycine, histamine, p-alanine and taurine at lOmM (Cully et al., 1994). Subsequent studies 
on other GluCl subunits revealed a similar pharmacology (Dent et al., 1997; Vassilatis et 
al., 1997a; Horoszok et al., 2001). In addition, both glutamate (ImM) and IVMPO4  (lpM ) 
activated currents were partially blocked by lOOpM picrotoxin (PTX), a chloride channel 
blocker, by 6 8 % and 61% respectively. Another chloride channel blocker, flufenamic acid 
(200pM), exhibited a similar degree o f inhibition o f the IVMPO4 response (Cully et al., 
1994). The concentrations o f both compounds (i.e. PTX and flufenamic acid) used were 
comparable to those used to partially block the chloride currents in oocytes injected with C. 
elegans mRNA (Arena et al., 1992). The IC50 values for PTX blockade o f the heteromeric 
channels to glutamate and IVMPO4 were later determined to be 42pM and 52jaM 
respectively (Etter et al., 1999).
Both the GluClal and GluClp subunits are also able to form homomeric channels. 
GluClal homomers were activated by IVMPO4 (EC5o=140nM) in typical fashion but were
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insensitive to glutamate. Later studies demonstrated that glutamate actually bound to 
GluClal subunits but could not couple binding to gating (Etter et al., 1996). Conversely, 
GluClp homomers were activated by glutamate (ECso=380pM) but were insensitive to 
IVM, either activating the channels or potentiating the glutamate response. PTX was 
significantly more effective at blocking GluClp homomers (IC5o=7 7 nM) compared to 
heteromeric channels.
The alternatively spliced GluCla2A and 2B subunits were both able to form homomeric 
receptors sensitive to both glutamate (EC5o=2 mM & 208pM respectively), to which they 
exhibited rapid desensitisation, and IVM or IVMPO4  respectively (GluCla2B IVMPO4  
EC5o=108nM) (Vassilatis et ah, 1997a). GluCla2B was shown to form heteromeric 
receptors with GluClp: these heteromeric receptors exhibited a slower desensitisation rate 
and also had increased sensitivity to glutamate (ECso=62pM) compared with homomeric 
channels o f either subunit. This was in contrast to GluClal p heteromers, which exhibited 
decreased sensitivity to glutamate compared with GluClp homomers. The IVMPO4  
sensitivity remained unchanged. PTX weakly blocked the GluCla2B homomers but had no 
effect at lOOpM on GluCla2Bp heteromers (Vassilatis et al., 1997a).
Of the other subunits GluCla3B formed homomeric channels that were glutamate- (lOmM) 
and IVM- (lOpM) sensitive (Dent et al., 2000). The alternatively spliced subunit 
GluCla3A did not respond to either agonist. It is not known whether this is due to a lack o f 
sensitivity or the inability o f this subunit to associate into homomeric channels. The 
GluCla4 subunit was also able to form homomeric receptors that responded to both 
glutamate (EC5o=1 .9 mM) and IVM (ECso=400nM) (Horoszok et al., 2001). Although PTX 
insensitive, the GluCla4 channels were blocked by BIDN (ICso=200nM) and fipronil 
(IC5o=l 1.5pM), compounds that have been demonstrated to act at insect GABA-gated 
chloride channels (Hosie et al., 1995; Rauh et ah, 1997; Hamon et ah, 1998).
Recently the first GluCl subunit from a parasitic nematode, HcGluCla, has been expressed 
in oocytes. This subunit forms homomeric channels that are gated by glutamate 
(EC5o=8 .4 pM) and IVM (EC5o=131nM). In addition, potentiation o f the glutamate response
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appeared to be observed by pre-application o f lOnM IVM but was deemed not to be 
statistically significant (Forrester et al., 2003).
The pharmacology, described above, clearly distinguishes the GluCls from other members 
o f the LGIC superfamily and notably, the cationic glutamate receptors. It remains difficult 
however to comment expansively and draw firm conclusions on the quantitative responses 
elicited by glutamate and other ligands, as it appears likely that not all o f these subunits 
form homomeric channels in vivo. In fact, as with other classes o f LGICs, it is plausible 
that most native GluCls are heteromers. These receptors may well have distinct quantitative 
(and possibly qualitative) differences in their responses to various ligands compared to that 
o f homomers comprised o f the heteromers’ constituent subunits. In addition, rates o f 
desensitisation, a key process in regulating the activity o f LGICs, may be significantly 
altered in these heteromers compared to the homomers. As described above there is some 
evidence to support such statements in GluCls (Cully et al., 1994, Vassilatis et al., 1997a). 
Perhaps to ascertain a more accurate quantitative profile o f native GluCl pharmacology, 
further studies using TEVC and the Xenopus oocyte expression system should focus on 
subunit combinations, based on localisation studies that are likely to exist in vivo.
The concentrations o f IVM required to gate C. elegans GluCls, expressed in Xenopus
oocytes are high when compared to the concentrations able to paralyse pharyngeal pumping
and motility in worms in vitro. However a recent electrophysiological study demonstrated
that the native pharyngeal GluCls from C. elegans were considerably more sensitive to
IVM than GluCls expressed in Xenopus oocytes (Pemberton et al., 2001). Glutamate
applied to the pharynx elicited a rapidly desensitising, reversible, chloride-dependent
depolarisation. An EC5o=166pM was within the range observed for subunits expressed in
oocytes. Interestingly the inhibitory response observed was caused by a depolarisation o f
the membrane and not the previously suggested hyperpolarisation (Dent et al., 2000;
discussed below). IVM also elicited a chloride-dependent depolarisation o f the muscle,
however the response was typically irreversible and highly potent, with an EC5o=2 .7 nM
(Pemberton et al., 2001). The potency o f the IVM response was comparable with
concentrations shown to paralyse the pharynx in vitro (Avery & Horvitz, 1990; Geary et
al., 1993). This could be explained by potentiation o f the IVM response by endogenous
glutamate (Pemberton et al., 2001). In support o f this, a recent study has shown that
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glutamate potentiated AM binding to the H  contortus HcGluCla subunit (Forrester et al., 
2002). Alternatively the differing IVM sensitivities could be explained by the native 
subunit composition. As outlined above, so far only a limited number o f subunit 
combinations have been successfully expressed in oocytes and none o f these may reflect 
the composition o f native GluCl.
The depolarisation o f the pharyngeal muscle described above, i.e. when the membrane 
potential becomes less negative than the resting potential o f the cell, is due to the relative 
local chloride ion concentrations within and outside the cells. In this instance, the 
intracellular chloride ion concentration appears to be greater than the extracellular 
concentration. Therefore when the GluCls are opened, by application o f glutamate or IVM, 
chloride ions flow down their concentration gradient out o f the pharyngeal muscle cells 
causing them to become less negative and hence, depolarised (Pemberton et a l ,  2001). 
Other studies have shown that glutamate and AM application to pharyngeal muscle and 
glutamate application to motor neurons, both preparations from A. suum, elicit 
hyperpolarizing currents (Martin, 1996; Davis, 1998). In these cases the relative local intra- 
and extracellular chloride ion concentrations are reversed. Hence, when the GluCls are 
activated the chloride ions flow down their concentration gradient into the cells. Therefore, 
the effect o f glutamate and IVM via GluCls (i.e. to elicit a depolarising or hyperpolarizing 
currents) is dependent on the local relative chloride ion concentration, which may vary 
between species and indeed regions o f the animal itself.
Studies o f H. contortus GluCl pharmacology have largely taken a radioligand binding assay 
approach. IVM has been shown to bind a high affinity site in H. contortus whole worm 
membrane preparations with a KD ranging from 0.07-0.6nM (Rohrer et al., 1994; Gill & 
Lacey, 1998; Hejmadi et al., 2000; Cheeseman et al., 2001) depending on the experimental 
conditions. This is comparable to the high affinity IVM binding site (KD = 0.26nM) 
described in C. elegans (Schaeffer & Haines, 1989) and to the concentrations o f the drug 
that exhibit anthelmintic activity. Further binding studies were conducted with membranes 
prepared from COS-7 cells, a mammalian cell-line, expressing individual H. contortus 
GluCl subunits (Cheeseman et al., 2001; Forrester et al., 2002). The HcGluCla and 
HcGluCla3B subunits were shown to bind [3H]-IVM with KD values o f 26-1 lOpM and
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70pM respectively. These data implicate the high-affinity IVM binding site to be a GluCl. 
The HcGluCla3B Kd value was very similar to that for [3H]-IVM at L3 membrane 
preparations (Cheeseman et al., 2001), so this subunit could conceivably represent the 
major IVM binding-site in this larval stage. Other studies indicating that the HcGluCla 
subunit was mainly expressed in adult worms support this possibility (Forrester et al., 
1999). Binding o f [3H]-IVM to the individual subunits and whole worm membranes was 
inhibited by a variety o f AVMs, implying they all bound the same site. However glutamate, 
GABA and PTX failed to compete for the IVM binding site. The recombinant 
HcGluCla3A and HcGluClp subunits exhibited no specific [3H]-IVM binding, as predicted 
from the properties o f their C. elegans orthologues expressed in Xenopus oocytes. A lower 
affinity-binding site ( K d =  8.7nM) has also been described in H  contortus L3 membranes 
but the importance o f this remains unknown and uncharacterised in molecular terms (Gill & 
Lacey, 1998).
From the experiments described above, the AMs appear to act by increasing the open 
probability o f the GluCls through either direct activation and/or maybe potentiation o f the 
channels (discussed in chapter 6 ). This appears to lead to either an essentially irreversible 
(partly explained by their high affinity interaction) hyperpolarisation or depolarisation o f  
the target cell, be it neuron or muscle. The loss o f excitability within in these cells 
presumably explains the paralysis observed.
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GluCl subunit ECsofor glutamate Hill coefT. 
glutamate
ECsofor IVM Hill coefT. 
IVM
Reference
C. elegans m RNA 300pM 1.7 90nM* 1.1 (Arena et al., 1991, 1992)
CeGluClal No response to ImM - 140nM 1.5 (Cully et al., 1994)
CeGluCip 380pM 1.9 No response to 1 pM* - (Cully et al., 1994)
CeGluClal p 1.36mM 1.7 190nM 2.5 (Cully et al., 1994)
CeGluCla2A 2.0mM 1.5 Response to 1 OpM No data (Dent et al., 1997)
CeGluCla2B 208.3pM 2.1 108nM* 1.6 (Vassilatis et al., 1997a)
CeGluCla2Bp 62pM 2.4 103nM* 1.85 (Vassilatis et al., 1997a)
CeGluCla3A No response to lOmM - No response to lOpM - (Dent et al., 2000)
CeGluCla3B Response to 10m M No data Response to lOpM No data (Dent et al., 2000)
CeGluCla4 1.9mM 1.5 400nM 4.9 (Horoszok et al., 2001)
C. elegans pharynx 166pM No data 2.7nM No data (Pemberton et al., 2001)
HcGluCla 8.4pM 2.13 131nM 1.15 (Forrester et al., 2003)
T a b l e  1 . 2 .  S u m m a r y  o f  t h e  p h a r m a c o l o g i c a l  p r o p e r t i e s  o f  G l u C l  c h a n n e l s  e x p r e s s e d  i n  Xenopus o o c y t e s .  The prefixes Ce- and H e -  denote C. elegans and H. 
contortus. Asterisks indicate where IVMPO4 was used instead of IVM. The GluCl described in the pharynx of C. elegans is included as a comparison to the data 
obtained from oocyte recordings.
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Membrane prep Kd [3 H]-IVM Reference
C. elegans membranes 260pM (Schaeffer & Haines, 1989)
H. contortus L3 membranes 130pM (Rohrer et al., 1994)
H. contortus L3 membranes llOpM, 8.7nM (Gill & Lacey, 1998)*
H. contortus L3 membranes 600pM (Hejmadi et al., 2000)
H. contortus L3 membranes 70pM (Cheeseman et al., 2001)
HcGluCla 26pM (Cheeseman et al., 2001)
HcGluCla3B 70pM (Cheeseman et al., 2001)
HcGluCla 126pM (Forrester et al., 2002)
T a b l e  1 . 3 .  S u m m a r y  o f  t h e  b i n d i n g  a f f i n i t i e s  d i s p l a y e d  b y  |  H ] - I V M  t o  w h o l e  n e m a t o d e  m e m b r a n e s  
a n d  i n d i v i d u a l  G l u C l  s u b u n i t s  d i s c u s s e d  i n  t h e  t e x t .  Binding studies for the H  contortus GluCls were 
conducted with membranes prepared from COS-7 cells, expressing the individual subunits. In the study of 
Cheeseman et al. (2001) no specific [3H]-IVM binding was detected to membranes prepared from COS-7 
cells previously transfected with either HcGluCip or HcGluCla3A plasmid DNA. *Gill & Lacey (1998) have 
described two distinct [JH]-IVM binding sites, one a high affinity site, which may be attributed to the GluCls 
and a second lower affinity that remains poorly characterised in molecular terms.
1.9.3 Distribution of nematode GluCl subunits
A full understanding of the functions o f the GluCls and the effect of the AMs requires that 
we know where the receptors are expressed and their subunit composition. In C. elegans, 
reporter gene constructs have shown that avr-14 and avr-15 are widely expressed in the 
nervous system (Dent et al., 1997; Dent et al., 2000) whereas glc-2 expression is confined 
to pm4 pharyngeal muscle cells (Laughton et al., 1997b). Avr-15 is also expressed in the 
pm4 and pm5 muscle cells of the pharynx (Dent et al., 1997), which is consistent with the 
IVM effect observed in the pharynx of C. elegans being dependent on GluCla2 (Pemberton 
et al., 2001). It is likely that the pharyngeal receptor is a heteromer comprised of GluCla2, 
GluClp and possibly one other GluCl subunit. To date, there have been no reported studies 
on the expression patterns o f the glc-1, glc-3 or glc-4 genes.
Localisation in H. contortus has largely been derived from studies using affinity-purified 
anti-subunit antibodies in immunofluorescence experiments. HcGluCip was detected on 
motor neuron commissures but not on pharyngeal muscle (Delany et al., 1998). Recently, 
using a different anti-HcGluCip antibody, this was confirmed, but expression o f this 
subunit was also localised to the lateral and sub-lateral nerve cords. HcGluCla has also
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been localised on motor neuron commissures and double immunolabelling experiments 
showed that the a - and p-subunits co-localise to the same commissures in adult worms 
(Portillo et al., 2003), strongly suggesting that these subunits are part o f the same receptor. 
Nematodes possess distinct excitatory and inhibitory motor neurons that release 
acetylcholine or GABA, respectively, at neuromuscular junctions (Stretton et al., 1985; 
Walrond et a l ,  1985). The anti-HcGluCla subunit fluorescence overlapped with that 
produced by an anti-GABA antibody, suggesting that an ‘a+P’ containing receptor is 
expressed on inhibitory motor neurons.
HcGluCla3A and a3B, were detected in motor neuron commissures, nerve cords and the 
nerve ring (Jagannathan et al., 1999), but the antibody used in these experiments did not 
discriminate between the two subunits. Recently, specific antibodies to the alternatively 
spliced forms have shown that both HcGluCla3 subunits are expressed in motor neuron 
commissures but that, outside o f these cells, they have different patterns o f expression. 
HcGluCla3B, but not HcGluCla3A, is expressed in nerve cords. Interestingly both 
subunits are expressed in the head o f the worm. HcGluCla3A was found in a pair o f lateral 
neurons, probably sensory amphid neurons and HcGluCla3B to three possible pharyngeal 
neurons (Portillo et al., 2003). In C. elegans, avr-14 is also expressed in extrapharyngeal 
neurons in the head o f the worm as well as in other sensory neurons (Dent et al., 2000). The 
expression o f the HcGluCla3B subunit in pharyngeal neurons might explain the paralytic 
effect o f the AMs on pharyngeal pumping (Geary et al., 1993). The significance o f the 
expression observed in likely sensory neurons is unknown.
The distribution o f the known GluCl subunits in H. contortus and C. elegans therefore 
seems to correlate well with the observed actions o f the AMs (Avery & Horvitz, 1990; 
Geary et al., 1993), providing further evidence that these receptors are the main drug 
targets in nematodes. One exception to this may be the effects o f the anthelmintics on 
fecundity, as there is as yet no direct evidence for any role for the GluCls in the 
reproductive system. However, it is clear that the distribution o f orthologous GluCl 
subunits is not completely conserved between even closely related species o f nematode, i.e. 
C. elegans and H  contortus. It may therefore be difficult to draw many conclusions from
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these studies regarding subunit expression, and hence function, for even orthologous GluCl 
subunits in more distantly related species, such as the filaria.
1.10 Project aims
The overall objective o f the project was to establish potential molecular targets for the AMs 
in D. immitis. It was hoped that this would further our understanding as to why the AMs are 
so effective at eradicating larval forms o f D. immitis and yet are so ineffective at killing the 
adult worms. Therefore the first aim o f the project was to amplify candidate GluCl cDNAs 
from D. immitis mRNA, the known partial avr-14 cDNA serving as a starting point from 
which to design oligonucleotide primers (chapter 3). Using degenerate PCR it was hoped 
that further GluCl cDNAs would be amplified. Cloned GluCl subunits cDNAs were then to 






2.1.1 Molecular biology reagents
Molecular biology grade chemicals were purchased from BDH chemicals (Poole, UK), 
Sigma Chemical Company Ltd (Poole, UK) or Fisons Scientific Equipment (Leicestershire, 
UK) except agarose, which was purchased from Life Technologies (Paisley, UK). Ethidium 
bromide, DEPC, 30% (v/v) hydrogen peroxide solution, 37% (w/v) formaldehyde solution 
and formamide were all supplied from Sigma.
2.1.1.1 General buffer/solution compositions
BufTer/solutions Components
50x TAE 2M Tris-acetate, pH 8.0; 50mM EDTA.
lOx TBE 0.89M Tris-HCl, pH 8.0; 0.89M boric acid; 20mM EDTA.
6x DNA Loading 
Buffer
0.25% (w/v) bromophenol blue; 0.25% (w/v) xylene cyanol; 30% 
(v/v) glycerol in ddH20 .
DEPC-ddH20 ddH20  was incubated with DEPC (0.1% v/v) overnight at room 
temperature with stirring and then autoclaved.
Pheno 1: chloro form 
(used for DNA)
Phenol:chlorofbrm:isoamyl alcohol (25:24:1) saturated with ImM 
EDTA containing lOmM Tris-HCl, pH 8.0.
Phenolrchloroform 
(used for RNA)
Phenol:chloroform:isoamyl alcohol (125:24:1), acid equilibrated, 
pH 4.7.
lOx MOPS Buffer 
(500ml)
20.9g MOPS in 350ml DEPC-ddH20 , adjusted to pH 7.0 with 2M 
NaOH; added 10ml 1M sodium acetate pH 7.0, 10ml 0.5M EDTA pH 
8.0 and adjusted to 500ml with DEPC-ddH20 . Sterilised by filtration.
lOx Formaldehyde 
Loading Buffer




T4 DNA ligase and all restriction endonucleases (including the appropriate reaction 
buffers) were supplied by Promega (Southampton, UK).
Enzyme Buffer Components (all lx)
T4 DNA Ligase 30mM Tris-HCl, pH 7.8; lOmM MgCl2, lOmM DTT, ImM ATP
BamHI Buffer E: 6mM Tris-HCl, pH 7.5; 6mM MgCl2, lOOmM NaCl, ImM 
DTT
EcoRI Buffer H: 90mM Tris-HCl, pH 7.5; lOmM MgCl2, 50mM NaCl
Notl Buffer D: 6mM Tris-HCl, pH 7.9; 6mM MgCl2, 150mM NaCl, ImM 
DTT
PstI Buffer H: see above.
SacI Buffer J: lOmM Tris-HCl, pH 7.5; 7mM MgCl2, 50mM KC1, ImM DTT
Sail Buffer D: see above.
Xbal Buffer D: see above.
Xhol Buffer D: see above.
Multicore Buffer (used for selected double digests): 25mM Tris-Acetate, 
pH 7.5 (at 37°C); lOOmM potassium acetate, lOmM magnesium acetate, 
ImM DTT
2.1.1.3 Plasmids
Plasmid Genotype and size Supplier
pCR^-Blunt II-TOPO Kanr, 3.5kb Invitrogen
(Groningen, Netherlands)pcDNA3 Ampr, 5.4kb
pcDNA3.1- Ampr, 5.4kb
pCMV/myc/cyto Ampr, 4.9kb
PGEM®-T Easy Ampr, 3 kb Promega
pFLAG-CMV-5a Ampr, 4.7kb Sigma
L4440 (pPD 129.36) Ampr, 3kb Fire Lab (Carnegie Institute of 
Washington, Baltimore, USA)
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2.1.2 Reagents used for bacteria and C. elegans cultivation
Media reagents were supplied by Difco laboratories (East Molesey, UK) and Sigma, whilst 
glycerol was purchased from BDH (Poole, UK). Ampicilin was purchased from Melford 
Laboratories Ltd (Chelsworth, UK), whilst kanamycin was supplied by Sigma.
2.1.2.1 Culture media/buffers
Medium Components (per litre)
LB lOg tryptone, 5g yeast extract, 5g NaCl.
LB agar LB and 15g Bacto-agar.
SOC 20g tryptone, 5g yeast extract, lOmM NaCl, 2.5mM KC1, lOmM 
MgCl2, lOmM MgSC>4, 20mM glucose.
TSB 0.5g Tryptone, 0.25g Bacto Yeat Extract, 0.25g NaCl, 5g PEG3350, pH 
6.1 with 1M HC1; autoclaved and added 2.5ml DMSO, 0.5ml 1M 
MgSC>4, 0.5ml 1M MgCl2, pH was re-adjusted as before if necessary.
NGM agar 3g NaCl, 2.5g Bacto-peptone, 17g Bacto-agar into 1L ddH20 , 
autoclaved and then added 1ml cholesterol (5mg/ml in ethanol), 1ml 
1M CaCl2, 1ml 1M M gS04, 25ml 1M potassium phosphate (pH 6.0).
M9 Buffer 6g Na2H P04, 3g KH2PQ4, 5g NaCl, 0.25g MgS04.7H20 .
2.1.2.2 Bacterial strains
E. coli Strain Genotype Supplier
XL-1 Blue supE44 hsd R ll recAX end AX gyrA46 thi re I AX 
lac F  \proAB+ laclq lacZ AMI 5 TnlO (tef)]
Stratagene Ltd, 
Cambridge, UK
TOP 10 F  mcrA A(mrr-hsdRMA-mcrBC) <j>80/acZzlM15 
AlacX74 deoR recAX araDX7>9 A(ara-leu)7697 
galXJ galK  rspL (StrR) end AX nupG
Invitrogen
OP50 supE44 hsdRX7 recAX end AX gyrA46 thi re I AX 




Antibiotic Stock concentration Working concentration
Ampicillin 50mg/ml in ddH20 50pg/ml
Kanamycin 50mg/ml in ddH20 50pg/ml
2.1.3 Mammalian cell-culture reagents
COS-7 (African green monkey kidney cells) and HEK-293T (human embryonic kidney 
cells) cell-lines were supplied by the European Collection of Cell Cultures (Salisbury, UK). 
These were maintained in Dulbecco’s Modified Eagles Medium (DMEM), supplemented 
with 10% (w/v) Foetal Bovine Serum, 2mM L-glutamine, 100,000 units/0.51 penicillin and 
100mg/0.51 streptomycin (all Sigma). Trypsin EDTA was also supplied from Sigma. The 
chemical reagents required for the calcium phosphate transfection were all supplied from 
Sigma.
Other cell culture & 
transfection buffers
Components
PBS (1 litre) 8g NaCl; 0.2g KC1; 1.44g Na2H P04; 0.24g KH2P 0 4, pH 7.4
HBS 50mM HEPES, pH 7.0; 140mM NaCl; 1.5mM Na2H P04-2H20
2.1.4 Immunocytochemistry reagents
The anti-flag M2® mouse IgGl monoclonal antibody was supplied from Sigma (catalogue 
number F3165) where as the anti-c-myc mouse IgGl monoclonal antibody was purchased 
from Chemicon (Harrow, UK; catalogue number MAB8864). The Fluorescein (FITC)- 
conjugated AffiniPure Goat Anti-Mouse IgG was supplied by Jackson ImmunoResearch 
(West Grove, PA, USA; catalogue number 115-095-003).
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2.1.5 Xenopus oocyte electrophysiology reagents
All buffer constituents and drugs were supplied by Sigma except for glutamate, which was 
purchased from USB (Cleveland, USA).
Buffer/solution Components
OR-Mg 5mM HEPES, pH 7.5; 82mM NaCl; 20mM MgCl2; 2mM KC1
Collagenase (type 1A) 1.5mg collagenase per ml of OR-Mg.
ND96 5mM HEPES, pH 7.5; 96mM NaCl; 2mM KC1; 1.8mM CaCl2; 
ImM MgCl2; 5% horse serum; filtered sterilised and then added 
2.5mM pyruvate, 50pg/ml gentamycin, lx  antibiotic antimycotic 
solution.
SOS 5mM HEPES, pH 7.5; 98mM NaCl; ImM MgCl2.
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2.2 Methods
2.2.1 General molecular biology methods
2.2.1.1 Agarose gel electrophoresis
Gels were prepared by dissolving 1% (w/v) agarose in lx  TAE or TBE buffer by boiling. 
After cooling the molten agarose to 50-60°C ethidium bromide was added (0.5pg/ml final 
concentration) and the mixture was poured into a horizontal perspex gel apparatus. Once 
set, the comb was removed and the gel was submerged in a tank o f lx  TAE or TBE. The 
DNA samples (0.1-2pg) and molecular weight markers (either lOObp or lkb DNA ladder; 
Promega) were mixed with 6 x Loading Buffer, loaded on to the gel and electrophoresed at 
100V until the marker dyes had sufficiently migrated. Fluorescent ultraviolet light (UV) 
was used to visualise the DNA.
2.2.1.2 Gel purification of DNA
DNA was purified from agarose gels by using the QIAquick Gel Extraction Kit (QIAGEN 
Ltd., Crawley, U.K.). All centrifugations during the procedure were performed at 10,000g 
for 1 minute at room temperature. The DNA fragment to be purified was excised from the 
gel and weighed. For every 1 volume o f gel, 3 volumes o f Buffer QG were added (lOOmg ~  
lOOpl). The mixture was incubated at 50°C until the gel completely dissolved 
(approximately 10 minutes), the sample being vortexed every 2-3 minutes to aid the 
process. Following the addition o f isopropanol (1 volume), the sample was applied to a 
QIAquick spin column that had been placed in a 2 ml collection tube, and centrifuged. 
After discarding the flow-through, 750jil o f Buffer PE (ethanol containing wash buffer) 
was added and the tube was re-centrifuged. Again the flow-through was removed and the 
tube was re-centrifuged to remove any residual ethanol. The column was then placed into a 
clean 1.5ml microfuge tube and 30pl o f sterile ddFLO was added. Following a 1-minute 
incubation at room temperature, the DNA was eluted by a final centrifugation step.
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2.2.1.3 Restriction endonuclease digestion of DNA
A typical restriction digest comprised l-5pg plasmid DNA, 3pi lOx Reaction Buffer, 3pi 
lOx BSA (1 mg/ml stock), 5-10 units o f each restriction enzyme and sterile ddH20  up to 
30pl. The reactions were incubated for 2-4 hours at 37°C. For double digestions, the 
enzymatic activities o f each restriction endonuclease in the various lOx Reaction Buffers, 
as determined by the manufacturer, were considered before selecting the appropriate one.
2.2.1.4 Ligation of DNA
Approximately 50-200ng o f linearised plasmid DNA was mixed with the DNA (the insert) 
to be sub-cloned in a molar vectorrinsert ratio somewhere between 1:1 and 1:3. To the 
sample was added 1 unit T4 DNA Ligase, lp l 10X Ligase Buffer and sterile ddH20  to 
lOpl. The ligation reactions were performed at 16°C for approximately 16 hours.
2.2.1.5 Preparation of E. coli competent cells
XL-1 Blue E. coli was used for routine sub-cloning. From one colony o f bacteria a small 
culture (5ml LB) was grown overnight at 37°C with shaking; a sample (1ml) o f which was 
subsequently used to inoculate 100ml LB in a 1-litre flask. The inoculated culture was 
grown at 37°C with shaking until an o f 0.5 was reached after which the cells were 
pelleted by centrifugation at 6,000g for 10 minutes at 4°C. The supernatant was removed 
and the cells were re-suspended in 10ml o f ice cold TSB. After a 10-minute incubation on 
ice, the re-suspended cells were aliquoted (lOOpl) and stored at -70°C until required.
2.2.1.6 Transformation of plasmid DNA
A sample o f the ligation reaction (5-10pl) was added to a lOOpl aliquot o f competent XL-1 
Blue E. coli that had previously been thawed on ice. The cells were carefully mixed by 
gently swirling with the pipette tip and left to incubate on ice for 5-30 minutes. Following 
heat shocking at 42°C for 30 seconds, the cells were replaced on ice for a further 2 minutes. 
SOC (250pl) was then added and the cells were incubated for 1 hour at 37°C with shaking. 
The transformation mixture was spread (usually 50 and 200pl) on to antibiotic-containing 
LB-Agar plates, which were incubated overnight at 37°C to enable colony growth.
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Colonies were then selected and grown in antibiotic containing LB overnight; the resultant 
cultures were miniprepped (see below) and restriction digested to identify recombinant 
clones.
2.2.1.7 Small-scale preparation of plasmid DNA (minipreps)
Small-scale isolation of plasmid DNA was carried out using the CONCERT™ Rapid 
Plasmid Miniprep System (Gibco BRL, Paisley, U.K.). All centrifugations during the 
procedure were performed at 12,000g at room temperature.
Buffer Composition
Cell Suspension Buffer 
(G l)
50mM Tris-HCl, pH 8.0; lOmM EDTA; 20mg/ml RNase A
Cell Lysis Buffer (G2) 200mM NaOH, 1% (w/v) SDS
Neutralization Buffer 
(M3)
Contains acetate and guanidine hydrochloride*
Wash Buffer (G4) Contains NaCl, EDTA, Tris-HCl, pH 8.0, and 75% ethanol*
TE Buffer (TE) lOmM Tris-HCl, pH 8.0; O.lmM EDTA
* Proprietary formulation
A sample (3-5ml) of an overnight bacterial culture (grown from one colony in antibiotic- 
containing LB) was centrifuged for 2 minutes. Often the remaining culture was used to 
make bacterial cell-stocks (300pl culture mixed with 600pl glycerol; stored at -70°C) for 
long-term storage o f useful plasmids. Following centrifugation, the supernatant was 
removed and the bacterial pellet was re-suspended in 250pl of Cell Suspension Buffer until 
homogeneous. Cell Lysis Buffer (250pl) was added to the re-suspended cells. The tube’s 
content was mixed carefully by inverting 5 times and then incubated for 5 minutes at room 
temperature. Neutralization Buffer (350pl) was added to stop the lysis reaction. As before 
the tube was carefully mixed by 5 inversions before being centrifuged for 10 minutes. The 
supernatant was loaded into a spin cartridge placed in a 2-ml wash tube and centrifuged for 
1 minute. This enabled the DNA to bind the silica-based membrane. Following 
centrifugation the flow-through was discarded and the spin cartridge was placed back into 
the wash tube. Wash Buffer (700pl) was added to the cartridge, which was then centrifuged 
for 1 minute. The flow-through was discarded and the tube was re-centrifuged for 1 minute
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to remove any residual Wash Buffer. The spin cartridge was then placed into a clean 1.5ml 
microfuge tube. Pre-warmed (65-70°C) TE (75pl) was added to the cartridge to elute the 
DNA, which was recovered following a 1 -minute incubation by a 1 -minute centrifugation.
2.2.1.8 Large-scale preparation of plasmid DNA (maxiprep)
Large-scale isolation of plasmid DNA was carried out using the QIAGEN Plasmid Maxi 
Kit (QIAGEN Ltd., Crawley, U.K.).
Buffer Composition
PI (Resuspension Buffer) 50mM Tris-HCl, pH 8.0; lOmM EDTA; lOOpg/ml RNase 
A; stored at 4°C.
P2 (Lysis Buffer) 200mM NaOH, 1% (w/v) SDS.
P3 (Neutralization Buffer) 3.0M potassium acetate, pH 5.5.
QBT (Equilibration 
Buffer)
750mM NaCl; 50mM MOPS, pH 7.0; 15% (v/v) 
isopropanol; 0.15% (v/v) Triton® X-100.
QC (Wash Buffer) 1.0M NaCl; 50mM MOPS, pH 7.0; 15% (v/v) isopropanol.
QF (Elution buffer) 1.25M NaCl; 50mM MOPS, pH 8.5; 15% (v/v) isopropanol.
A starter culture (2-5ml antibiotic-containing LB), inoculated initially with a single colony 
of the desired bacterial strain, was grown for ~8 hours at 37°C with shaking. A sample 
(lOOpl) of this culture was used to inoculate a 100ml LB in a 500ml flask, which was 
incubated overnight at 37°C with shaking. The bacterial cells were harvested by 
centrifugation (6,000g for 15 minutes at 4°C) and the supernatant was removed. After re­
suspension in lOmls o f Buffer PI, the cells were lysed by the addition of lOmls o f Buffer 
P2; the lysis reaction was gently mixed by 5 inversions and left to proceed for 5 minutes at 
room temperature. Buffer 3 (10ml) was added to neutralize the lysis reaction; the tube was 
mixed by inversion 5 times and left to incubate on ice for 20 minutes. The sample was 
centrifuged at >20,000g for 30 minutes at 4°C after which the supernatant was removed and 
re-centrifuged for 15 minutes. During the centrifugation the QIAGEN-tip 500 (anion- 
exchange column) was equilibrated by the addition of 10ml OF Buffer QBT. The column 
was allowed to fully empty by gravity flow before the cell lysate supernatant was applied. 
After fully emptying, the column was washed twice with 30ml of Buffer QC before 15ml of
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Buffer QF was added to elute the DNA. Isopropanol (10.5ml) was added to precipitate the 
DNA; the sample being mixed and then centrifuged at >15,000g for 30 minutes at 4°C. 
After the supernatant was removed the DNA pellet was washed with room temperature 
70% ethanol (5ml) and re-centrifuged at >15,000g for 10 minutes at 4°C. The ethanol was 
removed and the pellet was allowed to air-dry for 5-10 minutes before being re-suspended 
in 500pl ddFhO. The yield o f the maxiprep was determined using a spectrophotometer as 
described in the following section.
2.2.1.9 Nucleic acid quantitation by spectrophotometry
Concentration and purity o f nucleic acids were determined using a spectrophotometer. 
Nucleic acids absorb UV light maximally at 260nm enabling direct calculation o f the 
DNA/RNA concentration according to the equation:
Nucleic acid conc. (jig/ml) = A260 x dilution factor x extinction coefficient 
The extinction coefficients for DNA and RNA are 50 and 40 respectively. The purity o f the 
nucleic acid samples was calculated by the “260 to 280 ratio” (^W ^so)- RNA has an 
^ 26o/ ^ 2 8 0  o f 2.0 ± 0 .1 5 , and DNA has an o f 1.8 ± 0.15. Variations outside these
ranges indicated the presence o f contaminants, which had to be removed.
2.2.1.10 DNA sequencing and analysis
The DNA to be sequenced (~250ng) was mixed with lOpmol o f primer in 6pl ddtfeO and 
sent to the University o f Bath DNA Autosequencing Service. The sequencing primers used 
are detailed in the results chapters and nucleotide sequences for all the primers can be 
found in appendix A. Sequence data was analysed using the GCG (Genetic Computer 
Group, Wisconsin, USA) suite o f programs and Multalin (Corpet, 1988).
2.2.2 Cloning of D. immitis GluCl subunit cDNAs
2.2.2.1 Total RNA extraction from D. immitis
The following procedure was conducted in a ducted fume cupboard due to the antigenic 
nature o f D. immitis and the use o f phenol and chloroform during the extraction. All
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materials used were treated with 1 % (v/v) hydrogen peroxide and autoclaved where 
possible to ensure they were RNase free. Solutions were made with DEPC-treated ddFbO 
to ensure that they were also RNase free.
Approximately 0.3-0.5g o f frozen adult female D. immitis was ground into a fine powder 
under liquid nitrogen using a pestle and mortar. The powder was scraped into a 
homogeniser and TriPure® Isolation Reagent (a monophasic solution o f phenol and 
guanidine thiocyanate; Boehringer Mannheim, Lewes, U.K.) was added (1ml for every O.lg 
o f material). Following homogenisation (10 repeats) the mixture was left to stand at room 
temperature for 1-5 minutes to ensure the complete dissociation o f the nucleoprotein 
complexes. The mixture was transferred to a 15ml Corex tube and chloroform was added 
(0.2ml for every 1ml o f TriPure® used). After capping securely, the tube was shaken 
vigorously for 15 seconds and left to incubate at room temperature for 2-15 minutes. The 
mixture was centrifuged at 12,000g for 15 minutes at 4°C in order to separate the solution 
into 3 phases. The RNA containing upper aqueous phase was removed, with care taken not 
to remove any o f the interface, and placed into another 15ml Corex tube. Isopropanol was 
added (0.5ml for every 1ml o f TriPure® used) to precipitate the RNA, and the tube was 
mixed by 10 inversions and left to incubate on ice for 5-10 minutes. The RNA was 
recovered by centrifugation at 12,000g for 10 minutes at 4°C. The supernatant was 
removed and the RNA pellet was washed with 75% (v/v) ethanol (1ml for every 1ml o f 
TriPure® used) by vortexing. Following centrifugation at 7,500g for 5 minutes at 4°C, the 
ethanol supernatant was removed and the pellet was allowed to air-dry for 5-10 minutes. 
The RNA was re-suspended in 250pl o f 0.5% (w/v) SDS (made with DEPC-treated water). 
A sample o f the RNA (2pl) was diluted in lOOjul o f DEPC-treated water in order to 
determine its concentration and purity using the spectrophotometer (section 2.2.1.9). The 
RNA solution was then adjusted to a concentration o f lptg/pil by addition o f further 0.5% 
(w/v) SDS and aliquoted into 75pl samples that were stored at -70°C.
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2.2.2.2 Isolation of mRNA from total RNA
The mRNA component o f the total RNA was isolated using the Dynabeads® mRNA 
Purification Kit (Dynal, Wirral, U.K.). The following procedure was conducted under 
RNase-ffee conditions using RNase-free materials.
Buffer Composition
Binding Buffer 20mM Tris-HCl pH 7.5, 1M LiCl, 2mM EDTA.
Washing Buffer B lOmM Tris-HCl pH 7.5, 0.15M LiCl, ImM EDTA.
To a thawed aliquot of the D. immitis total RNA (75pl at lpg/pl) 25pl o f DEPC-treated 
ddfhO was added. The sample was heated to 65°C for 2 minutes in order to disrupt RNA 
secondary structures. Meanwhile, 200pl (lmg) o f the re-suspended Dynabeads Oligo (dT)25 
was removed from the stock solution and placed into a 1.5ml RNase-free tube. The tube 
was placed on the Dynal MPC (magnetic holder) and after 30 seconds the supernatant was 
removed. The tube was removed from the magnet and the Dynabeads Oligo (dT)25 were 
washed by re-suspending them in lOOpl o f Binding Buffer. Once again the tube was placed 
on the magnet, after 30 seconds the supernatant was removed and the beads were then re­
suspended in lOOpl Binding Buffer. The total RNA was added to the Dynabeads Oligo 
(dT)25 and was mixed thoroughly by rotating on a roller for 3-5 minutes at room 
temperature. This enabled the mRNA to anneal to the Dynabeads Oligo (dT)25. The tube 
was subsequently placed on to the magnet to separate the mRNA-bound Dynabeads Oligo 
(dT)25 from the other RNA components o f the solution. The supernatant was removed after 
30 seconds. The tube was removed and the Dynabeads Oligo (dT)25 were washed twice 
with 200pl Washing Buffer B using the magnet. Care was taken to completely remove all 
the supernatant between each washing step. The mRNA was eluted by re-suspending the 
Dynabeads Oligo (dT)25 in lOpl o f the provided lOmM Tris-HCl (pH 7.5) and incubating at 
65°C for 2 minutes. The tube was immediately placed on the magnet and the eluted mRNA 
was transferred to a new RNase-free tube. The mRNA makes up approximately 1% of the 
total RNA, therefore from 75pg of total RNA about 750ng should have been isolated, 
although some was probably lost during the procedure. However, this was an ample amount 
for cDNA synthesis.
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2.2.2.3 First strand cDNA synthesis
First strand cDNA synthesis was performed using the SUPERSCRIPT™ II RNase H“ 
Reverse Transcriptase (Boehringer Mannheim, Lewes, U.K.). An oligo (dT)i2-i8-RiRo 
primer (lp l o f lpg/p l stock) was added to the 10pl o f eluted mRNA and lp l DEPC-water 
in a nuclease-free microfuge tube. The mixture was heated at 70°C for 10 minutes and then 
quickly chilled on ice. To the mixture was added 4pl o f 5X First Strand Buffer, 2pi o f 0.1M  
DTT and lp l o f lOmM dNTP mix (lOmM each o f dATP, dGTP, dCTP and dTTP at neutral 
pH; lOOmM stocks from Boehringer Mannheim). The contents o f the tube was gently 
mixed and incubated at 42°C for 2 minutes at which point the SUPERSCRIPT™ II Reverse 
Transcriptase (lp l, 200 units) was added. Following incubation at 42°C for 50 minutes, the 
enzyme was inactivated by heating at 70°C for 15 minutes. The RNA was removed by 
addition o f E. coli RNase H (1 pi, 2 units; Promega) and incubation at 37°C for 20 minutes. 
This step was important to prevent complimentary RNA interfering with the cDNA in 
PCRs where the target was >lkb.
2.2.2.4 The polymerase chain reaction
Polymerase Chain Reactions (PCRs) were carried out in a Perkin-Elmer, Model PTC-100™ 
(MJ Research, Inc) thermo-cycling machine using the Expand™ High Fidelity PCR System 
(Boehringer Mannheim, Lewes, U.K.). This system employed an enzymatic mix o f 
thermostable Taq and Pwo DNA polymerases. Pwo DNA polymerase has an inherent 3’-5’ 
exonuclease proofreading ability, thus it was hoped use o f this system would increase the 
fidelity o f the PCR products. The PCRs were performed in 0.2ml thin-walled 
microcentrifuge tubes.
The reaction mix consisted o f 34.25pl o f ddH20 , 5pl o f 10X Expand High Fidelity DNA 
polymerase buffer (included 15mM MgCl2), 7.5pl o f 2mM dNTP mix (2mM each o f 
dATP, dGTP, dCTP and dTTP at neutral pH) lp l each o f the specific oligonucleotide 
primer (20pM stocks; synthesised by MWG Biotech, Milton Keynes, UK), lp l lOng cDNA 
template, and 0.75pl Expand High Fidelity polymerase enzyme mix (2.6 units). The 
enzyme mix was usually added to the reaction mix following a ‘hot-start’ to the PCR. The 
basic PCRs used a typical 3-step program consisting o f a hot start at 94°C for 2 minutes
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followed by 40 cycles o f 94°C for 30 seconds, ‘x’°C (annealing temperature for specific 
primers) for 30 seconds and 72°C for 1 minute. The final extension step was 72° for 7 
minutes.
Selected PCRs used a Touchdown approach. These PCRs essentially used a 3-step 
program, however over the first ten cycles the annealing temperature was continually 
lowered each time by typically 0.5/1 °C to enhance the specificity o f the reaction. The 
remaining cycles were conducted at the lowest annealing temperature. Details o f each PCR, 
i.e. program type (conventional 3-step or Touchdown PCR), annealing temperatures and 
primers, can be found in the appropriate figure legends. PCR products were analysed by gel 
electrophoresis and products o f interest were gel purified as previously described in 
sections 2.2.1.1 and 2.2.1.2 respectively.
2.2.2.5 Cloning of blunt-ended PCR products
Unless otherwise stated PCR products were cloned using the Zero Blunt™ TOPO™ PCR 
Cloning Kit (Invitrogen, Groningen, Holland). This system allowed the blunt-ended PCR 
products, generated by the Expand™ High Fidelity PCR System, to be efficiently ligated 
into the plasmid vector pCR®-Blunt II-TOPO in a 5 minute reaction at room temperature. 
The pCR®-Blunt II-TOPO system allowed direct selection o f positive recombinants via 
disruption o f the lethal E. coli gene, ccdB, during a successful ligation. The ligation 
reaction mix comprised o f 0.5 to 4pl o f the purified PCR product (10-20ng/pl), sterile H20  
to 4pl, and the pCR®-Blunt II-TOPO vector (lp l). The ligation reaction was gently mixed 
and incubated for 5 minutes at room temperature. After 5 minutes lp l o f the 6x TOPO™ 
Cloning Stop Solution (0.3M NaCl, 0.06M MgCl2) was added. The ligation reaction was 
mixed for 10 seconds at room temperature and then placed on ice. The addition o f the Stop 
Solution created conditions that favour dissociation o f the topoisomerase from the DNA 
and increased the yield o f transformants. For each transformation one vial o f TOPI 0 One 
Shot™ competent cells was thawed on ice. A sample o f the ligation reaction (2pl) was then 
added. The transformation then proceeded as outlined in section 2.2.1.6, however 
kanamycin (50pg/ml final concentration) was used instead o f ampicilin as the selective 
antibiotic contained within the LB-agar plates. Minipreps o f the transformants were
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typically analysed by digestion with EcoRI, as sites for this endonuclease were located on 
both sides o f the multiple cloning site o f pCR®-Blunt II-TOPO.
2.2.3 Expression of GluCl cDNAs in mammalian cell-lines
2.2.3.1 Maintenance of COS-7 and HEK-293T cell-lines
2.2.3.1.1 Routine cell culturing
COS-7 and HEK-293T cell-lines were routinely cultured in 75cm vented flasks containing 
12ml o f supplemented DMEM (Dulbecco’s Eagles Media supplemented with 10% (v/v) 
FBS, 2mM L-glutamine, and 100,000units penicillin/1 OOmg streptomycin). These were 
incubated at 37°C with 5% CO2 . At approximately 85% confluence cells were harvested 
with 0.4ml lOx trypsin-EDTA in 4ml lx  PBS. Cells were routinely split 1:8 for confluency 
after 3-4 days.
2.2.3.1.2 Preparation of cells for storage in liquid nitrogen
Approximately 80% confluent cells were harvested into 10ml DMEM and centrifuged in 
sterile Sterilin 20ml tubes at l,500rpm for 5 minutes. The pelleted cells were re-suspended 
in lm l FBS containing 10% (v/v) DMSO and transferred to cryotubes where they were 
cooled slowly for 24 hours in liquid nitrogen fumes before being transferred to liquid 
nitrogen for storage.
2.2.3.1.3 Re-establishment of frozen cells
Frozen aliquots o f cells were rapidly thawed in a 37°C water bath and added to 10ml o f 
DMEM. Following centrifugation at l,500rpm for 5 minutes, the supernatant was removed 
and the cell pellet was re-suspended in 15ml DMEM. After transferal to a 75cm2 vented 
flask the cells were maintained as described in section 2.2.3.1.1.
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2.23.2 Transient expression procedure
2.2.3.2.1 Preparation of COS-7 and HEK-293T cell-lines for transfection
Prior to transfection the cells were split 1:10 and then 1ml o f the culture was further diluted 
in 12-15ml (depending on level o f confluency o f original cells) o f DMEM. The diluted 
culture was then added drop-wise (typically 3-5) on to coverslips that had been placed in 6- 
well plates. After 1 hours incubation, sufficient time to enable cell adherence to the 
coverslip, 2mls o f DMEM was added to each well and the plates were incubated overnight 
at 37°C with 5% CO2 . Following this period the cells had usually reached the desired 
confluency (40-50% COS-7 cells; 20-30% HEK-293T cells) for the transfection procedure 
to be undertaken. If the cells had not reached this level o f confluency they were left to grow 
until it was achieved before starting the transfections. Although the COS-7 cells strongly 
adhered to the coverslips the HEK-293T cells had a tendency to float o ff during application 
o f the medium. Therefore before plating these cells the coverslips were first treated with 
PEI (described below).
2.2.3.2.2 Treatment of coverslips with polyethylenimine (PEI)
PEI (lg ) was dissolved in 10ml o f ddH20 and filter sterilised (using a 0.22pM filter). A 
1:100 dilution was prepared from the stock with sterile 0.1M Borax and 2ml was added to 
each coverslip in a 6 well plate. These plates were incubated for at least 2 hours at 37°C 
before the PEI solution was removed by aspiration. The plates were subsequently washed 3 
times with PBS before the HEK-293T cells were plated as described above.
2.2.3.2.3 Calcium phosphate-mediated transfection
3-4 hours prior to transfection the medium was changed, during which period the
transfection mixture was prepared. To one 1.5ml tube was added 12pl 2M CaCl2, l-10pg
DNA (depending on sample) and sterile ddH20  up to lOOpl total volume. To a second tube
was added lOOpl 2x HEPES Buffered Saline (HBS). The DNA mixture was then added
portion-wise (20 j l i 1) to the HBS, the tube being shaken between additions to increase
aeration o f the mixture and consequently precipitation formation. Once the DNA had been
completely added, the mixture was incubated at room temperature for 30 minutes after
which time the newly-form precipitates were added, drop-wise, to the appropriate well o f
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cells. The cells were then left to incubate overnight at 37°C with 5% CO2 . The following 
day the cells were washed twice with PBS in order to remove the precipitate and 2ml o f 
fresh medium was added to the cells. The cells were then incubated for a further 24-48 
hours at 37°C with 5% CO2 . Variations upon the method described, used during the 
optimisation process (see chapter 4), included incubating the cells in the DNA-calcium 
phosphate mixture for only 5-6 hours as suggested in some protocols. In additions cells on 
occasion were subjected to a “glycerol shock”, following removal o f the transfection 
mixture, to increase uptake o f the DNA. This involved incubating the cells in 15% (v/v) 
glycerol (in HBS) for 2 minutes before washing with PBS and re-incubating the cells in 
medium.
2.2.3.3 Immunocytochemistry
After 24-48 hours incubation the cells were washed three times with 2ml o f PBS. The cells 
were fixed by incubation in 2ml 4% (w/v) paraformaldehyde (in PBS) for 20 minutes at 
room temperature. Following 3 washes with 2ml PBS, the cells were permeabilized by 
incubation with 2ml 0.1% (v/v) Triton X-100 (in PBS) at room temperature for 5 minutes. 
After a further 2 washes with PBS the samples were blocked for 30 minutes with 2ml o f 
10% (v/v) Horse serum (in PBS). The coverslips were then removed, inverted and placed 
on to 70pl o f the primary antibody solution for 1 hour. The primary antibodies used were 
either anti-Flag M2® mouse IgGl monoclonal antibody at a dilution o f 1 in 1500 in 10% 
(v/v) horse serum or anti-c-zwyc mouse IgGl monoclonal antibody at a dilution o f 1 in 200 
in 10% (v/v) horse serum. After incubation with the primary antibody the coverslips were 
carefully removed and placed back, cells up, into the original 6 well plates. The samples 
were washed four times in PBS, each wash lasting five minutes. After the final wash the 
coverslips were removed, inverted and placed on to 70pl o f the secondary antibody solution 
for 20 minutes. The secondary antibody used for both primaries was the Fluorescein 
(FITC)-conjugated AffiniPure Goat Anti-Mouse IgG (1 in 200 dilution in 10% (v/v) horse 
serum). The coverslips during this step and subsequent steps were covered as much as 
possible to reduce the exposure o f the secondary antibody to the light. Once again 
following incubation, the coverslips were removed, placed cells up, and washed four times 
with PBS, each wash lasting for 5 minutes. Finally the coverslips were removed, inverted, 
and mounted on to coverslides using 30pl o f the mounting medium Mowiol (obtained from
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V. Portillo; prepared as described by Harlow & Lane, 1988) on to a coverslide. The slides 
were left to dry overnight at room temperature and then placed at 4°C until viewed. Slides 
for Green Fluorescent Protein (GFP), the control used to optimise the transfection reaction, 
were mounted following the fixation step. Protein expression was investigated by viewing 
the slides with a Zeiss LSM 510 inverted Axiovert 100M confocal microscope using a 
fluorescein filter set.
2.2.4 Functional expression of GluCls in Xenopus oocytes
2.2.4.1 Synthesis of capped GluCl RNA for injection
2.2.4.1.1 Preparation of template DNA
Before in vitro transcription o f cRNA could be performed the template DNA had to be 
prepared. The GluCl subunit cDNAs o f interest were sub-cloned, using methods described 
in section 2.2.1, into plasmids containing T7 promoters upstream o f their start codons. 
Details o f the plasmids used for each subunit cDNA can be found in the results chapter. 
The recombinant plasmids (~12ug) containing full-length cDNAs for the GluCl subunits 
were linearised at the 3’ end by restriction digestions (section 2.2.1.3). The resulting 
template DNA was purified by phenolrchloroform extraction and ethanol precipitation. 
Three volumes o f phenolrchloroform (Tris-saturated) were added to the sample which was 
vortexed vigorously and briefly centrifuged in order to collect the upper DNA-containing 
phase. A second extraction was carried out on the upper phase, in a similar manner, with 
the addition o f an equal volume o f chloroform. To precipitate the DNA sodium acetate 
(30pl; pH5.2) and absolute ethanol (720pl) were added to the sample, which was chilled for 
at least 15 minutes at -20°C. The DNA was recovered by centrifugation at 20,000g for 15 
minutes at 4°C after which the supernatant was removed and the pellet was re-suspended in 
12pl o f DEPC-ddH20 . A sample o f the DNA (~2pg) was run on an agarose gel (section 
2.2.1.1) to ensure complete linearisation o f the recombinant plasmid.
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2.2.4.1.2 Transcription of capped RNA
Capped RNA was generated using the T7 RNA polymerase mMESSAGE mMACHINE™ 
Kit (Ambion, Huntingdon, UK). The capped RNA transcription reaction comprised lOpl 2x 
NTP/Cap, 2pl lOx reaction buffer, lp g  linear template DNA, 2pl enzyme mix and
nuclease-free water to 20pl. The reaction contents was gently mixed and incubated at 37°C
for 1-2 hours. To ensure the template DNA did not interfere with subsequent procedures 
DNase I (included in the kit) was added (lp l) and the sample was incubated for a further 15 
minutes. Recovery o f the capped RNA was achieved by phenolxhloroform extraction and 
isopropanol precipitation. Nuclease-free water (115pl) and ammonium acetate stop solution 
(15pl), both included in the kit, were added to the RNA reaction and mixed thoroughly. 
The RNA was first extracted by the addition o f 1 volume o f phenolxhloroform (acidic), 
which was vortexed vigorously and briefly centrifuged in order to collect the upper RNA- 
containing phase. A second extraction was carried out on the upper phase, in a similar 
manner, with the addition o f an equal volume o f chloroform. To precipitate the RNA 
isopropanol was added and the mixture was chilled for at least 15 minutes at -20°C. The 
RNA was recovered by centrifugation at 20,000g for 15 minutes at 4°C after which the 
supernatant was removed and the pellet was re-suspended in lOpl nuclease-free water, 
supplied with the kit. The RNA concentration was determined by spectrophotometry 
(section 2.2.1.9) and adjusted to lpg/p l if the purity given by the ^ 2 6 0 /^ 2 8 0  fell within the 
acceptable limits (2.0 ± 0.15). Aliquots o f 2pl were then stored at -70°C.
2.2.4.1.3 Analysis of capped RNA by denaturing gel electrophoresis
The quality o f the RNA also had to be examined by denaturing gel electrophoresis to
ensure only one band o f the correct size had been transcribed. Prior to preparing the gel the
electrophoresis apparatus (gel tank and cast) was soaked in 1% (v/v) hydrogen peroxide for
at least 30 minutes to ensure the removal o f contaminant RNases. The hydrogen peroxide
was removed by rinsing the apparatus with DEPC-dcffbO. To prepare the denaturing gel
initially 0.75g agarose was dissolved in 36ml dd^O . Once the molten agarose had cooled
to approximately 55°C, 5ml o f lOx MOPS and 9ml formaldehyde (37% solution) were
added and gently mixed by swirling. Subsequently, the mixture was poured into the gel
apparatus. Once set, the comb was removed and the gel was submerged into a tank o f lx
MOPS. Before loading, the RNA samples had to be de-natured. The denaturation reaction
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was comprised o f 2-5pg RNA, 2ul lOx MOPS, 4pl formaldehyde solution, lp l ethidium 
bromide (200pg/ml stock concentration) and formamide solution up to 18pl, which were 
incubated for 5 minutes at 85°C. Following cooling 2pl o f lOx formaldehyde loading buffer 
were added and the samples were loaded on to the gel. The samples were electrophoresed at 
100V until the marker dye had sufficiently migrated and then visualised under UV light. An 
RNA Ladder from New England Biolabs (Hitchen, Hertfordshire) was used to determine 
the sizes o f the cRNA samples. Before loading, the RNA ladder (5pi) also had to be 
denatured in the way described above.
2.2.4.2 Xenopus oocyte preparation and injection
Ovarian tissue was surgically removed from sexually mature female Xenopus laevis 
following euthanasia with an overdose o f 0.05% (w/v) benzocaine. The isolated ovarian 
lobes, maintained in OR-Mg, were dissected into smaller clumps and placed into OR-Mg 
containing 1.5mg/ml collagenase (type 1A) for 1.5-2 hours until approximately 50% o f the 
oocytes had no follicle surrounding them. After washing 3 times with OR-Mg, stage V and 
VI oocytes were selected and incubated overnight in ND96 at 18°C on a gently rotating 
tabletop shaker.
Injection needles were pulled from 3.5 Drummond glass capillary tubing (Clark 
Electromedical, U.K.) on a stationary coil Narishige microelectrode puller (Optical 
Instruments Services Ltd., Croyden, U.K.) to produce a tip o f approximately lpM , which 
was then gently broken to give a tip with a slightly larger diameter. Needles were back 
filled with sterile mineral oil and attached to the plunger o f a Drummond “Nanoject” 
microinjector (Broomhall, PA, U.S.A.). With the aid o f a binocular microscope oocytes 
were injected cytoplasmically with either 50ng (lng/nl) o f the selected GluCl RNA or 50nl 
o f nuclease-free H2 O (injection control group). An uninjected control group was also 
established. The oocytes were left to incubate, with daily ND96 buffer changes, for 48-96 
hours before recording.
2.2.4.3 Two-electrode voltage clamp recordings
Microelectrodes were pulled from borosilicate glass capillaries on a microelectrode puller
to produce a resistance, when filled with 3M KC1, o f between 0.5 and 5 MQ. Each oocyte
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was placed in a Perspex-recording chamber, which was continuously perfused with ND98 
(from a gravity fed system at a rate o f 5ml/minute). The oocyte was subsequently impaled 
by the microelectrodes. Electrophysiological recordings were performed using a two- 
electrode voltage clamp amplifier (GeneClamp 500B, Axon Instruments) on oocytes with a 
resting membrane potential o f greater than -25m V and maintained at a holding potential o f 
Eh= -80m V. In response to applied drugs, e.g. glutamate or ivermectin, the change in 
current (or lack of) across the membrane o f the oocyte required to keep the oocyte clamped 
at -80m V was measured on an 800Mhz Pentium III PC using the data acquisition software 
pClamp8 (Axon Instruments). Data were digitised using a Digidata 1322A (Axon 
Instruments).
2.2.4.4 Data analysis
Data were analysed using the program Graphpad Prism version 3 (Graphpad Software, San 
Diego, U.S.A.) and presented as the mean ± the standard error o f the mean. Hill coefficients 
were calculated using the following equation:
I  =  Imta +  (Imax -  Imm)/(1 +  10 [('°sEC5° ~ [agl)H1)
This equation was used to fit a sigmoid curve o f variable slope to the normalised data. Imax 
and Imin represent the (percentage) maximal and minimal currents induced by a particular 
agonist. The EC50 is the concentration o f agonist necessary to elicit half the maximum 
response, H is the (Hill) slope coefficient, and [ag] is the log o f the agonist concentration.
2.2.4.5 Ligand application protocol
All ligands were dissolved in ND98. Saline insoluble IVM was dissolved in absolute 
ethanol (<1% v/v final concentration in saline); this solvent concentration was shown to 
have no undesirable effects either on drug-induced responses or on uninjected oocyte 
membranes when cells were clamped at Eh = -80m V. Only those oocytes, which gave 
stable responses to at least 2 applications o f ImM L-glutamate, were used.
L-glutamate-dose response curves were generated by initially challenging the expressed 
channels with ImM glutamate and then two increasing concentrations o f the ligand. Five-
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minute intervals were observed between each application to prevent desensitisation. Every 
third application ImM L-glutamate was applied to check for “run-down” o f the 
electrophysiological responses. Dose response protocols were not conducted for IVM but 
rather singular concentrations were applied to oocytes in order to obtain qualitative 
responses. A separate perfusion system and recording chamber was used for IVM 
experiments, which was washed thoroughly with absolute ethanol between applications due 
to the highly hydrophobic nature o f the compound.
2.2.5 Miscellaneous C. elegans methods
2.2.5.1 Routine culturing of C. elegans
The Bristol N2 strain o f C. elegans was routinely maintained on NGM agar plates seeded 
with a lawn o f OP50, the bacterial food source. Plates were incubated at 20°C and sub­
cultured every 4-7 days by transferring worms to a new plate using a wire loop. This was 
conducted using standard microbiological sterile precautions at the bench; the worms were 
visualised under a dissecting microscope (Zeiss, Germany).
2.2.5.2 Total RNA extraction from C. elegans
C. elegans total RNA was extracted using a similar methodology to that used for D. 
immitis, the major difference being the initial homogenisation step, which is described here. 
Further steps past that point are described in section 2.2.2.1.
During routine sub-culturing C. elegans were transferred to three large NGM plates (9cm  
diameter). These plates were incubated for a suitable period until they were considered to 
be “just clearing”, i.e. the density o f worms on the plate was at or approaching the 
maximum. M9 buffer was then used to wash the worms from the plates into 15ml Falcon 
tubes, which were subsequently centrifuged at 150g for 1 minute. Approximately 200pl o f 
“packed” worms were transferred to microfiige tubes, which contained 0.5ml o f glass beads 
(425-600 microns, acid washed, Sigma). TriPure® (0.8ml) was added and the worms were 
homogenised by vortexing the tubes for 1 minute. Following vortexing, the homogenate 
was centrifuged briefly. The supernatant was subsequently drawn off the beads and placed
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into clean 1.5ml microcentrifuge tubes. The beads were then rinsed with a further 200pl 
TriPure®, vortexed briefly and centrifuged as before. Once again the supernatant was 
removed and combined with that removed previously. From this point the method used for 
C. elegans was similar to that used for D. immitis, only differing in scale, meaning the 
process was carried out in microfuge rather than Corex tubes. The reader is referred, as 
stated, to section 2.2.2.1 for the chloroform wash onwards.
2.2.5.3 RNA-mediated interference protocol
NGM plates (6cm diamater) were prepared that contained ImM IPTG and 50pg/ml 
ampicilin. Meanwhile, the HT115(DE5) bacteria containing the L4440 plasmid constructs 
{unc-22, gene o f interest and empty) were grown overnight. The following day selected 
plates were seeded with one o f the three bacterial cultures (~100pl spread as a lawn) and 
left overnight at room temperature. C. elegans, o f different larval stages, were then 
transferred on to the plates (approximately 20 on each), which were subsequently incubated 
at 20°C. Each day the worms on all three plasmid constructs were monitored for the 
development o f any gross phenotypes. The unc-22 phenotype, which consisted o f affected 
worms exhibiting strong twitching, developed after approximately 48 hours and was 
therefore used as the positive control for the procedure.
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Chapter 3




The first GluCl subunit cDNAs (GluClal and GluClp) were isolated from the model 
nematode C. elegans (Cully et al., 1994). Alignment o f the clones’ sequences with 
nucleotide and protein databases revealed their high homology to both glycine and GABAa 
receptor subunits. This placed the GluCls firmly in the chloride channel “branch” o f the 
LGIC superfamily, o f which the muscle nAChR is considered the prototype member. There 
are a number o f characteristic motifs exhibited by members o f this superfamily, GluCl 
subunits included (Ortells & Lunt, 1995). A cleaved signal peptide is followed by a large 
N-terminal extracellular domain, which contains potential V-linked glycosylation sites, and 
a pair o f cysteine residues that form a disulphide bridge or loop. Indeed, members o f this 
superfamily are sometimes referred to as the “cys-loop” receptors to distinguish them for 
other types o f LGICs, such as the cationic glutamate receptors. Common to only the GluCl 
and glycine subunits is the presence o f a second pair o f disulphide-linked cysteine residues, 
downstream o f the first (Vassilatis et al., 1997b). These are distinct from the vicinal 
cysteine residues present in a-type nAChR subunits. The C-terminal contains four 
hydrophobic transmembrane domains (TM1-TM4), between the third and fourth o f which 
exists a long intracellular loop that contains consensus sequences for phosphorylation by 
protein kinases (Ortells & Lunt, 1995). As inferred from studies principally on nAChRs, 
mature LGICs are presumed to be homo- or heteropentamers, depending on the constituent 
subunits, the TM2 o f each polypeptide lining the ion pore (Unwin, 1993).
In C. elegans six genes encode for eight GluCl subunits, the avr-15 and avr-14 genes being 
alternatively spliced to produce two subunits each (Cully et ah, 1994; Dent et al., 1997; 
Laughton et al., 1997a; Vassilatis et al., 1997a; Horoszok et al., 2001). Analysis o f the 
completed C. elegans genome indicates that there are no other likely candidate GluCl genes 
(The C. elegans Sequencing Consortium, 1998) In H. contortus, the parasitic nematode in 
which GluCls have been most extensively studied, three genes have so far been described. 
Two o f these genes, glc-2 (encoding the HcGluClp subunit) and avr-14, are clearly 
orthologous to those found in C. elegans (Delany et al., 1998; Jagannathan et ah, 1999). 
The third gene, encoding a HcGluCla subunit (Forrester et ah, 1999), does not appear to be 
orthologous to any found in C. elegans, indicating that there are differences in the genetics 
o f the GluCls between even quite closely related nematode species: H. contortus and C.
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elegans are in the same clade o f the phylogenetic tree proposed by Blaxter et al (1998a). 
Partial GluCl cDNAs, all corresponding to avr-14, have also been isolated from D. immitis, 
the closely related filarial species O. volvulus (Cully et al., 1996a), and A. suum 
(Jagannathan et al., 1999).
The alternative splicing of the avr-14 gene (illustrated in figure 3.1), conserved between C. 
elegans and H. contortus, produces two mRNA that encode for the GluCla3A and a3B 
subunits. Although both subunits share a common N-terminal extracellular domain, which 
presumably includes the glutamate binding site, they have differing C-terminal channel 
forming domains. The coding region for the GluCla3B subunit C-terminal is located within 
a large 3’-untranslated region (UTR) of the GluCla3A mRNA (Laughton et al., 1997a; 
Jagannathan et al., 1999).
GIuCla3A mRNA 1 2  3 4
G I u C l a 3 B  m R N A
F i g u r e  3 . 1 .  T h e  a l t e r n a t i v e  s p l i c i n g  o f  t h e  avr-14 g e n e  i n  C. elegans a n d  H. contortus. Coding regions are 
shown as boxes and non-coding regions are shown as lines. The GluCla3 mRNAs encode for common N 
terminal glutamate-binding domains (blue boxes) attached to differing C terminals (red & green boxes), 
which contain the TM regions (numbered black boxes). Within the large 3’-UTR of the GluClcx3A mRNA is 
the alternative C-terminal coding region (red line), which is spliced (indicated by the broken lines) to the 
common N-terminal coding region to generate the GluCla3B mRNA. The GluCla3A and a3B mRNAs are 
-2.1 and ~1.5kb in size respectively (Laughton et al., 1997a; Jagannathan et al., 1999;).
The initial objective o f the project was to amplify a full-length D. immitis avr-14 cDNA 
corresponding to the partial sequence (termed GluClX in GenBank) that had already been 
cloned. A homology search using the partial sequence indicated the full-length cDNA 
would most likely encode a polypeptide orthologous to the GluCla3A subunits o f C. 
elegans and H. contortus. It was further hypothesised that a GluCla3B subunit cDNA could
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also be amplified from D. immitis given that the partial avr-14 cDNAs from the closely 
related species O. volvulus and A. suum, when translated, exhibited greater identity to this 
alternatively spliced form. Using degenerate PCR it was hoped that further D. immitis 
GluCl subunit cDNAs could also be amplified.
The cloning strategy heavily involved the PCR strategy, RACE (Rapid amplification o f 
cDNA ends). Using this method, oligonucleotide primers external to the sequence o f 
interest are used in tandem with internal primers to a known part o f the sequence to amplify 
the unknown 5’ and 3’ terminals (Frohman et al., 1988). In order to deduce the full-length 
coding region the RACE PCRs were designed to amplify overlapping 5’ and 3’ cDNAs. 5’ 
RACE in nematodes is facilitated by the spliced leader (SL) 1 sequence, which was used 
during the cloning process as the external sense primer to amplify the unknown 5 s terminal. 
SL1 is a highly conserved, 22-nucleotide sequence, which is /ra/w-spliced from a small 
(~ 100-nucleotide) SL RNA on to the 5’ terminals o f a large proportion o f pre-mRNA in 
nematodes. Despite its highly conserved nature the exact fimction o f the SL1 sequence 
remains unclear (Nilsen, 1993, Nilsen, 1995; Blumenthal, 1995). The external, anti-sense 
primer (RoRi) used in 3’ RACE was designed to a 3’ adaptor site, RiRo, incorporated 
during cDNA synthesis from isolated D. immitis mRNA.
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3.2 R esults and D iscussion 1: 
A m plification  o f  D iG lu C la3  cD N A s
3.2.1 Preparation of D. immitis cDNA
The initial step in the preparation of D. immitis cDNA, the template for subsequent PCRs, 
was the extraction of total RNA. Adult female microfilaria-bearing worms were selected 
for the extraction procedure. This increased the chances of amplifying rare transcripts, such 
as LGIC mRNAs, as both adult and larval mRNA pools were isolated. Figure 3.2 shows a 
sample (~2pg) of successfully extracted total RNA, analysed by conventional agarose gel 




F i g u r e  3 . 2 .  D. immitis t o t a l  R N A .  A 2fig
sample was electrophoresed on a 1.5% agarose 
gel. The arrows indicate the rRNA and tRNA 
components.
315bp
F i g u r e  3 . 3 .  A m p l i f i c a t i o n  o f  a  p a r t i a l  D. immitis avr- 
14 c D N A .  Lane 1: lOObp DNA ladder; lane 2: PCR 
product, amplified using a 3-step PCR program 
(annealing temperature of 52°C, extension time of 30 
seconds) and primers 5Di2/3Pl & 3Di2/3Pl.
The cDNA was synthesised by reverse transcription from the poly(A)+ selected mRNA 
component o f the total RNA. A control PCR to assess the quality o f the cDNA was 
successfully performed, using oligonucleotide primers (5Di2/3Pl and 3Di2/3Pl) designed 
to amplify a 315bp region of the partial D. immitis avr-14 cDNA (figure 3.3). The PCR 
product was subsequently cloned into pCR^-Blunt II-TOPO, recombinant clones being 
identified by restriction digest with EcoRI. Sequencing of one such clone, using the vector 
specific M l3 primers supplied with the cloning kit, confirmed the desired region had been
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amplified. The nucleotide sequences o f these and all other primers used in this study can be 
found in appendix A.
3.2.2 Amplification of the DiGIuCla3A cDNA
5’ and 3’ RACE, graphically illustrated in figure 3.4, was used to obtain overlapping cDNA 
clones from which a DiGluCla3A nucleotide sequence could be deduced. Using the anti­
sense primer 3Di2/3Pl in conjunction with a sense primer to the SL1 sequence, the 5’ 
RACE PCR amplified two cDNAs of 600 and 750bp (figure 3.5A). These products were 
subsequently cloned into pCR®-Blunt II-TOPO. As before, recombinant clones were 
identified by restriction digest with EcoRI and a selected clone was sent for sequencing 
using the M l3 primers. Both cDNAs exhibited identical sequence, over the predicted 
region, with the previously cloned partial avr-14 cDNA indicating they were all amplified 
from the same transcript. The 750bp cDNA exhibited an open reading frame with a putative 
start codon located 15bp downstream of the SL1 sequence. As predicted, translation of the 
open reading frame revealed a partial amino acid sequence that exhibited highest identity to 
the GluCla3A subunits (-80%). Identity ranged from 70-80% with GluCla3B subunits. 
The 600bp cDNA appeared to the result o f mis-annealing of the SL1 primer downstream of 
the actual SL1 site, otherwise the sequence was identical to that o f the 750bp product.
S L 1  5 D i 2 / 3 P l
SL1 424bp GluCLX Poly (A) RiRo
3 D i 2 / 3 P l  RoRi
F i g u r e  3 . 4 .  S c h e m a t i c  r e p r e s e n t a t i o n  o f  t h e  R A C E  s t r a t e g y  e m p l o y e d  t o  a m p l i f y  t h e  D i G l u C l a 3 A  
s u b u n i t  c D N A .  The boxed regions represent the DiGluCla3A mRNA sequence; yellow: SL1 sequence; 
grey regions: unknown mRNA sequence; red region: partial, known avr-14 sequence; orange poly(A) tail; 
green region: 3’ RiRo adaptor site. The opposing black arrows indicate the region that was to be amplified 
during 5’ RACE and the primers that were to be used. Conversely, the opposing blue arrows indicate the 
region that was to be amplified during 3’ RACE and the primers that were to be used.
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F i g u r e  3 . 5 .  A m p l i f i c a t i o n  o f  p a r t i a l  a n d  f u l l - l e n g t h  G l u C l a 3 A  c D N A s .  Lane 1: lOObp DNA ladder (A & 
B); lkb DNA ladder (C). Lane 2: PCR products. Each PCR used a standard 3-step program. A .  5 ’ R A C E  
P C R  (primers SL1 & 3Di2/3Pl; annealing temperature of 55°C); B :  3 ’ R A C E  P C R  (primers 5Di2/3Pl & 
RoRi; annealing temperature of 52°C); C :  F u l l - l e n g t h  c o d i n g  r e g i o n  P C R  (primers SDG2 & ASDG2; 
annealing temperature of 51 °C).
Using the sense primer 5Di2/3Pl with the anti-sense primer to the 3’ adaptor site, RoRi, the 
3’ RACE PCR amplified two cDNAs of approximately 1.2kb and 400bp (figure 3.5B), the 
larger product being cloned and sequenced as before. Analysis of the sequence revealed an 
open reading frame with a putative stop codon that when translated exhibited highest amino 
acid identity, as predicted, to the GluCla3A (80%) subunits. Again, identity to the 
GluCla3B alternatively spliced forms was lower, ranging from 70-80%. From the 
overlapping 5’ 750bp and 3’ 1.2kb cDNAs a full-length open reading frame (i.e. the coding 
region) of 1260 nucleotides was deduced. The coding region was amplified, using primers 
SDG2 and ASDG2 (figure 3.5C), cloned as before, and fully sequenced on both strands to 
ensure confidence in the nucleotide sequence. However, several nucleotide substitutions 
were observed between the amplified coding region cDNA and the compiled sequence. 
Therefore to ascertain a consensus nucleotide sequence, a second PCR of the coding region 
was carried out. The resulting cDNA was identical in sequence to the first coding region 
clone and was thus adopted as the consensus sequence for the DiGluCla3A coding region 
(see appendix B). The proposed 1260 nucleotide sequence therefore encodes a polypeptide 
o f 419 amino acids (figure 3.10). Addition of the 5’ and 3’ UTRs, determined from the 
overlapping RACE PCR products, meant the full-length GluCla3A mRNA was proposed 
to be ~1.5kb (see appendix B). Interestingly, the proposed mRNA did not exhibit the large
3’-UTR observed for the orthologous subunit mRNAs of C. elegans and H. contortus, 
raising the possibility that only one GluCla3 subunit may exist in D. immitis. However, as 
outlined in the introduction, partial GluCla3B-like cDNAs had been cloned from both O. 
volvulus and A. suum, species more closely related to D. immitis than C. elegans and H. 
contortus. It was therefore hypothesised that D. immitis also possessed two GluCla3 
subunits but the alternative splicing mechanism or mRNA processing in this species was 
somehow different from that seen in C. elegans or H. contortus.
3.2.3 Amplification of the DiGluCla3B subunit cDNA
The PCR strategy devised to amplify a DiGluCla3B subunit cDNA assumed that the 
alternative splicing o f the avr-14 gene was conserved between this filarial species, C. 
elegans and H. contortus (see figure 3.1), but the large 3’-UTR was simply not maintained 
in the mature DiGluCla3A mRNA. Therefore, a PCR using the sense primer (SDG2) to the 
DiGluCla3A coding-region in conjunction with the anti-sense primer RoRi was predicted 
to amplify both subunit cDNAs. In addition, both subunit cDNAs were expected to be of a
F i g u r e  3 . 6 .  A m p l i f i c a t i o n  o f  G l u C l a 3  
s u b u n i t  c D N A s .  Lane 1: lkb DNA 
ladder; lane 2: PCR product, amplified 
using a 3-step PCR protocol (annealing 
temperature of 49°C) with the primers 
SDG2 and RoRi.
1.5kb
similar size (~1.5kb) as they would be in C. elegans and H. contortus if the presence of the 
large 3’-UTR were removed. The PCR amplified a number of bands including one of 
1.5kb, which was subsequently cloned into pCR®-Blunt II-TOPO (figure 3.6). As this band 
was predicted to be a heterogeneous mix of PCR products individual clones were screened 
by restriction digestion. The endonuclease EcoRI was chosen for the screening process, as 
there was a conserved restriction site at the centre o f the GluCla3A nucleotide sequences of 
C. elegans, H. contortus and D. immitis that appeared to be absent in the GluCla3B 
nucleotide sequences. The expected restriction digestion pattern o f the GluCla3A clones 
was one band at ~3kb, the linearised plasmid (pCR®-Blunt II-TOPO), and a smaller band of
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750bp, the bisected insert. GluCla3B cDNAs were expected to exhibit the band at 3kb (the 
linearised plasmid) and a differing, although unknown, digestion pattern from that of 
GluCla3A cDNAs. The results of the restriction digest screen are shown in figure 3.7 with 
clones 3, 6, 7, 8, and 10 giving the expected digestion pattern for a GluCla3A cDNA. 
Systematic sequencing of the other clones indicated that clone 5, contained a potential (an 
intron was located at the centre o f the cDNA) open reading frame of 1284 nucleotides that 
encoded for a GluCla3B-type subunit; homology searches revealed the predicted
3kb 
750bp
F i g u r e  3 . 7 .  R e s t r i c t i o n  d i g e s t i o n  s c r e e n i n g  o f  p o t e n t i a l  G l u C l a 3 B  s u b u n i t  c D N A s .  Lane M: lkb 
DNA ladder; lanes 1-10: individual clones screened by restriction digestion with EcoRI. The arrows 
indicate the expected sizes of digested GluCla3A clones. The asterisk indicates the GluCla3B clone.
polypeptide to have >80% and 70-80% amino acid identities with orthologous GluCla3B 
and GluCla3A subunits respectively. The 5’ nucleotide sequence was identical to that of 
the DiGluCla3A coding region where as the 3’ sequences of each differed, appearing to 
affirm the hypothesis that the alternative splicing o f the avr-14 gene was conserved across 
examined species. An anti-sense primer (ASDG3) was subsequently designed and used in 
conjunction with the sense primer SDG2 to amplify the proposed coding region of 
DiGluCla3B (figure 3.8). The PCR product, which was of the expected size (~1.3kb), was 
cloned and fully sequenced on both strands. This cDNA did not contain any introns and the 
sequence confirmed the predicted open reading frame. Therefore the D. immitis GluCla3B 
coding region was proposed to be 1284 nucleotides (see appendix B) making the encoded 
subunit 427 amino acids in length (see figure 3.10). Addition o f the 5’ and 3’ UTRs meant 
the full-length DiGluCla3B mRNA was proposed to be ~1.5kb (see appendix B), similar in 
size to the orthologous subunit mRNAs from C. elegans and H  contortus.
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M 1 2 3 4 5* 6 7 S 9 10
F i g u r e  3 . 8 .  A m p l i f i c a t i o n  o f  t h e  D i G l u C l a 3 B  
c o d i n g  r e g i o n .  Lane 1: 1 kb DNA ladder; lane 2: 
PCR product. The amplification used a Touchdown 
PCR protocol (annealing temperature 55-50°C) with 
the primers SDG2 and ASDG3.
1.3kb
3.2.4 Sequence analysis of the DiGluCla3A and a3B subunits
As indicated in the previous sections, the amplified GluCl cDNAs from D. immitis encode 
polypeptides that are clearly orthologous to the GluCla3A and a3B subunits identified in 
other species o f nematode, exhibiting >80% amino acid identity; this level of homology is 
comparable to that between the GluClp subunits o f C. elegans and H. contortus. It is 
apparent from aligning the two DiGluCla3 subunit amino acid sequences (figure 3.10) that 
the pattern o f alternative splicing of the avr-14 gene in this species is identical to that 
observed in C. elegans and H. contortus, i.e. the resulting subunits share identical N- 
terminal domains but have differing C-terminal domains, the splice site being located just 
prior to TM1. However, the final processing of the D. immitis GluCla3A mRNA is 
evidently different; the large 3’-UTR in the filarial transcript is absent (see appendix B). It 
appears reasonable to suggest that in D. immitis the 3’-UTR may be present as part of a 
precursor mRNA (analogous to the mature GluCla3A mRNA in C. elegans and H. 
contortus) and that once the “instruction” to produce a GluCla3A subunit is made, this 
region is cleaved, leaving the mature transcript. Indeed, this would normally be the 
expected scenario as the maintenance o f splice sites downstream of a stop codon is 
normally detected by quality control mechanisms and the mRNA is degraded. The reason 
the 3’-UTR is maintained in C. elegans and H. contortus is unknown. Figure 3.9 
graphically summarises the mRNA generated following alternative splicing of the avr-14 
genes in C. elegans, H  contortus and D. immitis.
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C. elegans & H. contortus
G l u C l a 3 A  m R N A  1 2  3 4
G I u C l a 3 B  m R N A
D. immitis 
G l u C l a 3 A  m R N A
G l u C l a 3 B  m R N A
F i g u r e  3 . 9 .  C o m p a r i s o n  o f  t h e  m R N A  g e n e r a t e d  f o l l o w i n g  t h e  a l t e r n a t i v e  s p l i c i n g  o f  t h e  avr-14 
g e n e s  i n  C. elegans,  H. contortus a n d  D. immitis. Coding regions are shown as boxes and non-coding 
regions are shown as lines. In all three species the GluCla3 mRNAs encode common N terminal 
glutamate-binding domains (blue boxes) attached to differing C terminals (red & green boxes), which 
contain the TM regions (numbered black boxes). In C. elegans and H. contortus, within the large 3’-UTR 
of the GluCla3A mRNA is the alternative C-terminal coding region (red line), which is spliced (indicated 
by the broken lines) to the common N-terminal coding region to generate the GluCla3B mRNA. In both 
species the GluCla3A and a3B mRNAs are -2.1 and ~1.5kb in size respectively (Laughton et al., 1997a; 
Jagannathan et al., 1999]. The large 3’-UTR is absent in the D. immitis GluCla3A mRNA leaving both 
subunit transcripts of a similar size (~1.5kb). Presumably the 3’-UTR is cleaved during mRNA processing 
in this species.
As expected, the D. immitis GluCla3 subunits exhibit the characteristic motifs associated 
with members o f the LGIC superfamily. These are highlighted in figure 3.10, which shows 
an alignment o f these subunits with other ligand-gated chloride channel (LGCC) members 
of the superfamily, and are discussed below. A more extensive alignment of GluCl subunit 
amino acid sequences can be found in appendix C. At the common N-terminal o f the D.
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immitis GluCla3 subunits is a putative signal peptide o f 18 amino acid residues, as 
predicted by the program SignalP Vl . l  (Nielsen et al., 1997). As with other such 
polypeptides, the signal peptide would direct the N-terminal (and indeed the smaller C 
terminal) o f these GluCl subunits into the lumen o f the endoplasmic reticulum (ER) before 
being cleaved. It follows that correct insertion into the ER leads to the proper orientation o f  
the receptor within the plasma membrane, i.e. the large N-terminal region will be 
extracellular. Within the ER the N-terminus is also exposed to the enzymes that regulate the 
necessary post-translational modifications, e.g. A-linked glycosylation and disulphide 
bridge formation (Green & Millar, 1995). The mature GluCla3A and a3B subunits, 
following cleavage o f the signal peptides, would therefore be 401 and 409 amino acids in 
length respectively. It must be noted however that references within the text to numbered 
residues include the 18 amino acid signal peptide.
Analysis o f the common N-terminal amino acid sequence by the GCG program “Motifs” 
reveals that Asn-45 is a putative A-linked glycosylation site. A highly characteristic feature 
o f the N-terminals o f LGICs, the A-linked glycosylation site is clearly important for 
receptor function: mutation o f a comparable site (N38A) within the rat glycine a l  subunit 
abolishes glycine-activated currents (Akagi et al., 1991). However, it is not generally 
believed that this site plays a role in ligand binding, as could be inferred from this study. 
Instead, studies on chick GABAa and Torpedo nAChRs, expressed in Xenopus oocytes, 
indicate the putative A-linked glycosylation site is crucial for receptor stability and/or 
efficient insertion o f the mature receptors into the plasma membrane (Sumikawa et al., 
1988; Gehle & Sumikawa, 1991).
As outlined in the introduction, one o f the defining features o f the N-terminals o f LGIC 
subunits is a characteristic pair o f cysteine residues, which form a disulphide bridge o f 15 
amino acids. In the D. immitis GluCla3 subunits these residues are present at positions 166 
and 180. Although accepted not to be part o f the agonist-binding site, opinion on the 
function o f the cysteine loop remains polarised. Uncoupling o f the loop o f nAChRs, by 
mutating the cysteine residues has been suggested to result in the failure o f the subunits to 
properly assemble (Fu & Sine, 1996; Green & Wanamaker, 1997). However, other groups 
have suggested the function o f the loop is to both provide stability against degradation and
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also to determine the efficiency with which the receptors are transported to the cell surface 
(Blount et al., 1990; Sumikawa & Gehle, 1992). There is a high degree o f conservation o f 
amino acids within the loop and mutation o f these residues can also affect receptor 
function. For example, mutation o f the glycine-al subunit at Asp-148, a residue seemingly 
conserved across GluCls (Asp-176 in the DiGluCla3 subunits), appears to prevent receptor 
expression (Vandenberg et al., 1993).
The second cysteine pair, which is indicative o f the glycine and GluCl receptors only, 
emphasising their “orthologous” relationship (Vassilatis et al., 1997b), is located at 
residues 227 and 238; the length o f this disulphide bridge (11 amino acids) is also 
conserved. The function o f this loop has been studied in glycine receptors and it appears 
that uncoupling the loop or indeed mutating selected residues within it can dramatically 
affect both subunit assembly and agonist binding (Vandenberg et al., 1992a, 1992b; 
Rajendra et al., 1995).
The major determinants o f agonist binding are contained within the N-terminal o f LGIC 
subunits. Conversely the C-terminals are thought to be largely responsible for forming the 
ion channel within the membrane, discussed in more detail below. The functional autonomy 
o f these regions has been elegantly demonstrated: the ligand-binding domain o f a nACh 
receptor (N-terminal) has been shown to be capable o f activating a 5 -HT3 membrane 
channel (C-terminal) in a chimeric receptor (Eisele et al., 1993). Similarly, chimeric 
receptors formed from the GluClal (N-terminals) and GluCip (C-terminals) subunits o f C. 
elegans were used to infer that the major determinants for glutamate binding were also 
present on the N-terminals o f GluCls; the homomeric GluClal receptors were glutamate 
insensitive but GluCip homomers and the chimeric receptors were activated by the agonist. 
Subsequent site-directed mutagenesis within the pore o f GluClal revealed this subunit was 





























  .......     MNPRIVYWNLILLIL. . VW|KKKLKEQEIIQRTL. . KD. YDWRVRPRGSNLSW
................................... tOUPRlVYftNLILLIL. S^KKKLKEQEUQRTI*. . KD. YDWRVRPRGSNLSW
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DiGluCla3A IGVCLAFIFGALLEFALVNYAARK.......DITT..... RH. RMLSKYASHM. . . DY............... SSGYQPLV SA 367
DiGluCla3B I GVCLAFI FGALLEYALVNYYGRQ........EFLK.... KEKRKKTEYKGCLCPSDH............... LFNQDLRQ. . . . SL 371
CeGluCla3B IGVCLAFIFGALLEYAWNYYGRK........EFLR.... KEKKKKTRIDDCVCPSDR............... P...PLRL DL 372
CeGluClal IGACMT FIFCALLE FALVNHIANK........QGVE.... RKART EREKAEIPLLQNL............... HNDVPTKVFNQEEK 400
CeGluClp LGACQT FVFGALLE YAFVS YQDS V........RQND.... RS RE KAARKAQ RRRE KL E............... MVDAEVY QP 366
DmGluClal TGVCLTFVFGALLEFALVNYASRSGSNKANMHKENM KKKRRDLEQASLDAASDLLDTDSNATFAMKPLVRHPGDPLALEKRLQC 394
hGlyRal MAVCLLFVFSALLEYAAVNFVSRQ......HKELL..... RFRRKRRHHKEDEAGEGRFNFSA. . . YGMGPACLQAKDGISVKGANNS 388
mGABAAp2 LMGCFVFVFMALLEYALVNYIFFGRGPQRQKKAAEKAANANNEKMRLDVNKMDPHENILLSTLEIKNEMATSEAVMGLGDPRSTMLAYDA 398
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Figure 3.10. Alignment of the proposed DiGluCIa3 amino acid sequences with other LGCC subunits.
The D. immitis (Di) GluCla3 subunits amino acid sequences were aligned with selected GluCl subunits from 
C. elegans (Ce) and D. melanogastor (Dm), and representative mammalian (h=human; m=mouse; r=rat) 
LGCC subunits using MultAlin (Corpet, 1988). Characteristic features of all the subunits are the signature 
pair of cysteine residues (highlighted in yellow) and TMsl-4 (underlined). The cysteine residues, indicative of 
the GluCls and glycine receptors, are highlighted in light green. Features of the DiGluCla3 subunits are the 
18 amino acid signal peptides (light blue highlighted italics), the TV-linked glycosylation site (red star) and the 
potential regulatory phosphorylation sites between TM3-4 for protein kinases (red font=casein kinase II; blue 
font=protein kinase C; pink font=cAMP dependent protein kinase). The proposed alternative splicing site for 
the GluCla3 subunits is highlighted in dark green, the glycine residue marking the beginning of the differing 
C-terminals. The residues highlighted in grey have been proposed to be highly conserved across the 
superfamily and are thought to form the core structure of the LBD (Brejc et al., 2001). The blue and pink 
boxes above the text indicate the positions of the residues implicated to form the “loops” that form the 
binding site in nACh receptors (pink=“loops” A-C; blue=“loops” D-F) (Brejc et al., 2001; Sine, 2002). 
Tyrosine-182 of the CeGluClp subunit, which is implicated in glutamate binding, is highlighted in red (Li et 
al., 2002; Slimko & Lester, 2003). Highlighted in black above the TM2 region are the conserved residues 
found in nACh and 5-HT3A receptor subunits at the equivalent positions that confer their cation selectivity; the 
dash indicates the absence of the proline residue in these sequences (Galzi et al., 1992; Keramidas et al., 
2000; Gunthorpe & Lummis, 2001).
The ligand-binding domain (LBD) has been extensively studied in nAChRs using a variety 
o f approaches (reviewed in Karlin, 2002 & Sine, 2002). Binding has been determined to 
occur at a “pocket” formed at the interface between selected subunits. The a- subunits are 
thought to form the principle part o f the binding site contributing the so-called “loops” A-C 
whilst the neighbouring subunits contribute the “loops” D-F, the combined 3-dimensional 
arrangement forming the“ pocket”. There is not absolute conservation o f residues proposed 
to form the binding “loops” between subunits, possibly explaining, in part, why certain 
receptors and indeed, “pockets” within the receptors have differing affinities for agonist. As 
the nACha7 subunit forms homomeric receptors each polypeptide contains all the residues 
responsible for forming “loops” A-F. The positions o f the key agonist binding residues are 
indicated in figure 3.10. Crystallisation o f a molluscan acetylcholine binding protein also 
identified a number o f residues that appear to form the core structure o f the LBD, bringing 
these loops together (Brejc et al., 2001). These, mainly, hydrophobic amino acids exhibit a 
high degree o f conservation across the superfamily (also highlighted in figure 3.10). It has 
therefore been suggested that all LGICs have a similar LBD configuration (Brejc et al.,
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2 0 0 1 ), although little structural evidence exists to confirm such an assertion for other 
classes o f receptor.
Site-direct mutagenesis studies on GABAa subunits have revealed a number o f amino 
acids, which appear to be important for agonist binding to these receptors. As for all 
mutagenesis studies, it is sometimes difficult to be certain that the mutated residues are 
directly involved in binding or have a distant, indirect effect, which may still alter the 
activation o f the receptor. However, significant effects on agonist binding and channel 
activation have been observed within GABAa receptors following mutations o f residues 
that either align with the proposed binding or key structural amino acids o f nAChR 
subunits (reviewed in Chang & Weiss, 2000). For example, mutations within the rat 
GABAa a l subunit at positions F64 and R6 6  that correspond to residues T81 and R83 o f 
the D. immitis GluCla3 subunits and those residues, which form “loop” D o f the binding 
site in nAChRs (contributed by the P and a l  subunits), have lead to 73-320 fold increases 
in the GABA EC50 (Sigel et al., 1992; Smith & Olsen, 1994; Boileau et al., 1999). 
Similarly, mutation o f Y157 o f the rat GABAAp2 subunit or the equivalent (in position) 
Y198 o f the human GABAApl subunit also affects the GABA EC50 significantly (Amin & 
Weiss, 1993). These latter positions correspond to a tryptophan residue within “loop” B o f 
the nAChRs (contributed by the a  subunits) and indeed a conserved tyrosine (position 186 
o f the DiGluCla3 subunits) within GluCl subunits. Interestingly, this tyrosine is the only 
amino acid residue so far determined to play a key role in glutamate binding to GluCls. 
Mutation o f this residue in C. elegans GluCip subunits (tyr-182) to a phenylalanine reduced 
the glutamate response o f the GluClal p heteromers to 16%. During these studies a number 
o f other residues predicted to lie within “loop” regions o f GluCip were mutated. Although 
many lead to dramatic effects on receptor activation by glutamate it was difficult to discern 
whether these were truly due to effects on the binding site or not (Li et al., 2002; Slimko & 
Lester, 2003). Should the structure o f the binding sites be conserved across the superfamily, 
as highlighted by the above examples, it is tempting to hypothesise that the GABAAa  
subunits may contribute the equivalent “loops” to those D-F found in the nAChp subunits 
where as the GABAaP and p subunits may contribute the equivalent “loops” A-C found in 
nACha subunits. In addition, as most GluCl subunits examined so far are capable o f
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forming homomeric receptors this suggests all the determinants or “loops” for ligand 
binding must be typically contained within each polypeptide, as described for nACha7 
receptors.
The C-terminal o f the D. immitis GluCla3 subunits, simply from alignment with other 
GluCl subunits, clearly exhibits the four characteristic, hydrophobic TM regions; 
hydropathy plots for each subunit confirm their presence (see appendix D). Residues that 
comprise TM1-3 are highly conserved across the LGIC superfamily, particularly within 
each class o f receptor, where as TM4 varies more considerably in sequence. The TMs were 
classically viewed as four a-helices although increasing evidence suggests that only TM2 
and probably TM4 exhibit such secondary structure. A recent study focusing on glycine 
receptor subunits proposed a model where by the classical TM1 is actually three membrane 
spanning beta strands where as TM3 has a mixed single membrane spanning structure, 
which may only have partial helical character (Leite & Cascio, 2001). Extensive work on 
the nACh receptor structure also argues against the classical four a-helical nature o f the 
TMs (Unwin, 1993). The second TM o f each subunit lines the membrane channel, residues 
within this region being implicated in channel gating and ion selectivity. Where as the 
actual residues responsible for forming the gate remain somewhat controversial, although 
they appear to be located between the middle to cytoplasmic face o f TM2 (Xu et al., 1995; 
Xu & Akabas, 1996; Chang et al., 1996; Chang & Weiss, 1998), it has been well 
established that only three amino acid mutations within this region are required to change 
the ion selectivity o f the channel (highlighted in figure 3,10). Both a l  nACh and 5 -HT3A 
receptors can be made anion selective by changing a valine to a threonine, a glutamate to an 
alanine (neutralising a ring o f negative charge) and inserting an “extra” amino acid 
(proline), which is not present in these channels (the positions o f these mutations are 
highlighted in figure 3.10) (Galzi et al., 1992; Gunthorpe & Lummis, 2001). The reverse 
changes in glycine receptors bestow cation selectivity (Keramidas et al., 2000); given the 
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F i g u r e  3 . 1 1 .  A l i g n m e n t  o f  t h e  T M 2  d o m a i n s  o f  t h e  G l u C l a 3  s u b u n i t s .  The TM2 regions of 
nematode GluCla3 subunits were aligned using the GCG program “pileup”. The two-letter prefix on 
each subunit denotes the species of nematode: Ce (C. elegans); H e  (//. contortus); As (Ascaris suum);
Ov (Onchocerca volvulus); Di (D. immitis). The GluCLX sequences are so called because they are 
derived from partial GluCla3B cDNAs. The highlighted in yellow are the conserved residues 
consistently found in GluCla3B-type subunits where as in blue are those found in the GluCla3A type 
subunits.
There are notable conserved differences in amino acid sequence at selected positions 
between the GluCla3A and a3B subunit across species. As the N-terminals are identical, 
these key differences all occur in the C-terminals of these polypeptides. Although little is 
known about the functional roles of individual amino acids in GluCls, it is tempting to 
speculate that these conserved differences may well be important in explaining different 
properties between the two alternatively spliced subunit classes. For example, CeGluCla3B 
can form glutamate-sensitive, homomeric channels in Xenopus oocytes where as the 
CeGluCla3A subunits, despite seemingly having the same LBD cannot (Dent et al., 2000). 
Figure 3.11 highlights such differences with the TM2 domains o f the alternatively spliced 
forms. Towards the intracellular side of the TM, GluCla3A and GluCla3B subunits exhibit 
conserved threonine and serine residues respectively. Interestingly, it is at this position in 
the GluClal subunit o f C. elegans that the threonine residue can be located, which when 
mutated to an alanine, glycine, or proline, changed the ability o f the homomeric GluClal 
receptor to be gated by glutamate. However it must be noted that the conservative change to 
a serine residue (the difference observed between the GluCla3 spliced forms) did not 
appear to alter the channel properties (Etter et al., 1996). Mutations in the equivalent 
position in the Drosophila melanogastor RDL subunit (a GABA receptor subunit) can
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cause dieldrin- and picrotoxin-resistance (Ffrench-Constant et al., 1993). No evidence 
exists to speculate on the effect o f the second conserved change in the TM2 domains.
The large intracellular loop between TM3 and TM4 is the most variable region between the 
two subunits with little amino acid conservation. This is a common feature amongst closely 
related members o f LGIC sub-families and presumably relates to the differential regulation 
o f potentially otherwise similar polypeptides. In support o f this are a number o f putative 
phosphorylation sites within the loop regions o f these subunits, as predicted by the GCG 
program “Motfis”. The DiGluCla3A subunit has two predicted casein kinase II (CKII) 
phosphorylation sites at T342 and S354 and one potential protein kinase C (PKC) site at 
S392. In contrast the intracellular loop o f the GluCla3B subunit has two predicted PKC 
sites at S370 and S399, a CKII site at S394 and a cAMP-dependent phosphorylation site at 
T350. Whether all these sites are genuine substrates for protein kinases is unknown, as no 
studies have been conducted into the regulation o f GluCls. In other classes o f LGIC 
subunits numerous studies have indicated how important phosphorylation to regulating 
receptor function is, affecting the amplitude o f agonist activated currents, the rate o f 
desensitisation and the clustering o f receptors (Porter et al., 1990; Waflford & Whiting, 
1992; Leidenheimer et al., 1993; Krishek et al., 1994; McDonald & Moss, 1994, 1997; 
Macdonald, 1995; Moss et al., 1995, 1996; McDonald et al., 1998; Filippova et al., 2000).
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3.3 Results and Discussion 2:
Isolation of a novel LGIC subunit from D. immitis
3.3.1 Amplification of a putative LGIC subunit cDNA by degenerate PCR
As outlined in the introduction, one o f the initial aims o f the project was to amplify 
additional (to avr-14) D. immitis GluCl subunit cDNAs by PCR, using degenerate 
oligonucleotide primers. An alignment o f all available GluCl amino acid sequences was 
constructed and conserved regions were identified for the a-type and p-type subunits (see 
appendix C). Oligonucleotide primers, with degeneracy limited throughout the sequence to 
less than 1000-fold, were subsequently designed to these regions. In an attempt to enhance 
specificity during annealing and limit the overall degeneracy o f the primer, the 3’ ends o f 
the oligonucleotides were designed, if  possible, to amino acids encoded by limited codons, 
e.g. methionine. Asymmetric codon use, i.e. the preference for one codon over another to 
encode the same amino acid, is evident between different species o f nematode and was 
identified as another way o f limiting the degeneracy o f the primers. Filarial nematodes 
exhibit a significant AT (adenine-thymine) bias in their genomes (Rothstein et al., 1988; 
Fadiel et al., 2001), being most clearly evident in coding regions at the third position o f 
codons. A codon frequency chart (appendix E) was therefore constructed from 15 D. 
immitis mRNA sequences, using the GCG program “CodonFrequency”. Using this chart, 
the codons for particular residues, if possible or indeed if necessaiy to limit the degeneracy, 
could be predicted.
Nucleotide details o f the nine degenerate primers designed can be found in appendix A. Of
these, six were designed to conserved motifs shared between the GluClal and a2 subunits
o f C. elegans and three were designed to motifs shared between the GluCip subunits o f C.
elegans and H. contortus (highlighted in appendix C). A large number o f primer
combinations were attempted using both conventional 3-step and Touchdown approaches to
PCR. Limited success, leading to unexpected results, were had using two anti-sense
primers, designed to the highly conserved WxPDTFF motif, in conjunction with the SL1
primer; these primers ASDGAP2 and ASDGBP2 were biased in design to the a - and p-
type subunits respectively. The ASDGAP2/SL1 PCR produced three bands (150, 250, and
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450bp) where as the ASDGBP2/SL1 PCR produced four bands (250, 2x450, and 600bp) as 
shown in figure 3.12.
All the bands were cloned using pCR®-Blunt II-TOPO as before, recombinant plasmids 
being identified by restriction digest with EcoRI. These recombinants were then sequenced 
using either M l3 primer. Clones of the larger bands generated from the ASDGAP2/SL1 
PCR and the 250bp product of the ASDGBP2/SL1 PCR were identified as partial avr-14 
sequences, the differences in size appearing to be due to the mis-annealing of the SL1 
primer. The product of interest however, was the larger o f the two bands at ~450bp from 
the ASDGBP2/SL1 PCR.
Analysis of the 450bp cDNA sequence revealed a putative start codon, 44 nucleotides 
downstream o f the SL1 sequence, and a partial open reading frame that when translated 
exhibited 52% amino acid identity to a predicted LGIC subunit in C. elegans (T27A1.4). 
The clone also exhibited weaker identity (20-30%) with various GluCl, glycine and 
GABAa subunits. The full-length coding region was deduced following 3’ RACE, which 
was achieved, using a sense primer (SBETA2P2) designed to the partial cDNA sequence in 
tandem with the RoRi primer. The PCR product of 1.2kb (figure 3.13A) was cloned as 
before and sequenced. From the mRNA sequence, predicted from the overlapping cDNAs, 
full-length primers (SDG1 and ASDG1) were designed to amplify the proposed 1221 
nucleotide coding region. Figure 3.13B shows a band o f the expected size was amplified, 
which was subsequently cloned and fully sequenced on both strands. The sequence of this 
cDNA was identical to that compiled from the overlapping clones and was therefore
450bp following PCR using the primers ASDGAP2 
and SL1; Lane 3: Products amplified
150bp following PCR using the primers ASDGBP2 
and SL1. Both PCRs used 3-step programs 
with annealing temperatures of 50°C.
F i g u r e  3 . 1 2 .  A m p l i f i e d  p r o d u c t s  o f  
d e g e n e r a t e  P C R  u s i n g  A S D G A P 2  a n d  
A S D G B P 2  i n  t a n d e m  w i t h  S L 1 .  Lane 1: 
lkb DNA ladder; lane 2: Products amplified
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adopted as the consensus sequence for the coding region. When translated, this sequence 
exhibited amino acid identity to other LGICs comparable to that observed for the partial 
cDNA. It was therefore proposed that the 1221 nucleotide open reading frame (1362 
nucleotide mRNA) encoded a 406 amino acid, novel LGIC from D. immitis, termed DG1.
1.2kb
F i g u r e  3 . 1 3 .  A m p l i f i c a t i o n  o f  D G 1  c D N A s .  Lane 1; lkb DNA ladder; lane 2 PCR product. Each 
PCR used a 3-step PCR program; A :  3 ’ R A C E  P C R  (primers SBETAP2 & RoRi; annealing 
temperature of 51°C); B :  F u l l - l e n g t h  c o d i n g  r e g i o n  P C R  (primers SDG1 & ASDG1; annealing 
temperature of 51 °C).
3 .3 .2  Sequ en ce an a lysis o f  DG1
As stated earlier, the amino acid sequence of DG1 exhibits 52% identity with T27A1.4 (a 
predicted LGIC in C. elegans) and 20-30% identity with other LGCC subunits. This level 
o f homology is sufficient to indicate that DG1 could be a member o f the LGIC superfamily; 
GluCls and vertebrate GABAa receptor subunits share -30%  identity. Further analysis of 
the subunit’s amino acid sequence reveals it is highly unusual (figure 3.14) and although 
certain characteristic motifs o f the LGIC superfamily are present, others are surprisingly 
absent. The program SignalP Vl .l  (Nielsen et al., 1997) indicates the putative subunit to 
have a signal peptide o f 27 amino acids making the mature polypeptide, following 
cleavage, to be 379 residues in length, short compared to other LGIC subunits. Within the 
N-terminal a number of residues implicated to form the core LBD structure appear to be 
conserved in both DG1 and T27A1.4, e.g. the WxPD(T/L)(F/Y)F motif. Strikingly 
however, the pair of cysteine residues that form the signature disulphide bridge is absent. 
Curiously, the second pair of cysteines that form the characteristic loop observed in GluCls 
and glycine receptors only, is present at the conserved distance of 11 amino acid residues.
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In addition, within the loop lies a potential A-linked glycosylation site, as predicted by the 
GCG program “Motifs”
Analysis o f the C-terminal reveals little sequence identity across the proposed TM regions 
between DG1 and the LGCCs, although there is considerable identity with T27A1.4. A 
hydropathy plot for DG1 however, indicates four hydrophobic regions that align almost 
perfectly with the predicted TMs o f other subunit classes. The proposed TM2 domains o f 
DG1 and T27A1.4 are highly unusual, not least because o f the presence o f a proline residue 
in the middle o f this region. Indeed, the inclusion o f such an amino acid may be predicted 
to significantly distort the proposed a-helical character o f TM2. Between the TM3 and 
TM4 lies the intracellular loop, the length o f which for DG1 and indeed T27A1.4 
accounting for their overall comparably short nature. Within the loop, as for other LGICs, 
there are potential sites for regulation by phosphorylation (predicted by the GCG program 
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TTDNKLLRISRNGNVLYSIRITLTLACPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQ. EQGA. VQVADGLTL. PQFILKEEKDLR 
TVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGDDNA. VTGVTKIEL. PQFSIVDYKLITKK
AGNYTIGIYSBIDVLITFTGASSEAFWRIFIPSILLILVSWLHFWVHGSWSVPRTISAAVPFLIFVSILIFYPQPNLTTYGVSSLQIWLF 
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T27A1.4 FCLVLTFFSFVEYFLVICC.............. ____GGRRSIRYKTLGPQE...____DH..PMGAAKETVEVAYNEGCAS FRDN.. 363
CeGluClal ACMT FIFCALLE FALVNHI.............. .....EKAEIPLLQNLHNDVPTKVFNQEEKV.. 401
DiGluCla3B VCLAFIFGALLEYALVNYY.............. .....KKTEYKGCLCPSDHLFNQDLRQSLRL.. 373
CeGluClp ACQTFVFGALLEYAFVSYQ....................DSVRQNDRSREKAA........RKAQRR..REKLEMVDAEVYQPPCTC.. 370
hGlyRal VCLLFVFSALLEYAAVNFV.....SRQHK.... .....ELLRFRRKRRHHKE.......DEAGEGRFNFSAYGMGP..ACLQAKDGIS 379
mGABAAp2 GCFVFVFMALLEYALVNYIFFGRGPQRQKKAAEKAANANNEKMRLDVNKMDPHENILLSTLEIKNEMATSEAVMGLGDPRSTMLAYDASS 400
TM3
DG1.......... ............................................. HGIDLVSRMAFPIIFLLFLIIFFIFYLV ........... 406
T27A1.4 ........................... ................. NGIDVISRVAFPIVTIVFLIIYFIFIV............  390
CeGluClal .........RTVPLNRRQMNSFLNLLETKTEWNDIS........ KRVDLISRALFPVLFFVFNILYWSRFGQQNVLF......  4 61
DiGluCla3B .........DMNVYRRKWWTKFW. LNT YLCSNVEVS........ KRVDLISRFAFPTFFAFFLVLYYVNYVN...........  427
CeGluClp .........HTFEARETFRDK. . .VRRYFTKPDYLP........ AKIDFYARFWPLAFLAFNVIYWVSCLIMSANASTPESLV 434
hGlyRal V ....... KGANNSNTTNPPPAPSKSPEEMRKLFIQ...... RAKKIDKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNQ. . . 447
mGABAAp2 IQYRKAGLPRHSFGRNALERHVAQKKSRLRRRASQLKITIPDLTDVNAIDRWSRIFFPWFSFFNIVYWLYYVN........... 474
TM4
Figure 3.14. Alignment of the proposed DG1 amino acid sequence with T27A1.4 and selected LGCC subunits. The DG1 subunit amino acid sequence was aligned 
with the predicted LGIC subunit T27A1.4 from C. elegans, selected nematode GluCl subunits (Ce=C. elegans; Di=D. immitis), and representative mammalian 
(h=human; m=mouse; r=rat) LGCC subunits using MultAlin (Corpet, 1988). The pair of cysteine residues indicative of the LGIC super family (highlighted in yellow) 
appear to be absent in DG1 and T27A1.4, although the cysteine pair indicative of the GluCls and glycine receptors (highlighted in green) is conserved in these putative 
subunits. Features of the DG1 subunit are the 27 amino acid signal peptide (light blue highlighted italics), the iV-linked glycosylation site (red star) and two potential 
regulatory phosphorylation sites between TM3-4 for protein kinases (blue font=protein kinase C; orange font=tyrosine kinase).
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3.3.3 RNA interference using T27A1.4
As an aside to the major goal o f the project, i.e. the investigation o f D. immitis GluCl 
pharmacology, a number o f preliminary RNA interference (RNAi) experiments were 
conducted in an attempt to ascertain a function for the predicted LGIC subunit T27A1.4. It 
was hoped that progress in ascertaining a potential function for this protein would direct 
subsequent work on DG1.
RNAi is the selective down regulation (“knocking-down”) o f a target mRNA by the 
introduction o f homologous double-stranded RNA (dsRNA). Pioneered in C. elegans, the 
RNAi phenomenon has also been used to study gene function in, amongst others, fruit flies, 
plants and increasingly mammalian cells. Essentially the introduced dsRNA is cleaved into 
small interfering RNAs (siRNAs; 21-23 nucleotides in length), which then associate with a 
nuclease complex to direct the selective degradation o f the target mRNA (Hannon, 2002). 
Delivery o f the dsRNA into C. elegans can be achieved using several methods including 
microinjection and indeed, soaking the worms in a dsRNA solution. However, the method 
used here was that o f feeding (Fire et al., 1998), where the worms ingest dsRNase-deficient 
bacteria that are expressing the dsRNA corresponding to the gene o f interest, i.e. T27A1.4. 
The dsRNA is generated by transcription from opposing T7 primers located externally to 
the multiple cloning-site, on opposite strands, o f the L4440 “feeding” vector. Following a 
period o f incubation, the worms were then analysed for gross phenotypes.
Before conducting the experiments a T27A1.4 cDNA had to be cloned. Template (for PCR) 
cDNA was synthesised from C. elegans mRNA, which had previously been isolated from 
extracted total RNA, as described in section 2.2.5.2. Meanwhile, oligonucleotide primers 
(ST27A1.4 and AST27A1.4) were designed to amplify the predicted coding region o f 
T27A1.4. A 3-step PCR (annealing temperature o f 50°C) using these primers amplified a 
band o f the expected size (~1.2kb), which was cloned into pCR®-Blunt II-TOPO. A 
recombinant clone, identified by restriction digest with EcoRI, was subsequently sequenced 
with the M l3 primers, the resulting sequence confirming that deposited in the database. 
The cDNA was then sub-cloned (at the Pstl/SacI sites) into the L4440 plasmid (figure 
3.15). Finally, this construct was transformed into the (dsRNase deficient) HT115 E. coli
11
strain, used in the experiments. The RNAi experiments were then conducted as described in 
section 2.2.6.2.
F i g u r e  3 . 1 5 .  R e s t r i c t i o n  a n a l y s i s  o f  
p o t e n t i a l  r e c o m b i n a n t  L 4 4 4 0 / T 2 7 A 1 . 4  
c l o n e s .  Lane 1 : lkb DNA ladder; lanes 2- 
5: individual clones screened by restriction 
digestion with Pstl/Sacl. All four clones 
were positive, containing the L4440 band 
at 2.5kb and the T27A1.4 insert at 1.2kb.
The asterisk indicates the recombinant 
clone used in the RNAi experiments.
The RNAi experiments were repeated three-times but on each occasion no obvious gross 
phenotype was observed. The experimental procedure however, was validated by the strong 
characteristic twitching phenotype displayed in the unc-22 control. Although a positive 
result (i.e. a gross phenotype) from these experiments may have been very revealing it is 
difficult to draw many conclusions from such an apparently unaffected outcome. It is 
entirely possible that “knocking-down” this gene has no real effect on the nematode under 
lab conditions. Alternatively, it is entirely plausible that such a crude assay was missing 




In summary, the cloning aspect o f this study has proved largely successful: two D. immitis 
GluCls cDNAs and one, potentially novel LGIC cDNA, DG1, have been amplified. The 
high degree o f amino acid identity across orthologous GluCla3 subunits suggests similar 
pharmacological properties, the study o f which formed the basis for the remainder o f the 
investigation. DG1 and indeed, T27A1.4 may represent outlying members o f the LGIC 
superfamily; the contrasting conserved nature o f certain characteristic features o f these 
channels (i.e. second “cys-loop” and apparent 4 TM regions) against the absence o f such a 
defining feature as the first “cys-loop” remains a conundrum. Further investigation into the 
functional roles o f these putative subunits, although not pursued here, is certainly 
warranted. If it could be established that they were important for the worm’s viability, their 
highly unusual nature may make them promising drug targets.
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Chapter 4




Once the GluCla3 subunit cDNAs had been cloned, the objective o f the study became to 
investigate their pharmacology, in particular establishing whether either polypeptide was a 
molecular target for the AMs. If such a target could be identified, the question o f why these 
drugs are so effective against the larval stages o f D. immitis, compared to the adult worms, 
could begin to be addressed. In addition, from a commercial perspective, should either 
subunit be viably expressed in vitro then screens may be developed to identify new or 
modified existing compounds that exhibit high affinity interactions or activity towards 
them.
The initial approach proposed to investigate the pharmacology was to perform [3H]-IVM 
binding assays using membranes prepared from a mammalian cell-line transiently 
expressing the individual DiGluCla3 subunits. Using a similar method, the H  contortus 
GluCla and GluCla3B subunits had previously been shown to bind [3H]-IVM with Kd 
values o f 26-110pM and 70pM respectively (Cheeseman et al., 2001; Forrester et al.,
2002), figures that could account for [3H]-IVM binding to whole worm membrane 
preparations (Kd from 0.07-0.6nM) (Rohrer et al., 1994; Hejmadi et ah, 2000; Cheeseman 
et al., 2001). These values were also comparative to the high affinity IVM binding site 
described in C. elegans (Kd = 0.26nM) (Schaeffer & Haines, 1989) and the concentrations 
o f drug that exhibit anthelmintic activity in both species. The implications from these 
studies are that the GluCls are the molecular targets through which these compounds act. 
The recombinant HcGluCla3A and HcGluCip subunits exhibited no specific [3H]-IVM 
binding (Cheeseman et al., 2001). These binding data were largely in agreement with 
investigations using Xenopus oocytes expressing recombinant GluCls from C. elegans 
(Cully et al., 1994; Dent et al., 2000). In these studies CeGluCla3B formed homomeric 
channels capable o f being activated by glutamate and IVM whereas the CeGluClp subunit 
formed homomeric channels only able to respond to glutamate. GluCla3A did not respond 
to either ligand but it is unknown whether this was due the absence o f ligand binding sites 
or an inability to form homomeric receptors. There is no direct orthologue o f the H. 
contortus GluCla subunit in C. elegans. Based therefore on the properties o f the
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orthologous subunits o f C. elegans and H. contortus, it was hypothesised that membranes 
expressing DiGluCla3B and not DiGluCla3A would bind [3H]-IVM.
Delivery o f recombinant DNA by transient transfection, which can be achieved using a 
variety o f biochemical or physical methods, is a convenient and rapid way o f obtaining 
high levels o f protein expression, if  only temporarily, in mammalian cells. The 
transfections detailed in this chapter were conducted using a calcium phosphate mediated 
approach, a well-established and inexpensive method for such transient expression. DNA 
and calcium phosphate form an insoluble precipitate, when mixed, and it is believed that 
this becomes attached to the cell’s membrane where it is internalised by endocytosis 
(Sambrook & Russell, 2001). The mammalian cell-lines COS-7 and HEK-293T were 
chosen for these experiments as both are routinely for transient transfections. Indeed, COS- 
7 cells were used for expression o f the individual H. contortus GluCl subunits, as described 
previously, although the DNA transfection procedure was mediated by lipofection rather 
than calcium phosphate (Cheeseman et al., 2001; Forrester et al., 2002). Both COS-7 and 
HEK-293T cell-lines express high levels o f the SV40 large tumour antigen (T), which 
initiates viral DNA replication at the SV40 origin, a region included in the expression 
vectors chosen for these experiments. Therefore high copy-numbers o f these plasmids 
could be generated within the cells, theoretically enhancing the level o f transcription 
(Spector et al., 1998).
The initial strategy for these experiments was to conduct small-scale transfections, so that 
the conditions required for the expression o f these subunits could be optimised. Larger- 
scale transfections were then to be carried out to ensure there was sufficient membrane 
protein available with which to perform the radioligand binding assays. For the small-scale 
procedure the DiGluCla3 cDNAs were cloned into specialised plasmids, which enabled the 
incorporation o f an epitope-tag at the C-terminal o f the expressed polypeptides. Following 
transfection, protein expression was monitored by immunofluorescence, using primary 
antibodies to the epitope-tags and secondary species-specific antibodies coupled to the 
fluorescent label, FITC. The larger scale transfections were to be carried out using 
mammalian expression plasmids that did not incorporate epitope tags, removing the 
possibility that the additional amino acid residues may alter the binding o f the radioligand.
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4.2 Results
4.2.1 Production of epitope-tagged GluCla3 plasmid constructs
The DiGluCla3 cDNAs for cloning into the C-terminal tag expression plasmids had to be 
amplified by PCR, using previously made clones as template DNA. The common sense 
oligonucleotide primer, SDG2/3TAG, was used in tandem with either with the anti-sense 
primer ASDG2TAG, to amplify the GluCla3A cDNA, or ASDG3TAG to amplify the 
GluCla3B cDNA; the nucleotide sequences for all primers detailed in this chapter are 
found in appendix A. Both PCRs used a simple 3-step program, with an annealing 
temperature o f 50°C. Importantly, the anti-sense primers for each subunit were designed so 
that the stop codons o f each cDNA were removed, therefore enabling the polypeptides to be 
translated in frame with the 3’ tag. In addition, restriction sites were incorporated into all 
the primers to facilitate cloning. The amplified GluCla3A and GluCla3B cDNAs, both o f 
the expected size o f 1.3kb, were ligated into the C-terminal tag expression plasmids 
pFLAG-CMV-5a (at the Pstl/BamHI sites) and pCMV/zwyc/cyto (at the Pstl/Xhol sites) 
respectively. Transcription from both o f these plasmids is under the control o f the strong 
constitutive mammalian CMV (cytomegalovirus) promoter (see Stinski, 1999 for review) 
thus facilitating high-level protein expression. Recombinant clones were identified by 
restriction digestion using the aforementioned restriction enzymes; one o f these clones was 
sent to be sequenced (see chapter 3 for sequencing primers). Fully sequencing the construct 
ensured firstly, that no nucleotide errors had arisen during PCR and secondly, that the 
subunit coding region was in-frame with the epitope-tag. Following sequencing, maxipreps 
were made for each construct to ensure sufficient DNA was available for the transfections.
Later experiments used similar plasmid constructs that differed only by the inclusion o f the 
Kozak sequence, GCCACC, just prior to the start codons o f both DiGluCl cDNAs. Kozak 
sequences affect the efficiency at which ribosomes initiate translation at a particular ATG. 
The sequence incorporated into these plasmids has been shown to produce maximum 
initiation efficiency, i.e. little translation occurs at other ATGs within the mRNA sequence, 
thus increasing protein expression (Kozak, 1986, 1999). Indeed, this Kozak sequence was 
used during the expression o f HcGluCla subunits in COS-7 cells (Forrester et al., 2002). 
The Kozak sequence was incorporated during PCR, being included in the newly designed
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sense primer, SDG2/3TAGK, which aside from the six-nucleotide addition was identical to 
the original sense primer used. The anti-sense primers used in the PCRs were the same as 
those employed to amplify the original cDNAs (ASDG2TAG and ASDG3TAG). The PCR 
programs and subsequent cloning procedures were otherwise identical to those used to 
make the initial C-terminal tagged expression constructs. Figure 4.1 shows the products 
amplified by these PCRs, which were o f the expected size o f 1.3kb. Figure 4.2 shows 
restriction digests o f the two Kozak-incorporated expression constructs. Following 
sequencing, maxipreps of each plasmid were made.
W
F i g u r e  4 . 1 .  A m p l i f i c a t i o n  o f  G l u C l a 3  c D N A s  ( i n c l u d i n g  
t h e  K o z a k  s e q u e n c e s )  f o r  c l o n i n g  i n t o  C - t e r m i n a l  
e x p r e s s i o n  v e c t o r s .  Lane 1: lkb DNA ladder; lane 2: 
GluCla3A PCR product; lane 3 GluCla3B PCR product; 
Both PCRs used a 3-step program, with an annealing 
temperature of 50°C. The primer pairs used to amplify the 
a3A and a3B subunit cDNAs were SDG2/3TAGK with 
either ASDG2TAG or ASDG3TAG respectively.
~ 5 k b
^ — ~ 1 . 3 k b LiB U
~ 5 k b
~ 1 . 3 k b
F i g u r e  4 . 2 .  R e s t r i c t i o n  a n a l y s i s  o f  ( K o z a k  s e q u e n c e  i n c l u d i n g )  G l u C l a 3 A : p F L A G - C M V - 5 a  ( A )  a n d  
G l u C l a 3 B : p C M V / m y c 7 c y t o  ( B )  t r a n s f o r m a n t s .  A :  lane 1 : lkb DNA ladder; lanes 2-5:
GluCla3A:pFLAG-CMV-5a transformants digested with Pstl/BamHI. B :  lane 1: lkb DNA ladder; lanes 2- 
9:GluCla3B:pCMV/myc/cyto transformants digested with Pstl/Xhol. Recombinant plasmids for both 
constructs were characterised by the presence of one band at ~5kb, the linearised vector, and one band at 
~1.3kb, the insert cDNA, as indicated by the arrows. The asterisks denote the clones sequenced and used in 
the subsequent transformations.
Maxipreps were also made for the plasmid constructs used in the control transformations. A 
GFP expressing plasmid construct (GFP-CD36; obtained from V. Portillo, University of 
Bath) was used to initially assess the efficiency of transfection protocol. To assess the
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abilities o f each C-terminal epitope-tag to be detected, plasmid constructs expressing 
HcGluCip-FLAG (obtained from V. Portillio) and hTRPC3-myc (obtained from I. 
Franklin, University o f Bath) were used. hTRPC3 (Human Transient Receptor Potential 
type C) is a type o f calcium channel. Importantly, the C-terminal tag expression vectors 
used to make these constructs (pFLAG-CMV-5a and pCMV/wyc/cyto) were identical to 
those used to express the DiGluCla3 subunits.
4.2.2 Expression of epitope-tagged DiGluCla3 subunits
As outlined in the introduction to this section, calcium phosphate mediated transient 
transfection was used to deliver the plasmid DNA into the COS-7 and HEK-293T 
mammalian cell-lines. Expression o f GFP was initially used as the marker for optimising 
the transfection conditions. The maximum transfection efficiency observed, 20-30%, was 
obtained following addition o f 5-7pg plasmid DNA using the protocol outlined in the 
methods section. These conditions appeared to be optimal for both cell-lines. Factors 
altered during the optimisation o f the transfection procedure included the length o f time the 
DNA-calcium phosphate mixture was incubated with the cells (either 5-6 hours or 
overnight as indicated by different methodologies), the subjection or not o f the cells to a 
“glycerol shock” (see method section 2.2.3.2.3) following removal o f the mixture, and the 
length o f time (24 to 48 hours) allowed for protein expression before cell fixation. Results 
from transfection experiments using the positive control constructs (i.e. HcGluCla3-FLAG 
and TRP3-myc) indicated that similar conditions also lead to optimal transfection 
efficiencies and expression o f these proteins. Again, both cell-lines exhibited similar 
transfection efficiencies under similar experimental conditions, although these were 
generally lower than those observed for GFP.
Unfortunately, over a range o f 1-1 Opg DNA the epitope-tagged DiGluCla3 subunits, using
either expression construct (i.e. with or without the Kozak sequence) appeared to be
transfected with a very poor efficiency in both cell-lines. Expression o f the GluCla3A-
FLAG subunit could occasionally be detected in both cell-lines although only at the rate o f
1-5 cells per coverslip. Typically however no expression was observed. No expression was
detected for the DiGluCla3-myc subunit in either cell-line, using either construct. Altering
the protocol in ways like those described above for the initial “optimisation” o f this
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transfection method did little to enhance the transfection efficiency or expression o f the 
tagged DiGluCla3B subunits in either cell-line. Figure 4.3 summarises the typical results 
following transfection o f the subunit and control DNA into COS-7 cells. The results 
however were also indicative o f the expression observed in HEK-293T cells as well.
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FLAG negative control HG4-FLAG positive control GluCla3A-FLAG GFP
1
F i g u r e  4 . 3 .  E x p r e s s i o n  o f  t h e  e p i t o p e - t a g g e d  D i G l u C l a 3  s u b u n i t s  i n  C O S - 7  c e l l s .  Forty-eight hours following transfection the cells were fixed. They were 
subsequently incubated (except the GFP control) with primary antibody (either mouse anti-FLAG, 1/1500 dilution or mouse anti-myc, 1/200 dilution) and 
secondary antibody (FITC-conjugated anti-mouse, 1/200 dilution) before being viewed under a confocal microscope. Negative controls were included for both 
subunits, where staining was conducted on untransfected cells. Antigen detection was typically only observed in the positive controls for both epitope-tags.
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4.3 Discussion
The epitope-tagged DiGluCla3 subunits were expressed poorly (i.e. few cells expressed 
the polypeptides) in COS-7 and HEK-293T cell-lines, preventing the proposed radioligand 
binding assays from being performed. Expression o f the DiGluCla3A-FLAG subunit could 
occasionally be detected in both cell-lines but only at the rate o f 1-5 cells per coverslip. The 
levels o f expression within these cells appeared to be quite high according with their 
brightness, although was never quantified. Usually however, no expression o f this subunit 
could be detected. Expression o f the DiGluCla3B-myc subunit was not detected in either 
cell-line. Discussed below are possible explanations for the poor expression observed. 
Additionally, alterations to the procedures used that may lead to improved transfection 
efficiencies and protein expression are considered.
There are a number o f empirical measures that are often taken in attempting to improve 
transfection efficiencies and protein expression. As alluded to earlier, there are a number o f  
biochemical and physical methods for transiently transfecting DNA into mammalian cells, 
which could be used instead o f the calcium phosphate approach undertaken here. A 
commonly used alternative is lipofection-mediated transfection, which has been previously 
used to successfully express selected H. contortus GluCls in COS-7 cells (Cheeseman et 
al., 2001; Forrester et al., 2002). Further studies, interestingly, showed that calcium 
phosphate mediated transfection was actually sufficient for expressing epitope-tagged 
HcGluCla and HcGluClp subunits in COS-7 cells (V. Portillo, pers. comm). This may 
indicate that these proteins are simply more amenable to expression in mammalian cells 
than the D. immitis GluCls, a topic briefly considered below. In addition to the transfection 
methodology the expression system may also be changed, often to an alternative 
mammalian cell-line or indeed to cell-lines from organisms more closely related to the 
species o f interest. For example, the Drosophila S2 cell-line has been used to express 
selected H  contortus GluCl subunits. For the epitope-tagged HcGluCla subunit the 
transfection efficiency achieved using these cells appeared to be significantly greater than 
that achieved in COS-7 cells, validating their use (V. Portillo, pers. comm.).
In contrast to the empirical changes proposed above, a more careful examination o f the
transfection procedure used here indicates further alternative measures that could be
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implemented to improve protein expression. The success o f the positive controls, in terms 
o f both efficiency and levels o f protein, suggest that the major problems associated with 
expression o f the GluCla3 subunits probably occurred after transcription, either at the level 
o f translation or post-translation. This reasoning derives from the fact that prior to 
translation the regulation o f the combined processes o f DNA uptake, replication o f plasmid 
DNA and transcription, was largely dependent on common nucleotide sequences found 
within the expression vectors and not the insert cDNA. For example, the CMV promoter 
was the regulatory sequence that principally governed transcription. A simple way to test 
this hypothesis would be to perform RT-PCR on transfected cells, to see if the GluCla3 
mRNAs could be amplified. Presence o f such transcripts would evidently support the 
deductions made above.
It is interesting to note that potentially the GluCla3-tagged subunits were expressed in both 
cell-lines with acceptable efficiencies and that simply the levels o f expression within the 
cells were below the sensitivity o f the immunofluorescence method used to detect them. 
The use o f Western Blotting may resolve whether both subunits were consistently 
expressed. If either subunit could be detected using this method it may support the 
hypothesis discussed above. However, the establishment o f low-level expression would still 
not be sufficient to begin radioligand binding assays as the number cells required to 
generate enough protein for such experiments would be unfeasible.
One possibility for explaining the poor expression o f the DiGluCl subunits in mammalian 
cells, at the level o f translation, is the asymmetrical use o f codons in different species. 
Filarial nematodes have a pronounced adenine-thymine (AT) bias o f -70%  within their 
DNA, which extends to both coding and non-coding regions (Rothstein et al., 1988; Fadiel 
et al., 2001). In contrast the situation in mammals is overall more balanced with a -50%  
AT content to their DNA. Within the codons o f D. immitis the AT bias is most clearly 
evident at the third or wobble position (Fadiel et al., 2001). Therefore the possibility exists 
that high level expression o f the DiGluCla3 subunits may have been hindered by frequent 
use, within the coding cDNAs, o f what in mammalian cells may be considered unusual or 
rare codons. A recent study by Slimko and Lester (2003) highlighted this issue o f 
asymmetric codon use between species. Their objective was to express the C. elegans
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GluClal and GluClp genes in rat hippocampal neurons. Expression however was poor so 
they constructed synthetic genes for each subunit using codons that were optimal for 
mammalian cells. The optimisation process provided a 6- to 9-fold increase in expression o f 
these subunits. Interesting, the coding regions o f C. elegans DNA have a similar base 
composition (i.e. ~50% AT) to mammalian DNA although a clear difference in codon 
usage exists (Emmons, 1988). As the D. immitis cDNAs possess a more exaggerated 
nucleotide bias, a potentially more striking improvement in expression following codon 
optimisation for these proteins may be predicted.
Alternatively, the poor expression observed maybe due to reasons associated with post- 
translational processes occurring within the endoplasmic reticulum (ER), the intracellular 
location where the majority o f membrane proteins are folded and oligomerised (Hurtley & 
Helenius, 1989). For example, selected mammalian GABAa subunits (a l, 02, y2) when 
expressed alone, or in double combinations (either a ly 2  or 02y2) not known to be 
representative o f the native receptors, are largely retained in the ER and rapidly degraded 
(Connolly et al., 1996; Gorrie et al., 1997). It is possible that a similar fate awaited the 
DiGluCla3 subunits when expressed alone, the continual rapid degradation preventing the 
protein build up that could have been detected by immunofluorescence. Co-expression with 
other GluCl subunits may therefore be required to stabilise expression however, which 
subunits should the DiGluCla3 polypeptides be co-expressed with? Due to the lack o f D. 
immitis GluCl cDNAs the most obvious experiment may be to co-express both alternatively 
spliced forms o f GluCla3. Alternatively, each subunit could be expressed with GluCl 
subunits from other nematode species on the basis that orthologous subunits may exist in D. 
immitis. Like any experiments o f this type any subsequent binding data would be difficult 
to interpret, particularly from cross species subunit combinations, without complimentary 
studies supporting the potential association o f the subunits in vivo. Finally, it remains 
possible that the addition o f the epitope-tag may have affected the ability o f the subunits to 
fold correctly, and hence assemble into viable receptors. They may therefore have been 
rapidly degraded preventing expression being detected.
To summarise, the major objective o f this part o f the study was to establish whether either 
DiGluCla3 subunit was a molecular target o f AMs. Unfortunately, due to poor expression
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o f these subunits in the selected mammalian cell-lines, the proposed radioligand binding 
assays that would have addressed this issue were unable to be performed. Hopefully the 
measures considered above, may be o f some use in directing future transient expression o f 
D. immitis GluCl subunits.
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Chapter 5
Pharmacological Study of GluCla3 




Following the difficulties encountered expressing the DiGluCla3 subunits in mammalian 
cell-lines an alternative approach was sought to investigate their pharmacology. The 
method chosen to achieve this objective was that o f two-electrode voltage clamping 
(TEVC) using Xenopus laevis (the South African clawed frog) oocytes as the surrogate 
expression system for the recombinant ion channels. The TEVC method uses one electrode 
to monitor the transmembrane potential o f the oocyte (relative to a bath electrode), which is 
compared to the desired holding or clamping potential set by an amplifier (often -80mV). 
Current is then injected into the oocyte via the second electrode to minimise any difference 
observed. It is the change in current, which is measured during a recording, as the amplifier 
attempts to maintain the desired holding potential in the face o f ion flow through activated 
channels following, in this case, ligand application (Betrand et al., 1991).
Aside from the polypeptide encoded by glc-4, all other C. elegans GluCl subunits have 
been studied (to varying degrees) using this methodology. The GluCla2A, a2B, a3B , and 
a4 subunits are all capable o f forming homomeric channels in oocytes that are gated by 
glutamate and IVM (Dent et al., 1997; Vassilatis et al., 1997b; Dent et al., 2000; Horoszok 
et al., 2001). GluCip forms homomeric channels gated by glutamate but not IVM where as 
reverse is true for GluClal; the GluClalp and GluCla2Bp heteromers are gated by both 
ligands (Cully et al., 1994; Vassilatis et al., 1997b). Only GluCla3A appears unable to 
form homomeric receptors activated by either ligand (Dent et al., 2000). The only other 
nematode GluCl subunit to have been studied using this method is the HcGluCla, which 
was recently shown to form homomeric channels gated by both ligands (Forrester et al.,
2003).
As observed in these studies, both glutamate and IVM induce highly characteristic current 
in oocytes expressing sensitive GluCls. Glutamate elicits fast-onset chloride currents that 
are fully reversible upon removal o f the ligand; the channels exhibit varying degrees o f 
desensitisation depending on their constituent subunits and concentration o f glutamate 
used. IVM however, induces slow-onset chloride currents that do not desensitise and are 
essentially irreversible despite removal o f the ligand and prolonged washing with buffer
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(Cully et al., 1994; Dent et al., 1997, 2000; Vassilatis et al., 1997b; Horoszok et al., 2001; 
Forrester et al., 2003); the irreversible nature o f the currents is partially explained by the 
slow dissociation o f IVM from its binding site (Schaeffer & Haines, 1989). The EC50 
values generated for glutamate in these studies (including both the homomeric and 
heteromeric GluCls) range from 8.4pM to 1.9mM (Cully et al., 1994; Dent et al., 1997; 
Vassilatis et al., 1997b; Horoszok et al., 2001; Forrester et al., 2003). These figures are 
generally consistent with glutamate concentrations shown to gate chloride currents in 
nematode tissue preparations (Martin, 1996; Pemberton et al., 2001). Gating by IVM o f  
sensitive GluCls in oocytes generally requires concentrations o f ligand >10nM; the 
determined EC50 values range from 103nM to 400nM (Cully et al., 1994; Dent et al., 1997, 
2000; Vassilatis et al., 1997b; Horoszok et al., 2001; Forrester et al., 2003). These figures 
are significantly higher than the concentrations o f IVM that have been shown to bind 
individual H. contortus GluCl subunits (Cheeseman et al., 2001; Forrester et al., 2002) and 
the concentrations able to paralyse pharyngeal pumping and motility in H. contortus, C. 
elegans and selected other nematodes in vitro (Kass et al., 1980; Avery & Horvitz, 1990; 
Gill et al., 1991, 1995; Geary et al., 1993; Arena et al., 1995; Paiement et al., 1999). 
Interestingly, IVM at lower concentrations (<10nM) potentiates currents induced by sub- 
maximal concentrations o f glutamate in oocytes expressing the GluClalp heteromers 
(Cully et al., 1994).
The overall objective for these experiments was identical to that outlined in the last chapter, 
i.e. to express the DiGIuCIa3 subunits in a system that would allow their pharmacology to 
be investigated. Based on the qualitative responses o f their C. elegans orthologues, it was 
hypothesised that the DiGIuCIa3B subunit would form homomeric receptors in oocytes 
that would be gated by glutamate and IVM. Conversely, oocytes injected with DiGluCla3A 
cRNA were hypothesised not to respond to either ligand. Any responses obtained, whether 
accepting or rejecting these hypotheses, would direct further experiments. In tandem with 
these studies it was hoped that glutamate and IVM dose response curves could be generated 
for the CeGluCla3B homomers and in addition, to establish whether the CeGluCla3 
subunits could associate with each other to form heteromeric channels.
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Xenopus oocytes have been extensively used to characterise neurotransmitter receptors and 
other recombinant ion channels, as they are highly amenable to electrophysiological 
methods such as TEVC. The late stage oocytes (V and VI) typically used for these 
experiments reach I-1.2mm in diameter, the large size facilitating both microinjection o f  
the mRNA into the cytoplasm (or in some cases nuclear injection o f cDNA) and the 
subsequent insertion o f the microelectrodes. In addition, oocytes readily synthesise 
exogenous proteins when injected with foreign mRNA; post-translational modifications, 
assembly, sorting and other processes all appear to proceed appropriately within the cells. 
Finally, although they do possess some voltage-operated ion channels and G-protein 
coupled receptors these usually offer little interference to studying recombinant ion 
channels. With particular reference to this study, no electrical responses are observed from 
oocytes following application o f glutamate. There are however, some disadvantages to this 
system, not least the short duration o f the expression period (maximum o f two weeks) 
compared to stably transfected cell-lines. Also, few cells can be assessed during one 
experiment and oocyte reliability is often seasonally dependent, with cells used outside this 
period liable to exhibiting erratic non-functional responses (Sigel, 1990).
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5.2 Results
5.2.1 Preparation of in vitro transcribed capped GluCla3 RNA
As the transcription kit used a T7 RNA polymerase to generate the capped GIuCla3 RNAs, 
each subunit cDNA had to be orientated in the 5’-3’ direction downstream o f a T7 
promoter. Initially, each subunit cDNA was sub-cloned from existing constructs into 
plasmids incorporating this region. DiGluCla3A and a3B were sub-cloned from pCR®- 
Blunt II-TOPO constructs into pcDNA3 (KpnI/Xbal sites) and pcDNA3.1- (EcoRV/BamHI 
sites) respectively. CeGluCla3A and a3B were sub-cloned from pBluescript constructs 
(obtained from A. J. Wolstenholme) into pcDNA3.1- (Xbal/Kpnl sites) and pcDNA3 
(Notl/Xbal sites) respectively. The new constructs were linearised, using the 3’ restriction 
site and cRNA was transcribed as outlined in section 2.2.4.1. cRNA was also transcribed 
from a CeGluCla4/pGEM®-T Easy construct (obtained from L. Horoszok), linearised at the 
3’ end with SalT, to be used as the positive control
Application o f glutamate to Xenopus oocytes injected with CeGluCla4 cRNA elicited the 
typical robust inward currents previously described (Horoszok et al., 2001). However, no 
responses to glutamate were observed with oocytes injected with cRNA for any o f the four 
GIuCIa3 subunits (n>10 tested per subunit per frog; oocytes were tested from at least four 
frogs). These recordings were made over a period o f 1-4 days post-injection and used 
concentrations o f  1-1 OmM glutamate to elicit a response. As CeGIuCIa3B had been 
previously shown to form homomeric channels capable o f responding to glutamate (Dent et 
al., 2000), it was concluded that this subunit, at least, should show similar properties in 
these experiments. Therefore, subsequent experiments (those considered in the results 
section) used subunit cRNAs that included the 5’ untranslated leader sequence from the 
coat protein mRNA o f alfalfa mosaic virus (referred to the 5’-AMV sequence in the text) 
directly upstream o f the start codons. The 5’-AMV sequence has been used, as one o f  
several methods, to increase the translational efficiency o f mRNA in Xenopus oocytes 
(Jobling & Gehrke, 1987; FigI et al., 1998).
The 36-nucleotide 5’-AMV sequence was incorporated by PCR, being included in the sense
primer for each subunit (see appendix A for primer details). The DiGIuCIa3A and a3B 5’-
AMV-incorporated cDNAs were amplified by PCR using the common sense primer,
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SDiGluCla3AMV, with either the anti-sense primer ASDiGluCla3AAMV or 
ASDiGluCIa3BAMV respectively. The CeGIuCla3A and a3B 5’-AMV-incorporated 
cDNAs were amplified by PCR using the common sense primer, SCeGluCla3AMV, with 
either the anti-sense primer ASCeGIuCla3AAMV or ASCeGluCIa3BAMV respectively. 
All four PCRs used a conventional 3-step program with an annealing temperature o f 50°C. 
The amplified cDNAs were all cloned into pcDNA3.1- at Xbal/Notl sites, ensuring they 
were all correctly orientated 5’-3’ downstream of a T7 promoter (figure 5.1); the restriction 
sites were included in the primers. These constructs were subsequently linearised as before 
at the 3’ restriction site, i.e. Notl, and were used as the template DNA in the cRNA 
transcription reactions (figure 5.2).






F i g u r e  5 . 1 .  R e s t r i c t i o n  d i g e s t i o n  o f  G l u C l a 3 -  
A M V / p c D N A 3 . 1 -  c o n s t r u c t s .  A :  DiGluCla3A (lanes 2- 
4) and DiGluCla3B (lanes 5-7). B :  CeGluCla3A (lanes 
2-3). C :  CeGluCla3B (lanes 2-4). Lane 1 for each gel is 
the lkb DNA ladder. Following digestion with Xbal and 
Notl, recombinant clones were identified by two bands, 
the insert cDNA at -1.3-1.4kb and the linearised plasmid 
at 5.4kb. Asteriks denote the clones used subsequently.
5.4kb
1.3kb
^ _ 1 .3 k b
1
1.3kb
F i g u r e  5 . 2 .  In vitro t r a n s c r i b e d  c R N A  f o r  t h e  G l u C l a 3  s u b u n i t s  o f  ( A )  D. immitis a n d  ( B )  C. elegans.
For each gel, lane 1: RNA ladder. Lanes 2 and 3: cRNA samples for GluCla3A and GluCla3B subunits 
respectively.
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5.2.2 Actions of glutamate and IVM on oocytes injected with DiGluCla3 
cRNAs
Xenopus oocytes injected with DiGluCla3B cRNA were shown to respond to glutamate in 
the characteristic manner when clamped at a holding potential o f -80m V : the agonist 
elicited a dose-dependent, rapid-onset, inward current that was fully reversible. These 
channels also exhibited rapid desensitisation (figure 5.3A). Unfortunately and despite 
extensive screening (>10 cells tested per frog; at least four animals tested in total), only a 
limited number o f oocytes responded to glutamate (n=7) and o f these only three exhibited 
maximum currents >30nA. This made generation o f a glutamate dose response curve for 
DiGluCla3B homomers unfeasible. Instead, two o f these glutamate-sensitive oocytes were 
used to demonstrate that DiGluCla3B homomers are also gated by lpM  IVM (figure 
5.3B). Characteristically, the current elicited by IVM had a slow onset, did not desensitise, 
and was essentially irreversible despite removal o f the ligand and washing for 5 minutes 
with ND98 buffer only. No currents were observed upon application o f glutamate (10- 
lOOmM) to oocytes (n>10 tested per frog; four animals tested in total) injected with 
DiGluCla3A cRNA. In addition, no responses were observed upon application o f 
glutamate or IVM at concentrations o f lOmM or 1pm respectively to the uninjected or 







F i g u r e  5 . 3 .  G l u t a m a t e - g a t e d  a n d  I V M - g a t e d  c u r r e n t s  i n  o o c y t e s  i n j e c t e d  w i t h  D.immitis 
G l u C l a 3 B  c R N A  a n d  v o l t a g e - c l a m p e d  a t  - 8 0 m V .  For all traces the downward deflections denote 
the inward nature of the currents. The horizontal bars indicate the period of ligand application, the 
numbers above indicating the concentrations used. A :  Example traces of the dose-dependent 
glutamate-gated currents. The currents generated by glutamate exhibited both a rapid-onset and a rapid 
desensitisation, and were fully reversible upon removal of the ligand. B :  Example traces of the 
glutamate-gated and IVM-gated currents generated from the same oocyte injected with DiGluCla3B 
cRNA. Unlike the glutamate-gated currents, IVM induced a slow-onset, essentially irreversible 
current, which exhibited no desensitisation.
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5.2.3 Quantitation of the glutamate EC50 for CeGluCla3B homomers
Xenopus oocytes injected with in vitro transcribed CeGluCla3B cRNA and clamped at a 
holding potential o f -80mV, exhibited robust inward-currents that rapidly desensitised in 
response to glutamate (figure 5A). In contrast, the CeGluCla3A subunits appeared to be 
unable to form glutamate sensitive channels in oocytes; the recordings were made on > 1 0  
oocytes per frog (four animals in total), using lOmM glutamate. These findings confirmed 
the observations made previously, as to the qualitative response o f each subunit to 
glutamate when expressed in this system (Dent et al., 2000). As shown in figures 5A and 
5B further investigation using oocytes injected with CeGluCla3B cRNA revealed that the 
dose dependent currents elicited by glutamate generated an EC50 value o f 2.2 ± 0.12mM 
with responses peaking (i.e. the maximum response) at concentrations o f >50mM. The Hill 
co-efficient o f 0.72 ± 0.08 suggested only one molecule was required to gate the channel. 
Control oocytes (uninjected and injected with 50nl dctt^O) failed to respond to glutamate at 
concentrations o f 1, 10 and lOOmM (n=5). Expression o f this subunit in oocytes was almost 
exclusively found on days 2 and 3 post-injection. Although more consistent than was 
observed for the DiGluCla3B subunit, expression problems were also encountered for this 
polypeptide, preventing further experiments from being conducted.
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Figure 5.2 Dose dependent glutamate-gated currents in Xenopus oocytes injected with C. elegans 
GIuCla3B cRNA and voltage clamped at -80mV. A: Example traces of the glutamate-gated currents; the 
downward deflections denote the inward nature of the currents. Horizontal bars relate to the duration of 
glutamate application, the numbers above indicating the concentrations used. The currents generated by 
glutamate exhibited both a rapid-onset and a rapid desensitisation, and were folly reversible upon removal of 
the agonist. B: Glutamate concentration response curve for oocytes injected with CeGluCla3B cRNA. Data 
were normalised to the maximum glutamate responses seen with each oocyte and are shown as the standard 
error of the mean of five oocytes (taken from two frogs). The observed currents generated an EC50 value of 2.2 




As hypothesised, DiGluCla3B subunits are able to form homomeric channels in Xenopus 
oocytes that are gated, in typical fashions, by both glutamate and IVM. In addition, initial 
results indicate that DiGluCla3A subunits cannot form homomers sensitive to glutamate. 
These data are in general agreement with those responses observed for their C. elegans 
orthologues (Dent et aL, 2000); the effect o f IVM on oocytes injected with DiGluCla3A 
subunit cRNA remains untested. The ability o f IVM to activate both C. elegans and D. 
immitis GluCla3B homomers complements a study that demonstrated that HcGluCla3B 
bound [3H]-TVM with high affinity (KD=70pM) (Cheeseman et al., 2001). HcGluCla3A 
did not bind [3H]-IVM (Cheeseman et al., 2001), which is also in line with the inability o f 
CeGluCla3A subunits to form IVM-sensitive homomers in oocytes (Dent et al., 2000; this 
chapter). Given this apparent conservation in, albeit limited, pharmacology across species 
for the GluCla3 subunits it would be predicted that the DiGluCla3A subunits were also 
unable to form IVM-sensitive homomeric channels. This perhaps should not be surprising 
given the high amino acid sequence identity between orthologous GluCla3 subunits 
(>80%).
With regard to the results from the application o f glutamate, it remains unknown whether 
the GluCla3 A subunits o f both D. immitis and C. elegans are deficient in agonist binding, 
coupling binding to gating or indeed the ability to associate into homomeric channels. The 
pattern o f alternative splicing o f the avr-14 gene, conserved across the species examined, 
results in the GluCla3A and a3B subunits having identical N-terminals. These regions are 
presumed to contain all the elements o f glutamate binding, indicating the first o f these 
possibilities is unlikely (see chapter 3; Laughton et al., 1997a; Jagannathan et al., 1999). 
Both alternative explanations remain plausible, as illustrated in earlier chapters for other 
LGICs: CeGluClal homomers are unable to couple glutamate binding to channel gating 
(Etter et al., 1996) where as selected mammalian GABAa subunits (a l, p2, y2) will only 
form functional receptors in vitro that are equivalent in subunit composition to the native 
channels in vivo (Connolly et al., 1996; Gorrie et al., 1997).
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All three reasons given above could also explain why CeGluCla3A subunits are unable to 
form IVM-sensitive homomers in oocytes (Dent et al., 2000); for glutamate-binding site 
read IVM binding site, as it appears unlikely these are one and the same (discussed in 
chapter 6). However, if we assume that the pharmacology o f these subunits is conserved 
across species then it appears unlikely that an inability to couple binding to gating alone, 
explains the lack o f IVM response because as stated, HcGluCla3A subunits cannot bind 
[3H]-IVM (Cheeseman et al., 2001). Actually, given this assumption, there are only two 
likely explanations for the observed pharmacology o f GluCla3A subunits in oocytes. Either 
they simply cannot associate into homomeric channels, regardless o f other factors, or they 
form homomers that do not possess an IVM binding site and are deficient in coupling 
glutamate binding to gating. Either way, both scenarios would suggest that GluCla3A 
subunits do not form homomeric channels in vivo.
The glutamate dose response curve for CeGluCla3B homomers generated an EC50 value o f 
2.2 ± 0.12mM, which is comparable to those described for the C. elegans GluCla2A 
(2mM) (Dent et al., 1997) and GluCla4 (1.9mM) homomers (Horoszok et al., 2001). All 
these figures are significantly higher than EC50 values determined for oocytes injected with 
C. elegans mRNA (EC5o=300pM) (Arena et al., 1992) and a GluCl described in a C. 
elegans pharyngeal preparation (EC50=166pM) (Pemberton et al., 2001). This suggests 
CeGluCla3B subunits do not form homomeric receptors in vivo. Interestingly, the Hill 
coefficient for CeGluCla3B was only 0.72 ± 0.08, suggesting only one glutamate molecule 
was required to gate the channel. Hill coefficients determined for other GluCls (see table 
1.2) have generally indicated that more than one molecule is required to gate the channel, 
lending support to the notion that this subunit does not form homomers in vivo (Arena et 
al., 1992; Cully et al., 1994; Cully et al., 1996a; Vassilatis et al., 1997a; Dent et al., 1997; 
Horoszok et al., 2001; Pemberton et al., 2001; Forrester et al., 2003). It remains a 
possibility however that due to the rapid desensitisation o f the GluCla3B homomers in the 
presence o f agonist, the maximum glutamate current was underestimated, which in turn 
may have subsequently lead to an underestimation o f the Hill coefficient.
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There is a great deal o f scope for future work with the GluCla3 subunits from both D. 
immitis and C. elegans. The most obvious experiments for the DiGluCla3B homomers 
would be to quantify the glutamate and IVM responses. Additional generation o f an IVM 
dose response curve for the CeGluCla3B homomers would permit the first direct 
comparison o f quantitative pharmacology for orthologous GluCls. For the GluCla3B 
homomers o f both species the subsequent experiments should probably be directed at 
confirming their GluCl status; the standard application o f other common neurotransmitters 
and the determination o f the reversal potential o f the channels would suitably achieve this 
objective. As for the DiGluCla3A subunit, it needs to be established whether or not oocytes 
injected with this polypeptide’s cRNA can respond to IVM or not. This would support (or 
not) the assumption that orthologous GluCla3 subunits exhibit conserved pharmacology.
Beyond those initial experiments two avenues o f investigation may prove very revealing. 
Firstly, it would be very interesting to establish if low concentrations o f IVM (<10nM) 
were able to potentiate sub-maximal applications o f glutamate when applied to GluCla3B 
homomers from either species, as was demonstrated for CeGluClalp heteromers (Cully et 
al., 1994). The background for these experiments, as alluded to earlier, is that there is a 
clear discrepancy between the concentrations o f AMs that activate recombinant channels in 
oocytes (>10nM; EC50 values range from 90-400nM) (Arena et al., 1992; Cully et al., 
1994; Cully et al., 1996a; Dent et al., 1997; Vassilatis et al., 1997a; Horoszok et al., 2001; 
Forrester et al., 2003) compared to those, which have been shown to bind individual GluCls 
(pM range) (Cheeseman et al., 2001; Forrester et al., 2002) and exert their effects (paralysis 
o f pharyngeal pumping and motility) on worms in vitro (>0.1 nM) (Kass et a l ,  1980; Avery 
& Horvitz, 1990; Gill et al., 1991, 1995; Geary et al., 1993; Arena et al., 1995; Paiement et 
al., 1999). This has lead to some debate regarding the true mechanism o f action o f the AMs 
at low concentrations (<10nM) (Pemberton et al., 2001; Yates et a l ,  in press), a subject 
which is expanded upon in chapter 6.
Due to the pharmacology outlined above, it appears unlikely the CeGluCla3A subunits
form homomeric receptors in vivo. By inference, partially supported by the limited data
available, the same may well be true for the D. immitis orthologues. Therefore, a second
interesting avenue o f investigation may be to conduct TEVC recordings on oocytes injected
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with multiple GluCl subunit cRNAs to see if  they able form heteromeric channels; these 
may (or may not) be more indicative o f the in vivo receptors. In C. elegans, limited subunit 
combinations (GluClalp and GluCla2BP) have already been examined (Cully et al., 1994; 
Vassilatis et al., 1997b). As the CeGluCla3 subunits appear to be widely expressed in the 
nervous system, it would not be surprising if they were be able to associate with a number 
o f other GluCl subunits to form heteromeric receptors, including with each other (Dent et 
al., 2000). Elucidating the correct subunit stoichiometries o f the native receptors will be o f 
major importance. For example, it may explain the different sensitivities o f the nematode’s 
biological targets, i.e. pharyngeal pumping, motility and fecundity, to AM action. 
Activation o f native receptors may also require lower concentrations o f AM than observed 
for the GluCls so far expressed in oocytes, dispelling the debate surrounding the 
mechanism o f action o f these drugs (see chapter 6). Finally, learning the true nature o f the 
in vivo channels would provide a much more accurate target for screening further potential 
anthelmintics. Obviously, these experiments are certainly possible in C. elegans, as it 
appears likely that all the GluCl subunits are known (The C. elegans Sequencing 
Consortium, 1998). However in D. immitis the only subunits that have been identified are 
GluCla3A and a3B. As initially stated, it is possible that these subunits may associate with 
each other to form heteromers, a hypothesis that can be readily tested. It may also be 
possible to express these subunits with GluCl subunits from other species. If seemingly 
genuine associations o f the CeGluCla3 subunits with other C. elegans GluCl polypeptides 
were made, similar experiments could be conducted substituting the D. immitis subunits for 
their orthologues. As discussed in section 4.3, the value o f these experiments is debatable 
given there is no evidence to suggest that the other C elegans GluCl subunits have 
orthologues in D. immitis let alone evidence regarding matters o f co-localisation. Certainly, 
it seems the GluCl subunit genetics between even closely related species o f nematode are 
not highly conserved; the HcGluCla subunit has no direct orthologues in C. elegans. In 
addition, expression patterns o f the orthologous GluCla3 subunits between C. elegans and 
H. contortus, whilst consistent in parts also exhibit considerable differences (Dent et al., 
2000; Portillo et al., 2003).
The above discussion regarding future work will be academic unless the expression o f the
C. elegans and especially the D. immitis GluCla3 subunits in Xenopus oocytes can be
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improved. Clearly the addition o f the 5’-AMV sequence improved expression o f the 
polypeptides, as during the initial trial experiments no glutamate-sensitive oocytes were 
observed, even with those injected with CeGluCla3B cRNA. However, the expression 
obtained following the inclusion o f this sequence was still inconsistent; oocytes injected 
with CeGluCla3 cRNA from batch to batch varied considerably in their response to 
glutamate while few oocytes injected with DiGluCla3B cRNA responded to this ligand at 
all. It is quite probable that some o f the expression inconsistencies were due to a natural 
variation in oocyte quality from one frog to the next. However, there remain a number o f 
steps that could be taken, at the DNA/RNA level to improve expression. As illustrated by 
the 5’ AMV sequence, expression o f foreign RNA in oocytes can be heavily influenced by 
5’ and 3’ untranslated sequences. Therefore, one way o f increasing expression maybe to 
sub-clone the subunit cDNAs into specialist Xenopus oocyte expression vectors, such as 
pSP64T (or one o f its derivatives). Coding sequences inserted into these vectors are flanked 
by 5’ and 3’-untranslated regions derived from the Xenopus P-globin mRNA, which appear 
to significantly enhance the foreign RNA’s translation efficiency in this system (Krieg & 
Melton, 1984). Vectors o f this type have been used in the expression o f the CeGluCla2A 
and HcGluCla subunits in oocytes (Dent et al., 1997; Forrester et al., 2003). An alternative 
method, which was attempted to increase expression o f the DiGuCla3 subunits in 
mammalian cell-lines, would be to incorporate a Kozak sequence directly upstream o f the 
start codon; Kozak sequences promote efficient translation from whichever ATG codon 
they are located next to (Kozak, 1986). Polyadenylation o f cRNA is another way shown to 
improve stability and translational efficiency. This can be achieved by incorporating such a 
region into the vector at the 3’ end o f the multiple cloning site (pSP64T has one), hence it is 
added during transcription, or can be added post-transcription using an RNA poly(A) 
polymerase. Whilst incorporation o f this sequence has improved expression for some 
proteins it certainly does not stabilise or promote translation o f all foreign mRNAs injected 
into oocytes (Wormington, 1991). An alternative method to cRNA injected into the 
cytoplasm, is to inject the subunit cDNA into the nucleus o f the oocyte. Although more 
technically difficult, by doing this one bypasses the need for the in vitro procedures 
required for preparing cRNA and the inherent problems associated with possible 
degradation (Betrand et al., 1991). As discussed in section 4.3, it might be interesting 
whether codon optimisation for the GluCla3 subunit cDNAs may improve expression in
Xenopus oocytes as has been shown for C. elegans GluCl subunit cDNAs in mammalian 
cells (Slimko & Lester, 2003). This may be particularly important given the striking AT 
bias in D. immitis codons (Fadiel et al., 2001).
In summary, the responses (or lack of) elicited by glutamate and IVM applied to oocytes 
injected with either DiGluCla3A or a3B cRNA were consistent with the known 
pharmacology o f orthologous subunits. DiGluCla3B formed homomeric channels gated by 
both glutamate and IVM whilst in DiGluCla3A cRNA injected oocytes no currents were 
observed upon application o f glutamate at high concentrations; the IVM response in these 
cells remains to be tested. As discussed above it is unknown whether the DiGluCla3A 
subunits are even able to associate into homomers. The GluCla3B subunit is therefore a 
potential molecular target for the AMs in D. immitis. But how sensitive is DiGluCla3B to 
AMs? And where and at which developmental stage(s) is the subunit expressed? Questions 
like this need to be addressed to establish how important (or not) this subunit is in 
conveying the sensitivity o f the larval stages o f D. immitis to the AMs. Additionally, 
answers to these questions may indicate why these drugs are so ineffective at killing adult 
worms. Studies using oocytes have also allowed a glutamate dose response curve to be 
determined for CeGluCla3B homomers, the EC50 and Hill coefficients generated being 
comparable to other GluCls in oocytes. However they also indicate that this subunit 
probably does not form homomers in vivo. This is probably true for the CeGluCla3A 
subunits also. Unfortunately, not all o f the original objectives outlined in the introduction 
were achieved, which was mainly due to the highly variable expression o f the subunits in 
the oocytes. Hopefully, the measures suggested to overcome these problems, will aid 




6.1 DiGluCla3B is a molecular target for the AMs
D. immitis is a filarial nematode that primarily infects domesticated dogs causing 
cardiopulmonary disease. In severe cases this can lead to right-sided heart failure. It is a 
widely distributed parasite and hence drugs used to combat infections are o f significant 
economic importance in the rapidly expanding animal health care market (Witty, 1999). 
Chemoprophylaxis is the most effective and safest way o f controlling heartworm disease. 
The major drugs used in this preventative treatment are the AMs. Although these 
compounds are extremely effective at killing larval forms o f the parasite, they are 
ineffective at killing adult worms, hence their roles as prophylactics (Knight, 1998). The 
overall objective o f this study was to address why this may be so by establishing which 
molecules are the likely targets for such drugs. It is hoped that a greater understanding o f  
the target molecules might, in the future, direct the development o f improved therapies that 
are also effective against the adult worms. This is important, as the treatments available to 
remove the adult worms are also very toxic to the host (Knight, 1998). Numerous studies 
have indicated that the GluCls are the targets for the AMs (see section 1.8.3). Therefore the 
aims o f the study were to firstly clone GluCl subunit cDNAs from D. immitis and then 
express the polypeptides in order to investigate their pharmacology with respect to the 
AMs. The results o f this study, summarised below, indicate that these aims have largely 
been achieved.
From the research undertaken two GluCl subunit cDNAs were cloned. Based on homology 
searches, the encoded subunits are clearly orthologous to the alternatively spliced GluCla3 
subunits (from the avr-14 gene) identified in C. elegans and H. contortus (Laughton et al 
1997a; Jagannathan et al., 1999). The D. immitis GluCla3 subunits failed to express at 
detectable levels in mammalian cell-lines. Therefore TEVC recordings were made from 
Xenopus oocytes injected with subunit-specific cRNA to investigate their pharmacology. 
The GluCla3B subunits formed channels that were gated by glutamate (1-lOOmM) and 
IVM (lpM ), in typical fashions, establishing this molecule as a potential target for the AMs 
in vivo. However, oocytes injected with GluCla3A cRNA failed to respond to glutamate; 
the response to IVM in these oocytes was not tested. The qualitative responses obtained 
were consistent with the pharmacology observed for the GluCla3 subunits in C. elegans
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(Dent et al., 2000; this study) and H. contortus (Cheeseman et al., 2001; Forrester et al., 
2002), perhaps not surprising given the high degree o f amino acid identity (>80%) between 
orthologues.
The next stage o f achieving the original objective would be to ascertain if the GluCla3B 
subunit is an important target for AMs. As outlined in the last chapter, this would entail 
addressing a number o f questions including how sensitive the receptors formed from these 
subunits are to the AMs? When during the lifecycle, i.e. during which developmental 
stages, are the subunits expressed? Where in the worms are they expressed? And finally, 
does their tissue distribution correlate well with the typical biological activities displayed 
by the AMs, i.e. inhibition o f pharyngeal pumping, motility and fecundity? Without 
addressing such questions there remains a number o f explanations for why these 
compounds exhibit such different potencies against larvae and adult worms. An obvious 
and rather simple explanation could be that while larval worms express AM-sensitive 
GluCls, adult worms do not; the CeGluClp subunit has been shown to form functional 
channels that are glutamate but not IVM sensitive (Cully et al., 1994). The GluCla3 
subunit cDNAs were amplified from mRNA isolated from adult female D. immitis. 
However, the presence o f unreleased microfilaria within these worms makes it impossible 
to draw many conclusions as to the stage specific expression o f these subunits. An 
alternative explanation could be that all stages express AM-sensitive GluCls, but in adults 
their expression pattern may not correlate well with the processes typically affected by the 
AMs in other species (and presumably D. immitis larvae), i.e. activation o f GluCls does not 
lead to an inhibition o f pharyngeal pumping or motility. Indeed, the expression pattern o f 
the GluCla3B subunits appears not to be absolutely conserved between even closely related 
species (Dent et al., 2000; Portillo et al., 2003). O f course it remains possible that 
inhibition o f these processes in adult D. immitis is simply not important; the worms do not 
have to constantly move to fight against forces such as the peristaltic flow in the gut and 
appear to be able to derive their nutrients through transcuticular absorption rather than via 
the pharynx (Geary et al., 1995). One final explanation could be that the drugs are simply 
unable to access their target, although transcuticular absorption o f IVM uptake in other 
species o f nematode has been demonstrated (Smith & Campbell, 1996).
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6.2 What is the true molecular mechanism of AM action?
Aside from establishing whether the GluCla3B subunit is potentially an important target 
for the AMs it would be interesting to further investigate the true mechanism o f action o f 
these compounds in respect to the GluCls. As stated, there is a clear discrepancy between 
the high concentration o f AMs required to activate recombinant GluCls expressed in 
oocytes (>10nM) (Arena et al., 1992; Cully et al., 1994; Cully et al., 1996a; Dent et al., 
1997; Vassilatis et al., 1997a; Horoszok et al., 2001; Forrester et al., 2003) with the 
significantly lower concentrations able to bind individual GluCl subunits (pM range) 
(Cheeseman et al., 2001; Forrester et al., 2002) and those that exert activity towards worms 
in vitro (>0.1nM) ( Kass et al., 1980; Avery & Horvitz, 1990; Gill et al., 1991, 1995; Geary 
et al., 1993; Arena et al., 1995; Paiement et al., 1999). Low concentrations o f IVM 
(<10nM) have been reported however, to potentiate sub-maximal concentrations o f 
glutamate in oocytes injected with selected GluCls (Cully et al., 1994, 1996b; Forrester et 
al., 2003).
A recent electrophysiological study demonstrated that the native pharyngeal GluCls from 
C. elegans were considerably more sensitive to IVM than GluCls expressed in Xenopus 
oocytes (Pemberton et al., 2001). The potency o f the IVM response (ECso=2.7nM) was 
comparable with concentrations shown to paralyse the pharynx in vitro (Avery & Horvitz, 
1990; Geary et al., 1993) and bind individual GluCl subunits (Cheeseman et al., 2001; 
Forrester et al., 2002). Two explanations could account for this result, as outlined in 
Pemberton et al (Pemberton et al., 2001). Firstly, the differing IVM sensitivities could be 
explained by the subunit composition o f the native receptors. Only a limited number o f 
subunit combinations have been successfully expressed so far in oocytes and none o f these 
may reflect the stoichiometry o f native the GluCl. Secondly, and perhaps more intriguingly, 
the potency observed reflected the potentiation o f the IVM response by endogenous 
glutamate. In support o f this, a recent study has shown that glutamate potentiated AM 
binding to the H. contortus HcGluCla subunit (Forrester et al., 2002).
Therefore, the pharmacological evidence suggests that while GluCls are the high-affinity 
molecular targets for the AMs in nematodes, glutamate does not share the same binding
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site; glutamate does not compete for IVM binding-sites in membrane preparations 
(Schaeffer & Haines, 1989). This is perhaps not surprising given the highly lipophilic 
nature o f the AMs (Burkhart, 2000). The potentiation o f the electrophysiological response 
to glutamate by IVM and o f IVM binding by glutamate, indicate an allosteric relationship 
between the glutamate and ivermectin binding sites. How these potentiation effects relate to 
the AMs ability to directly activate the channels is not easily reconciled. It is tempting to 
speculate that the direct activation o f the channels is due to a second, lower affinity, AM 
binding site on the receptor. A site with an affinity close to the observed EC50 for IVM on 
oocyte-expressed GluCl (~100nM) would not have been detected in the binding 
experiments o f Cheeseman et al (2001) or Forrester et al (2002), in which the highest 
concentrations o f radioligand used were <5nM. Whether it is a direct activation o f GluCl or 
potentiation o f glutamate responses, or both, that is important for AM anthelmintic activity 
in vivo is unknown.
6.3 Summary of other results
Complimentary TEVC studies were conducted on the C. elegans GluCla3B subunits, 
expressed as homomers in oocytes. The glutamate dose response curve generated for these 
channels had an EC50 value o f 2.2 ± 0.12mM and a Hill coefficient o f 0.72 ± 0.08. As 
discussed in section 5.3, the EC50 value is comparable to those determined for GluCla2A 
and GluCla4 homomers (Dent et al., 1997; Horoszok et al., 2001). However, it is 
significantly higher than EC50 values determined for oocytes injected with C. elegans 
mRNA (Arena et al., 1992) and the GluCl described in the C. elegans pharynx (Pemberton 
et al., 2001). This suggests CeGluCla3B subunits do not form homomeric receptors in vivo. 
Interestingly, the Hill coefficient for CeGluCla3B homomers indicated that only one 
glutamate molecule was able to activate the receptor. This is unusual compared with other 
GluCls (see table 1.2) and may reflect an underestimation o f the true value caused by the 
rapid desensitization o f the receptors in the presence o f glutamate.
During the original cloning phase o f the project, numerous PCRs were conducted using 
degenerate oligonucleotide primers in an attempt to amplify further D. immitis GluCl 
cDNAs. Although no new GluCl cDNAs were amplified, a potentially novel LGIC subunit 
cDNA, termed DG1, was isolated. The subunit exhibited low amino acid identity with other
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LGCCs (20-30%), but exhibited ~50% identity to a predicted LGIC subunit in C. elegans 
(T27A1.4). DG1, and indeed T27A1.4 may represent outlying members o f the LGIC 
superfamily; the contrasting conserved nature o f certain characteristic features o f these 
channels (i.e. second “cys-loop” and apparent 4 TM regions) against the absence o f such a 
defining feature as the first “cys-loop” remains a conundrum. Interestingly, there appears to 
be a related sequence in the Brugia malayi genome.
6.4 Final conclusions
During this study, two D. immitis GluCl subunit cDNAs have been amplified, the encoded 
subunits being clearly orthologous to the alternatively spliced GluCla3 subunits from C. 
elegans and H. contortus. The D. immitis GluCla3B subunit has been identified as a 
potential molecular target for the AMs in vivo, by forming IVM-sensitive homomeric 
channels in oocytes. As discussed, it will be interesting to examine if  this subunit plays an 
important role in explaining why the AMs exhibit such different potencies against adult and 
larval forms o f D. immitis. From a commercial aspect, this subunit may now be used as a 
molecular target in screens to develop new or existing anthelmintic compounds.
Interest in GluCls as molecular targets partially stems from the fact that they are only found 
in invertebrates, a particularly advantageous characteristic with regards to the design o f 
anthelmintic drugs. It follows, that if the drugs target molecules only found in the parasite 
then there is decreased likelihood o f side effects (caused by the drug) in the host. Therefore 
it will be very interesting to see if  the DG1 or T27A1.4 subunits are important for the 
viability o f their respective species o f nematode. They both appear to be highly unusual 





Oligonucleotide primer details 
From chapter 3:
Primers used to amplify DiGluCla3 subunit cDNAs
Primer Nucleotide sequence (5’->3’) Comments
5Di2/3Pl gaagcaagaagacatcttattgacaag Internal sense primer
3Di2/3Pl gctatattcacctgtatttgttttactcg Internal anti-sense primer
SL1 ggtttaattacccaagtttgag SL1 sense primer
RoRi gactacgttagcatctagaattctcgag RiRo adaptor site anti-sense primer
SDG2 ctattatgaatcctcgtatagtttattgg a3A/B coding region sense primer
ASDG2 ccaagcttttgttaaatgaggtaaacag a3A coding region anti-sense primer
ASDi2/3P2 gtgcactatattccatgttaacgtcatc Internal anti-sense sequencing primer
ASDG3 cttcatgttaattgacataattcac a3B coding region anti-sense primer
Degenerate primers










The primers in blue font represent those designed with bias towards the GluCla-type subunits. The primers in 
red font represent those designed with bias to the GluCl(3-type subunits. “S” prefix denotes the sense primers 
whilst “AS” prefix denotes the anti-sense primers. The regions the primers were designed to are indicated in 
appendix C.
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Primers used to amplify DG1 and T27A1.4 subunit cDNAs
Primer Nucleotide sequence (5’->3’) Comments
SL1 ggtttaattacccaagtttgag SL1 sense primer
RoRi gactacgttagcatctagaattctcgag RiRo adaptor site anti-sense primer
SBETA2P2 ggtctcgagggtcaggtgctg Internal sense primer
SDG1 gcaatgtggtcaacaattgtatcg Coding region sense primer
ASDG1 gacgaatgtatcagtcaattatac Coding region anti-sense primer
SBETA2P3 cggttgttgaaccaaccggatatg Internal sequencing primer
ST27A1.4 atgaggaacattttcttatttctagtacta Coding region sense primer
AST27A1.4 ttaaacaataaaaataaagtaaataatcaa Coding region anti-sense primer
T27seql gtcagcaatggcaggatagtcgtttg Internal sequencing primer
T27seq2 gagaagaaggtgagcacaaggcag Internal sequencing primer
F r o m  c h a p te r  4 :
Primers used to amplify DiGluCla3 cDNAs for cloning into the epitope-tag vectors





Underlined italic sequence indicates the position of the incorporated restrictions site given in brackets. The 
Kozak sequence is highlighted in bold type.
F r o m  c h a p te r  5 :
Primers used to amplify the AMV-GIuCla3 subunit cDNAs
Primer Nucleotide sequence (5 ’-> 3 ’)
SDiGluCla3AMV nnnnnn/ctogtfgtttttatttttaattttctttcaaatacttccatatgaatcctcgtatagttc (Xbal)
ASDiGluCla3AAMV nnnnnngcggccgcttaaatgaggtaaacagccca (Notl)
ASDiGluCla3 BAMV nnnnnngcggccgcttaattgacataattcacata (Notl)
SCeGluCla3AMV nnnnnn/c/agagtttttatttttaattttctttcaaatacttccatcatgtggcattatcgactg (Xbal)
ASCeGluCla3AAMV nnnnnngcggccgctcacatcaggtagacggc (Notl)
ASCeGluCla3BAMV n n n nn n gcggccgcttaatt gacataattcacata (Notl)
Underlined italic sequence indicates the position of the incorporated restrictions site given in brackets. The 
AMY sequence is highlighted in bold type.
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Appendix B
Nucleotide sequences of cloned D LGIC subunit cDNAs
The black sequence indicates the coding-region. The blue region is the SL1 sequence and 
the red regions the untranslated sequence. The proposed start codon is highlighted in 
yellow.
>GluCla3A
1 GGTTTAATTA CCCAAGTTTG AGGAAAATTT 
61 AATCTCATTC TTCTAATCCT TGTTGTGGCA 
121 CAGAGAACGT TGAAGGATTA CGATTGGCGT 
181 CCAGATACGG GTGGTCCAGT ATTGGTTTCT 
241 ATTGATGACG TTAACATGGA ATATAGTGCA 
301 GCACGATTGG CATATGAACG TCTGGCGGAT 
361 CTGGCAGCTA GTGAACAAGC TGATTTAACG 
421 CCAAACGAAA AAGAAGCAAG AAGACATCTT 
481 CATCCAGATG GTCAAATATT GTACAGTGTT 
541 TCGTTAGAAT ATTATCCATT GGATCGACAG 
601 TACACCACCG ACGATATTAA ATATGAATGG 
661 GGCTTACGAC AAAGTCTGCC AAGTTTCGAA 
721 AGTAAAACAA ATACAGGTGA ATATAGCTGT 
781 TTCAGCTACT ATCTTTTGCA GCTCTATATA 
841 GTAAGCTTTT GGCTCGACAA GGATTCGGTG 
901 CTTCTAACGA TGACCACACA AAGTTCAGGC 
961 ACAAAGGCAA TAGATGTTTG GATTGGTGTT 
1021 GAATTTGCCT TGGTCAATTA TGCGGCAAGG 
1081 TCAAAATATG CCAGTCATAT GGATTACTCA 
1141 ACTGCTATGC CGCCTTCCCG TTCTTGGTTG 
1201 GAACGTTCCA AGCGAATTGA TGTTGTTTCA 
1261 TTCAACGTGT TATATTGGGC TGTTTACCTC 
1321 GTGTTTATGC GATCAAATTG TACACTATAG 
1381 TATTAACCAA TCAAAATGGC GCTACTTTTT 
1441 TTATACCGAA TATATCTATA CATATATTCC
ACTATTATGA ATCCTCGTAT AGTTTATTGG 
AAGAAAAAAC TGAAAGAGCA AGAAATAATC 
GTACGACCAC GTGGCAGTAA TCTTTCCTGG 
GTAAACATAT ATTTGCGATC TATTTCAAAA 
CAATTTACCT TTCGAGAAGA ATGGCATGAT 
GAGAATACCC AAGTACCGCC GTTTGTAGTA 
CAGCAAATTT GGATGCCGGA TACATTTTTT 
ATTGACAAGC CTAATGTGCT TATTAGAATA 
AGGCTTTCAT TGGTATTATC TTGCCCGATG 
ACGTGTCTTA TTGATCTTGC AAGTTATGCT 
AAATTGAAGA ATCCGATTCA GCAGAAAGAA 
CTCCAAGATG TCCTAACAGA TTACTGTACG 
TTAAGGACAA AAATGATTTT ACGACGCGAA 
CCTTCATTTA TGCTGGTTAT CGTCTCATGG 
CCTGCGCGTG TTACCCTTGG CGTAACAACT 
ATCAACGCTA AACTTCCCCC CGTTTCCTAT 
TGCTTAGCCT TCATTTTTGG TGCATTGCTT 
AAGGATATAA CTACTAGACA TCGAATGTTA 
TCTGGTTATC AACCTCTAGT ATCAGCGACC 
TGCTTCCGGC TATTTGTCCG ACGCTACAAA 
CGCTTGGTAT TTCCGATTGG TTACGCCTGC 
ATTTAACAAA AGCTTGGGAT ACAGTAATCT 
ATATATATAT ATATTCATTG TACCAATCAT 




1 GGTTTAATTA CCCAAGTTTG AGGAAAATTT 
61 AATCTCATTC TTCTAATCCT TGTTGTGGCA 
121 CAGAGAACGT TGAAGGATTA CGATTGGCGT 
181 CCAGATACGG GTGGTCCAGT ATTGGTTTCT 
241 ATTGATGACG TTAACATGGA ATATAGTGCA 
301 GCACGATTGG CATATGAACG TCTGGCGGAT 
361 CTGGCAGCTA GTGAACAAGC TGATTTAACG 
421 CAAAATGAAA AAGAAGCAAG AAGACATCTT 
4 81 CATCCAGATG GTCAAATATT GTACAGTGTT 
541 TCGTTAGAAT ATTATCCATT GGATCGACAG 
601 TACACCACCG ACGATATTAA ATATGAATGG 
661 GGCTTACGAC AAAGTCTGCC AAGTTTCGAA 
721 AGTAAAACAA ATACAGGTGA ATATAGCTGT 
781 TACAGTTATT ACTTAATTCA GCTATACATA 
841 GTCTCATTCT GGCTCGATAA GGATGCAGTA 
901 TTGCTAACAA TGACTACACA AGCATCAGGT 
961 ATCAAAGCAG TTGATGTATG GATTGGTGTA 
1021 GAATATGCAT TGGTCAATTA TTATGGACGT 
1081 AAAACTGAAT ACAAGGGTTG TTTATGTCCA 
1141 CAGTCGTTAC GATTAGACAT GAACGTATAT 
1201 AATACATACC TATGCAGTAA TGTTGAAGTT 
1261 GCTTTTCCAA CTTTTTTTGC TTTCTTCCTT 
1321 CATGAAGAAA TGATTTTCTC TTCCTGGTGC 
1381 AACAGTCAAT TCAAATACGT GAAAAAAGGA 
1441 AAATTTATAT AAATTTTCTG TGACAATTTG 
1501 GGGTCTTTGT AATAGTATTT CTTT GAT AAA
>DG1
1 GGTTTAATTA CCCAAGTTTG AGGTTATATC 
61 GAGCTGATGC AATGTGGTCA ACAATTGTAT 
121 TCAGTATTGG AATAATGGTA ACAGTACATG 
181 AAATTGGTCT CGAGGGTCAG GTGCTGTCGA 
241 GACCACCAGT CAGGGACTCG GCCGATCATT 
301 TCAACCGCAT CTTGTGGCAC GATCATCAAG 
361 GGGAGGATGG TCGGCTTGTA TATGAGCTAG 
421 TGCCACATAA TAGACATATC TGGATACCGG 
481 AT CAT GAAAA ACTTCATCGA ACGGTTGTTG 
541 TGCGTACAGT AACAGTACCA GTAGAATATG 
601 TGATCAAATT AAGATTATCA AGCTATAAGT 
661 CAAATTCACC ACCAACTGTA ATACCAGTTG 
721 ATGAATTTAA AGAAGCAGTA GCAGAAGATT 
781 CATGTATCGA TGTTCTCATA ACATTTACTG 
841 TCATCCCATC GATACTTCTG ATATTAGTAT 
901 GGTCAGTACC ACGAACAATT AGTGCTGCGG 
961 TATTCTATCC ACAGCCTAAT CTAACAACAT 
1021 TCTTCTGCCT TATTTTTACA TTTGCATCAT 
1081 GAATCAGAAG GACCATTCGA TATAGAGATG 
1141 TTACTGTTAC TAGAGAGACG GTCGAAGTTG 
1201 ACAATCACGG AATCGATCTT GTTTCACGCA 
1261 TTATCATCTT TTTCATTTTT TATTTGGTAT 
1321 CTCATCTTAT CTTAACATCT ATACCGAAAG
ACT AT TAT GA ATCCTCGTAT AGTTTATTGG 
AAGAAAAAAC TGAAAGAGCA AGAAATAATC 
GTACGACCAC GTGGCAGTAA TCTTTCCTGG 
GTAAACATAT ATTTGCGATC TATTTCAAAA 
CAATTTACCT TTCGAGAAGA ATGGCATGAT 
GAGAATACCC AAGTACCGCC GTTTGTAGTA 
CAGCAAATTT GGATGCCAGA TACTTTTTTC 
ATTGACAAGC CTAATGTGCT TATTAGAATA 
AGGCTTTCAT TGGTATTATC TTGCCCGATG 
ACGTGTCTTA TTGATCTTGC AAGTTATGCT 
AAATTGAAGA ATCCGATTCA GCAGAAAGAA 
CTCCAAGATG TCCTAACAGA TTACTGTACG 
GCTCGTGTTA TGCTACTTCT TCGTCGTGAA 
CCGTGCATTA TGTTGGTCGT CGTTTCTTGG 
CCTGCCCGTG TATCATTAGG AGTAACAACA 
ATCAATGCCA AACTTCCACC TGTATCATAC 
TGCCTAGCAT TTATCTTTGG AGCTTTGTTA 
CAAGAATTCC TGAAAAAGGA GAAGAGAAAG 
TCAGATCATC TCTTTAATCA AGACCTAAGG 
AGAAGAAAGT GGTGGACAAA ATTTTGGTTG 
AGCAAACGTG TAGATCTCAT TTCACGATTC 
GTGCTTTATT ATGTGAATTA TGTCAATTAA 
AAATGAAATA GAAAATTGAT GCATAAATGA 
CCCTGAATTA TACGAATATG AAAACATTTA 
AAAAACTGTT GTGTAATGAA TGAATAAAGC 
AATTATAT GA TTA
AGCAAACAGT TAACACTATT ATTAACCACG 
CGCGAATTTT TTGGATTCCA TTACTCATTG 
GACAATCTCC AAAAGTATTA CGATCACGTC 
GGATCCTCTC GGAATACGAT CCACAAACAC 
CCGCAATCGT TGTTATCGCA TCGATCTTCA 
CGGTTGTCGA TTTATATTTA CGACAACAAT 
ACGATCGAGA TGGAATTGAA GAGGTGGTCG 
ATACATATTT CTCAAATGGT CATGATGTAA 
AACCAACCGG ATATGTTCGA TCATCTGAAA 
GTTCCAAATA TCCGTTTGAA AATACTCGAA 
ATCCAATTGA AGATATTGTC TATTTATGGG 
AAGTATCGCA AGAATTGTTG ACCGGTTTCT 
GTGCTGGAAA TTATACCATC GGTATATATT 
GCGCATCTTC TGAAGCATTT TGGCGTATTT 
CATGGCTTCA TTTTTGGGTT CATGGTTCAT 
TGCCATTCCT CATCTTCGTT TCTATTTTAA 
ATGGTGTTAG CAGTTTGCAA ATATGGCTTT 
TGGTTGAATA TTTCATTGTG ATTTGTTGTG 
GAAAGGCTAT GAAAGATGAT GAATCCCCTC 
CATACGATAC GAAATGCGCC AATTTTAAGC 
TGGCTTTTCC GATTATCTTT CTTCTTTTCC 




Alignment of GluCl subunit amino acid sequences
D iG luC la3A
D iG luC la3B
C eG luC la3A
H cG luC la3A
C eG luC la3B
H cG luC la3B
AsGluClX
OvGluClX
C e G lu C la l
C eG luC la2B
C eG luC la4
H cG luC la
C eG luC ip
H cG luC lp
D m G luClal




D iG luC la3A
D iG luC la3B
C eG luC la3A
H cG luC la3A
C eG luC la3B
H cG luC la3B
A sGluClX
OvGluClX
C e G lu C la l
C eG luC la2B
C eG luC la4
H cG luC la
C eG luC ip
H cG luC lp
Dm G luClal

























D iG luC la3A Q. . . . RTLK. . . . DYDWRVRPRGSNLSWPDTG. . . GPVLVSVNIYLRSIS
D iG luC la3B Q. . . .R TL K .. . . DYDWRVRPRGSNLSWPDTG. . .GPVLVSVNIYLRSIS
C eG luC la3A Q. . . .R IL K .. . . DYDWRVRPRGMNATWPDTG. . . GPVLVTVNIYLRSIS
H cG luC la3A Q. . . .R IL N .. . . NYDWRVRPRGLNASWPDTG. . . GPVLVTVNIYLRSIS
C eG luC la3B Q. . . .R IL K .. . . DYDWRVRPRGMNATWPDTG. . .GPVLVTVNIYLRSIS
H cG luC la3B Q. . . .R IL N .. . .NYDWRVRPRGLNASWPDTG. . .GPVLVTVNIYLRSIS
AsGluClX . .GPVLVSVNIYLRSIS
OvGluClX Q. . . .R TL K .. . . DYDWRVRPRGNNLSWPDTG. . .GPVLVSVNIYLRSIS
C e G lu C la l A. . . . HLFTS. . . GYDFRVRPP____TDNG. . . . , GPVWSVNMLLRTIS
C eG luC la2B E. . . . HLLTR. . . GYDHRVRPPGEDGTIHG. . . . . GPVWSVNMLLRSIS
C eG luC la4 K. . . . KLLGK. . . GYDWRVRPPGINLTIPGTH. . . GAVIVYVNMLIRSIS
H cG luC la K. . . . HLLESPYSDYDWRVRPRGRLGPADDDDYDSEPVFITVNMYLRSIS
C eG luC ip N. . . .A LLK .. . . NYDMRVRPPPAN. SSTE. . . GAVNVRVNIMIRMLS
H cG luC ip N. . . . ELLS. . . . NYDMRVRPPPSNYSDPM, , , . GPVTVRVNIMIRMLS
Dm GluClal D. ____QILG. AGKYDARIRPSGING. . .T D .. . . GPAIVRINLFVRSIM
h G ly R a l D, , , KLMGRTSGYDARIRP.. .N F . . .K G .. . . PPVNVSCNIFINSFG
rGABAAa l R. ____ILDRLLDGYDNRLRP. . . GL. . . GE. . . . RVTEVKTDIFVTSFG











































D iG luC la3A  KIDDVNMEYSAQFTFREEWHDARLAYERLADEN. TQVPPFWLAASEQAD 116
D iG luC la3B  KIDDVNMEYSAQFTFREEWHDARLAYERLADEN.TQVPPFWLAASEQAD 116
C eG luC la3A  KIDDVNMEYSAQFTFREEWTDQRLAYERYEESGDTEVPPFWLATSENAD 120
H cG luC la3A  KIDDVNMEYSAQFTFREEWVDARLAYGRFEDES. TEVPPFWLATSENAD 128
C eG luC la3B  KIDDVNMEYSAQFTFREEWTDQRLAYERYEESGDTEVPPFWLATSENAD 120
H cG luC la3B  KIDDVNMEYSAHFTFREEWVDARLAYGRFEDES.TEVPPFWLATSENAD 128
AsGluClX KIDDVNMEYSAQFTFREEWRDARLAYERFADEN.TQVPPFWLATSEQAD 67
OvGluClX KIDDVNMEYSAQFTFREEWNDARLGYERLADEN.TQVPPFWLAASEQPD 117
C e G lu C la l KIDWNME Y S AQLTLRE S WIDKRLS Y GVKGDGQ--PDFVILTVG  143
C eG luC la2B  KIDNVNMEYSVQLTFRESWVDKRLS FGVKGDAQ--PDFLILTAG  156
C eG luC la4  KIDDVNMEYSVQLTFREEWVDGRLAYGFPGDST-------- PDFLILTAG------ 113
H cG luC la  KVDDVNMEYSLHFTFREEWIDERLYFNSP.. .T _LKHIVLSPG  115
C eG luC ip  KIDWNMEYSIQLTFREQWIDPRLAYENLGFYN. . . PPAFLTVPHVK. . . 113
H cG luC ip KIDWNMEYSMQLTFREQWLDSRLAYAHLGYHN. . . PPKFLTVPHIK. . . 116
D m GluClal TISDIKMEYSVQLTFREQWTDERLKFDDIQGRL KYLTL T 113
h G ly R al SIAETTMDYRVNIFLRQQWNDPRLAYNEYPDDS LDLDP S 116
rGABAAa l  PVSDHDMEYTIDVFFRQSWKDERLKFKG. PMTV LRLNN L 115
CeGLC4 AVSEKNMEFVAQFRFRQEWYDDRLRFIEHQGLL SSDYRNFEFIHVA 192
mGABAAp2 MVSEVNMDYTLTMYFQQAWRDKRLS YNVIPLNL TLDNR V 111
D iG luC la3A  LTQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHPD.GQILYSVRLSLVLS 165
D iG luC la3B  LTQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHPD.GQILYSVRLSLVLS 165
C eG luC la3A  QSQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHKN.GQILYSVRLSLVLS 169
H cG luC la3A  QSQQIWMPDTFFQNEKVARRHLIDKPNVLIRIHKD.GSILYSVRLSLVLS 177
C eG luC la3B  QSQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHKN.GQILYSVRLSLVLS 169
H cG luC la3B  QSQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHKD.GSILYSVRLSLVLS 177
AsGluClX LTQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHQD.GQILYSVRLSLVLS 116
OvGluClX LTQQIWMPDTFFQNEKEARRHLIDKPNVLIRIHPD.GQILYSVRLSLVLS 166
C e G lu C la l . . HQIWMPDTFFPNEKQAYKHTIDKPNVLIRIHND.GTVLYSVRISLVLS 190
C eG luC la2B  . . QEIWMPDSFFQNENQAYKHMIDKPNVLIRVHKD.GTILYSVRISLVLS 203
C eG luC la4  . . QQIWMPDSFFQNEKQAHKHDIDKPNVLIRIHRD.GRILYSVRISMVLS 160
H cG luC la  . . QRIWVPDTFFQNEKDGKKHDIDTPNILIRIHNGTGKILYSCRLTLTLS 163
C eG luC ip . . KSLWIPDTFFPTEKAAHRHLIDMENMFLRIYPD.GKILYSSRISLTSS 160
H cG luC ip . . SNLWIPOTFFPTEKAAHRHLIDTDNMFLRIHPD.GKVLYSSRISITSS 163
Dm GluClal EANRVWMPDLFFSNEKEGHFHNIIMPNVYIRIFPN. GSVLYSIRISLTLA 162
h G ly R a l MLDSIWKPDLFFANEKGAHFHEITTDNKLLRISRN.GNVLYSIRITLTLA 165
rGABAAa l  MASKIWTPDTFFHNGKKSVAHNMTMPNKLLRITED.GTLLYTMRLTVRAE 164
CeGLC4 RDQSLWIPDTFFQNEKNGWYHMLNQENRFLKIRSD.GKLIYDRRLTLHLA 241
mGABAAp2 ADQ.LWVPDTYFLNDKKSFVHGVTVKNRMIRLHPD.GTVLYGLRITTTAA 159
D iG luC la3A  CPMSLEYYPLDRQTCLIDLASYAYTTDDIKYEWKLKNPIQQKEG.LRQSL 214
D iG luC la3B  CPMSLEYYPLDRQTCSLIDLASYAYTTDDIKYEWKLKNPIQQKEG. LRQSL 214
C eG luC la3A  CPMSLE FY PLDRQNCLIDLASYAYTTQDIKYEWKEKKPIQQKDG. LRQSL 218
H cG luCla3A  CPMSLE FY PL DRQNCLIDLASYGYTTQDIKYEWKEQN PVQQKDG. LRQSL 226
C eG luC la3B  BPMSLE FYPLDRQNBLIDLASYAYTTQDIKYEWKEKKPIQQKDG. LRQSL 218
H cG luC la3B  CPMSLEFYPLDRQNCLIDLASYAYTTQDIKYEWKEQNPVQQKDG.LRQSL 226
AsGluClX CPMSLEYYPLDRQTCLIDLASYAYTTDDIKYEWKLTNPIQQKEG.LRQSL 165
OvGluClX CPMSLEYYPLDRQTCLIDLASYAYTTDDIKYEWKVKNPIQQKEG.LRQSL 215
C e G lu C la l CPMYLQYYPMDVQQCSIDLASYAYTTKDIEYLWKEHSPLQLKVG.LSSSL 239
C eG luC la2B  CPMHLQYYPMDVQQCFIDLASYAYTTKDIEYVWKEETPVQLKAG.LSSSL 252
C eG luC la4  CPMHLQYYPMDVQTCLIDLASYAYTENDIEYRWKKTDPVQLKKG.LHSSL 209
H cG luC la  CPMRLADYPLDVQTCWDFASYAYTTKDIEYGWKEEKPIQIKDG. LRQSL 212
C eG luC ip  CPMRLQLYPLDYQSCNFDLVSYAHTMNDIMYEWDPSTPVQLKPG.VGSDL 209
H cG luC ip CHMQLQLY PLDLQFCD FDLVSYAHTMKDIVYEWDPLAPVQLKPG.VGS DL 212
Dm GluClal CPMNLKLYPLDRQICSLRMASYGWTTNDLVFLWKEGDPVQW. . .KNLHL 209
h G ly R a l CPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQEQGAVQVA.. . DGLTL 212




D iG luC la3A
D iG luC la3B
C eG luC la3A
H cG luC la3A




C e G lu C la l
C eG luC la2B
C eG luC la4
H cG luC la
C eG luC ip
H cG luC ip
Dm GluClal



































LRTKMILRREF.. SYYLLQLYIPS F 
ARVMLLLRREY. . SYYLIQLYIPCI 
LRTRMVLRREF.. SYYLLQLYIPSF 
LRTQMVLRRE F . . SYYLLQLYIPSF 
ARWLRLRREY. . SYYLIQLYIPCI 
ARVKLLLRREY. . SYYLIQLYIPCI 




LRTVLELRRQF. . SYYLLQLYIPST 
LRTIIELKREF.. SYYLLQLYIPSF 
LRMQLLFKRQF.. SYYLVQLYAPTT 
LRMQLTLKRQF. . SYYLVQLYGPTT 
LKVDLLFRREF.. SYYLIQIYIPCC 
IEARFHLERQM. . GYYLIQMYIPSL
NQYDLLGQ. TVDSGIVQSSTGEYWMTTHFHLKRKI. . GYFVIQTYLPCI
PNFEIASFKNA.sJ t SKTNTGTYSJl KVEIRLNRVF.. S FFLLQLYIPSS 




















D iG luC la3A  MLVIVSWVSFWLDKDSVPARVTLGVTTLLTMTTQSSGINAKLPPVSYTKA 311
D iG luC la3B  MLWVSWVSFWLDKDAVPARVSLGVTTLLTMTTQASGINAKLSPVSYIKA 311
C eG luC la3A  MLVIVSWVSFWLDKDSVPARVTLGVTTLLTMTTQSSGINANVPPVSYTKA 315
H cG luCla3A  MLVIVSWVSFWLDKDSVPARVTLGVTTLLTMTTQSSGINANVPPVSYTKA 323
C eG luC la3B  MLWVSWVSFWLDKDAVPARVSLGVTTLLTMTTQASGINTKLPPVSYIKA 315
H cG luC la3B  MLLWSWVSFWLDKDAVPARVSLGVTTLLTMTTQASGINSKLPPVSYIKA 323
AsGluClX MLWVSWVSFWLDKDAVPARVSLGVTTLLTMTTQASGINSKLPPVSYIKA 262
OvGluClX MLWVSWVSFWLDKDAVPARVSLGVTTLLTMTTQASGINAKLPPVSYIKA 314
C e G lu C la l MLVIVSWVSFWFDRTAIPARVTLGVTTLLTMTAQSAGINSQL P PVSYIKA. 336
C eG luC la2B  MLVIVSWVSFWIDRTAVPARVTLGVTTLLTMTTQSSGINAKLPPVAYIKA 349
C eG luC la4 MLVIVSWVSFWLDRGAVPARVTLGVTTLLTMTTQASGINAKLPPVSYTKA 306
H cG luC la MLVAVSWVSFWLDKDSVPARVTLGVTTLLTMTTQASGVNANLPPVSYTKA 309
C eG luC ip  MIVIVSWVSFWIDLHSTAGRVALGVTTLLTMTTMQSAINAKLPPVSYVKV 307
H cG luC ip MIVIVSWVS FWIDMHSTAGRVALGVTTLLTMTTMQAAINAKLPPVSYVKV 310
D m GluClal MLVIVSWVSFWLDQGAVPARVSLGVTTLLTMATQTSGINASLSPVSYTKA 306
h G ly R al LIVILSWISFWINMDAAPARVGLGITTVLTMTTQSSGSRASLPKVSYVKA 310




D iG luC la3A  IDVWIGVCLAFIFGALLEFALVNYAARKDITTRH. RMLS........................... 349
D iG luC la3B  VDVWIGVCLAFIFGALLEYALVNYYGRQEFLKKEKRKKT..........................  350
C eG luC la3A  IDVWIGVCLAFIFGALLEFALVNYAARKDMTQVSQRIR.............................  353
HcGluCla3A  I DVWIGVCLAFI FGALLEFAWVNYAARKDM. . . SCGQR.............................  358
C eG luC la3B  VDVWIGVCLAFIFGALLEYAWNYYGRKEFLRKEKKKKT..........................  354
H cG luC la3B  VDVWIGVCLAFIFGALLE YA W NYYGRKE FLRKEKKKKT..........................  362
AsGluClX  VDVWIGVCLAFI FGALLE YALVNYHGRQEFLKKEKKKKT..........................  301
OvGluClX VDVWIGVCLAFI FGALLEYALVNYHGRQEFLKKEKKK................................ 351
C e G lu C la l IDVWIGACMTFIFCALLEFALVNHIANKQGVERKARTER........................... 375
C eG luC la2B  IDVWIGACMT FI FCALLE FAWVT YIANKQDANKRARTER........................... 388
C eG luC la4  IDVWIGACLTFIFGALLEFAWVTYISSRSFYKRNKNCSSRNSLLIETKQA 356
HcGluCla IDIWI GVCLAF I FGALLE F AL VNWAARQD L VAH S RAR Y R ........................... 348
C eG luC ip VDVWLGACQTFVFGALLEYAFVSYQDSVRQNDRSREKAA..........................  34 6
H cG luC ip VDVWLGACQTFVFGALLEYAFVSYQDSQRQTEQAKSRAA..........................  34 9
DmGluClal IDVWTGVCLTFVFGALLEFALVNYASRSGSNKANMHKENMKKKRRDLEQA 356
hG ly R a l IDIWMAVCLLFVFSALLEYAAVNFVSRQ................. HKELLRFRRKRRHHK 353
rGABAAa l  MDWFIAVCYAFVFSALIEFATVNYFTKRG YAWDGKSWPEKPKK 355




D iG luC la3A
D iG luC la3B
C eG luC la3A
H cGluCla3A
C eG luC la3B
H cG luC la3B
AsGluClX
OvGluClX











C eG luC la2B ....................................EKAELPFLQ.......................................................NSHN 401
C eG luC la4 LIIPNTWAQFPEHPEEVEMGLAQAPDVWIRQSGNGKTVSRVNGHINHNN 406
H cG luC la ........................................... QSPLF........................................................... FRN 356
C eG luC ip ....................................RKAQR........................................................................ R 352
H cG luC ip ....................................RKAQK.................................................... ....................R 355
D m GluClal SLDAASDLLDTDSNATFAMKPLVRHPGDPLALEKRLQCEV....................... 396
hG ly R al EDEAGEGRFNFSA. . . YGMGPACLQAKDGISVKGANNSNT....................... 390
rGABAAa l VKDPLIKKNNTYAPTATSYTPNLARGDPGLATI. AKSATI....................... 394
CeGLC4 ENDNFGESLQSLTFSPQEKKRLIRRRPKKNMEMQEGDFEAIEMVDRGPPR 484
mGABAAp2 LDVNKMDPHENILLSTLEIKNEMATSEAVMGLGDPRSTMLAYDASSIQYR 404
D iG luC la3A . DYSSGYQPLVSATTAMPPSRSWLCFRLFVR. . RYK____ERSKRIDWS 398
D iG luC la3B SDHLFNQDLRQSLRLDMNVYRRKWWTKFWLN. . TYLCSNVEVSKRVDLIS 406
C eG luC la3A GY................RP. . . LSASQGRSSFCCRIFVR..............RYKERSKRIDWS 395
H cG luCla3A GY................RP. . . LAGSQPRTSFCCRIFVR..............RHKERSKRIDWS 382
C eG luC la3B SD................RPPLRLDLSAYRSVKRLPIIKRISEILSTNIDISRRVDLMS 405
H cG luC la3B SE................RPALRLDLSNYRRRGWTPL. NRLLDMLGRNADLSRRVDLMS 412
AsGluClX NDQPLTQGAHPITRLDMSVYRKRKLLNMPGL. . AWFSSTSEVSKRVDLIS 357
OvGluClX
C e G lu C la l D V .. PTKVFNQEEKVRT. VPLNRRQMNSFLNLLETKTEWNDISKRVDLIS 435
C eG luC la2B DVWVPREVAEQEREVMT. VRMNRRQTN SVWKWIKTKTEWNDKSKRADLIS 450
C eG luC la4 DEAAE L11FDAKHKNRRFVWWTNFRNIRLIRWIRNRLNVDDNAKRADLIS 456
H cG luC la PDSRQENSHHFYAPIQQEVTLEDLPFSWWDKIWKIR.. YKERSRRIDLIS 404
C eG luC ip REKLEMVDAEVY QP PCTCHT FEARE. TFRDKVRRYFTKPDYLPAKIDFYA 401
H cG luC ip RAKMELVEREQYQPPCTCHLYQDYEPSFRDRLRRYFTKPDYLPAKIDYYA 405
D m GluClal ...................................... HMQAPKRPNCC KTWL. SKFPTRQCSRSKRIDVIS 429
h G ly R a l ...................................... TNPPPAPSKSPEEMR.KLF____ IQRAKKIDKIS 419
rGABAAa l ...................................... EPKEVKPETKPPEPK. KTF............NSVSKIDRLS 422
CeGLC4 SAGLMEEGWTFHDTT. DLVYIGQRKRVELVR. WCSVLSSRGRAERIDIIA 532
mGABAAp2 KAGLPRHSFGRNALERHVAQKKSRLRRRASQ.LKITIPDLTDVNAIDRWS 453
D iG luC la3A RLVFPIGYACFNVLYWAVYLI............................ 419
D iG luC la3B RFAFPTFFAFFLVLYYVNYVN............................ 427
C eG luC la3A RLVFPIGYACFNVLYWAVYLM............................ 416
H cGluCla3A RLV FPIGYACFNVL YWAVY LM............................ 403
C eG luC la3B RLTFPLTFFSFLIFYYVAYVKQSRD.................. 430
H cG luC la3B RITFPSLFTAFLVFYYSVYVKQSNLD............... 438
AsGluClX RFTFPSFFTCFLVFYYVTYVK............................ 378
OvGluClX
C e G lu C la l RALFPVLFFVFNILYWSRFGQQNVLF............... 461
C eG luC la2B RVMFPVLFLTFNISYWTHYGQYGVAIST.......... 478
C eG luC la4 RVLFPTLFVCFNFVYWTKYSQYHAPEAK.......... 484
H cG luC la RVMFPLCFIIFNIMYWWRYLIPYMAVQAQLE.. 435
C eG luC ip RFWPLAFLAFNVIYWVSCLIMSANASTPESLV 434
H cG luC ip RFCVPLGFLAFNAIYWTSCLVMVSRLV............. 432
D m GluClal RITFPLVFALFNLVYWSTYLFREEEDE............. 456
h G ly R a l RIGFPMAFLIFNMFYWIIYKIVRREDVHNQ.. . 449




Cysteine residues that form the disulphide bridges are highlighted in yellow (indicative of the LGICs) and 
green (indicative of the GluCls and glycine receptors) while the underlined regions indicate the TM regions. 




Hydropathy plots for the DiGluCla3 and DG1 subunits
DiGluCla3A
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The hydropathy plots were constructed using the GCG program “PeptideStructure”; this program uses the Kyte-Doolittle method for calculating hydrophilicity (Kyte & 
Doolittle, 1982). The numbered bar indicates the amino acid residue. The jagged line deviating from the horizontal black bar is an indication of the hydropathy of the 
amino acid sequence. Upward and downward deflections from the bar represent hydrophilic and hydrophobic residues respectively. The proposed hydrophobic TM 
regions are marked on the plot with numbered horizontal red bars.
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Appendix E
I). immitis codon frequency table
Amino acid Codon % Amino acid Codon %
Alanine GCG 15 Leucine CTA 9
Alanine GCA 42 Leucine CTT 17
Alanine GCT 32 Leucine CTC 9
Alanine GCC 11
Lysine AAG 27
Arginine CGG 13 Lysine AAA 73
Arginine CGA 16
Arginine CGT 20 Methionine ATG 100
Arginine CGC 5
Arginine AGG 19 Phenylalanine TTT 67
Arginine AGA 28 Phenylalanine TTC 33
Asparagine AAT 73 Proline CCG 20
Asparagine AAC 27 Proline CCA 44
Proline CCT 25
Aspartate GAT 80 Proline CCC 11
Aspartate GAC 20
Serine AGT 16
Cysteine TGT 53 Serine AGC 16
Cysteine TGC 47 Serine TCG 15
Serine TCA 29
Glutamate GAG 15 Serine TCT 12
Glutamate GAA 85 Serine TCC 11
Glutamine CAG 26 Threonine ACG 19
Glutamine CAA 74 Threonine ACA 36
Threonine ACT 25
Glycine GGG 10 Threonine ACC 19
Glycine GGA 36
Glycine GGT 33 Tryptophan TGG 100
Glycine GGC 21
Tyrosine TAT 71
Histidine CAT 74 Tyrosine TAC 29
Histidine CAC 26
Valine GTG 18
Isoleucine ATA 22 Valine GTA 24
Isoleucine ATT 54 Valine GTT 41
Isoleucine ATC 24 Valine GTC 18
Leucine TTG 30 Stop TGA 58
Leucine TTA 21 Stop TAG 9
Leucine CTG 13 Stop TAA 33
The codon frequency table was constructing using 15 D. immitis mRNA sequences and the GCG program 
“CodonFrequency”. The GenBank accession numbers of the nucleotide sequences used are: Af000668, 
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